{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "393085c4",
   "metadata": {},
   "outputs": [],
   "source": [
    "# retrieval of gene disease associations from DisGeNET via disgenet2r\n",
    "# vignette: https://www.disgenet.org/static/disgenet2r/disgenet2r.html"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9868257d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# install disgenet2r:\n",
    "# library(devtools)\n",
    "# install_bitbucket(\"ibi_group/disgenet2r\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "e41f215a",
   "metadata": {},
   "outputs": [],
   "source": [
    "library(xlsx)\n",
    "library(disgenet2r)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "be9eaa4b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# register with DisGeNET and enter credentials here:\n",
    "disgenet_api_key = get_disgenet_api_key(email = \"your@email.com\", password = \"your password\" )\n",
    "Sys.setenv(DISGENET_API_KEY= disgenet_api_key)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "f7b2da76",
   "metadata": {},
   "outputs": [],
   "source": [
    "setwd(\"..\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "bba21de5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<style>\n",
       ".list-inline {list-style: none; margin:0; padding: 0}\n",
       ".list-inline>li {display: inline-block}\n",
       ".list-inline>li:not(:last-child)::after {content: \"\\00b7\"; padding: 0 .5ex}\n",
       "</style>\n",
       "<ol class=list-inline><li>'APBB1'</li><li>'BAHD1'</li><li>'BCL11B'</li><li>'C1RL'</li><li>'CD84'</li><li>'CYB5A'</li><li>'FBXL15'</li><li>'GGCT'</li><li>'GPR132'</li><li>'LDLR'</li><li>'MST1R'</li><li>'OCIAD2'</li><li>'PTGER4'</li><li>'RBM38'</li><li>'SPAG16'</li><li>'SPI1'</li><li>'TRABD'</li><li>'TTLL7'</li><li>'ZNF233'</li><li>'ZNF468'</li></ol>\n"
      ],
      "text/latex": [
       "\\begin{enumerate*}\n",
       "\\item 'APBB1'\n",
       "\\item 'BAHD1'\n",
       "\\item 'BCL11B'\n",
       "\\item 'C1RL'\n",
       "\\item 'CD84'\n",
       "\\item 'CYB5A'\n",
       "\\item 'FBXL15'\n",
       "\\item 'GGCT'\n",
       "\\item 'GPR132'\n",
       "\\item 'LDLR'\n",
       "\\item 'MST1R'\n",
       "\\item 'OCIAD2'\n",
       "\\item 'PTGER4'\n",
       "\\item 'RBM38'\n",
       "\\item 'SPAG16'\n",
       "\\item 'SPI1'\n",
       "\\item 'TRABD'\n",
       "\\item 'TTLL7'\n",
       "\\item 'ZNF233'\n",
       "\\item 'ZNF468'\n",
       "\\end{enumerate*}\n"
      ],
      "text/markdown": [
       "1. 'APBB1'\n",
       "2. 'BAHD1'\n",
       "3. 'BCL11B'\n",
       "4. 'C1RL'\n",
       "5. 'CD84'\n",
       "6. 'CYB5A'\n",
       "7. 'FBXL15'\n",
       "8. 'GGCT'\n",
       "9. 'GPR132'\n",
       "10. 'LDLR'\n",
       "11. 'MST1R'\n",
       "12. 'OCIAD2'\n",
       "13. 'PTGER4'\n",
       "14. 'RBM38'\n",
       "15. 'SPAG16'\n",
       "16. 'SPI1'\n",
       "17. 'TRABD'\n",
       "18. 'TTLL7'\n",
       "19. 'ZNF233'\n",
       "20. 'ZNF468'\n",
       "\n",
       "\n"
      ],
      "text/plain": [
       " [1] \"APBB1\"  \"BAHD1\"  \"BCL11B\" \"C1RL\"   \"CD84\"   \"CYB5A\"  \"FBXL15\" \"GGCT\"  \n",
       " [9] \"GPR132\" \"LDLR\"   \"MST1R\"  \"OCIAD2\" \"PTGER4\" \"RBM38\"  \"SPAG16\" \"SPI1\"  \n",
       "[17] \"TRABD\"  \"TTLL7\"  \"ZNF233\" \"ZNF468\""
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<style>\n",
       ".list-inline {list-style: none; margin:0; padding: 0}\n",
       ".list-inline>li {display: inline-block}\n",
       ".list-inline>li:not(:last-child)::after {content: \"\\00b7\"; padding: 0 .5ex}\n",
       "</style>\n",
       "<ol class=list-inline><li>'AIM2'</li><li>'BCL11B'</li><li>'DDX60L'</li><li>'FES'</li><li>'GATA3'</li><li>'LRRC61'</li><li>'RGS1'</li><li>'SPAG16'</li><li>'SPEF2'</li><li>'TC2N'</li></ol>\n"
      ],
      "text/latex": [
       "\\begin{enumerate*}\n",
       "\\item 'AIM2'\n",
       "\\item 'BCL11B'\n",
       "\\item 'DDX60L'\n",
       "\\item 'FES'\n",
       "\\item 'GATA3'\n",
       "\\item 'LRRC61'\n",
       "\\item 'RGS1'\n",
       "\\item 'SPAG16'\n",
       "\\item 'SPEF2'\n",
       "\\item 'TC2N'\n",
       "\\end{enumerate*}\n"
      ],
      "text/markdown": [
       "1. 'AIM2'\n",
       "2. 'BCL11B'\n",
       "3. 'DDX60L'\n",
       "4. 'FES'\n",
       "5. 'GATA3'\n",
       "6. 'LRRC61'\n",
       "7. 'RGS1'\n",
       "8. 'SPAG16'\n",
       "9. 'SPEF2'\n",
       "10. 'TC2N'\n",
       "\n",
       "\n"
      ],
      "text/plain": [
       " [1] \"AIM2\"   \"BCL11B\" \"DDX60L\" \"FES\"    \"GATA3\"  \"LRRC61\" \"RGS1\"   \"SPAG16\"\n",
       " [9] \"SPEF2\"  \"TC2N\"  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<style>\n",
       ".list-inline {list-style: none; margin:0; padding: 0}\n",
       ".list-inline>li {display: inline-block}\n",
       ".list-inline>li:not(:last-child)::after {content: \"\\00b7\"; padding: 0 .5ex}\n",
       "</style>\n",
       "<ol class=list-inline><li>'APBA2'</li><li>'CD247'</li><li>'GGCT'</li><li>'KRT10'</li><li>'N6AMT2'</li><li>'PYCARD'</li><li>'SLA2'</li><li>'SLAMF6'</li><li>'TTLL7'</li><li>'ZNF620'</li></ol>\n"
      ],
      "text/latex": [
       "\\begin{enumerate*}\n",
       "\\item 'APBA2'\n",
       "\\item 'CD247'\n",
       "\\item 'GGCT'\n",
       "\\item 'KRT10'\n",
       "\\item 'N6AMT2'\n",
       "\\item 'PYCARD'\n",
       "\\item 'SLA2'\n",
       "\\item 'SLAMF6'\n",
       "\\item 'TTLL7'\n",
       "\\item 'ZNF620'\n",
       "\\end{enumerate*}\n"
      ],
      "text/markdown": [
       "1. 'APBA2'\n",
       "2. 'CD247'\n",
       "3. 'GGCT'\n",
       "4. 'KRT10'\n",
       "5. 'N6AMT2'\n",
       "6. 'PYCARD'\n",
       "7. 'SLA2'\n",
       "8. 'SLAMF6'\n",
       "9. 'TTLL7'\n",
       "10. 'ZNF620'\n",
       "\n",
       "\n"
      ],
      "text/plain": [
       " [1] \"APBA2\"  \"CD247\"  \"GGCT\"   \"KRT10\"  \"N6AMT2\" \"PYCARD\" \"SLA2\"   \"SLAMF6\"\n",
       " [9] \"TTLL7\"  \"ZNF620\""
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# load all target genes\n",
    "# separate SG1 genes into log2 impact ration >/<0 ??\n",
    "targetGeneFile = \"FiguresTables/SupplTable-S10-target-gene-candidates.xls\"\n",
    "genesSG1 = read.xlsx(file = targetGeneFile, header = T, sheetIndex = 1)$gene\n",
    "genesSG3 = read.xlsx(file = targetGeneFile, header = T, sheetIndex = 2)$gene\n",
    "genesSG2 = read.xlsx(file = targetGeneFile, header = T, sheetIndex = 3)$gene\n",
    "genesSG1\n",
    "genesSG2\n",
    "genesSG3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "ba164c28",
   "metadata": {},
   "outputs": [],
   "source": [
    "minScore = 0"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "9b548577",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "1142"
      ],
      "text/latex": [
       "1142"
      ],
      "text/markdown": [
       "1142"
      ],
      "text/plain": [
       "[1] 1142"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "3 SG1 melanoma interaction:\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3 genes: LDLR MST1R GGCT"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A data.frame: 3 Ã— 20</caption>\n",
       "<thead>\n",
       "\t<tr><th></th><th scope=col>gene_pli</th><th scope=col>year_initial</th><th scope=col>geneid</th><th scope=col>disease_class_name</th><th scope=col>disease_type</th><th scope=col>gene_dsi</th><th scope=col>uniprotid</th><th scope=col>disease_class</th><th scope=col>protein_class_name</th><th scope=col>disease_name</th><th scope=col>gene_dpi</th><th scope=col>diseaseid</th><th scope=col>el</th><th scope=col>ei</th><th scope=col>score</th><th scope=col>disease_semantic_type</th><th scope=col>gene_symbol</th><th scope=col>source</th><th scope=col>protein_class</th><th scope=col>year_final</th></tr>\n",
       "\t<tr><th></th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><th scope=row>628</th><td>9.8410e-24</td><td>2018</td><td> 3949</td><td>   Neoplasms</td><td>disease</td><td>0.449</td><td>P01130</td><td>C04</td><td>      </td><td>melanoma</td><td>0.885</td><td>C0025202</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>LDLR </td><td>ALL</td><td>            </td><td>2018</td></tr>\n",
       "\t<tr><th scope=row>768</th><td>7.8684e-37</td><td>2011</td><td> 4486</td><td>   Neoplasms</td><td>disease</td><td>0.542</td><td>Q04912</td><td>C04</td><td>Kinase</td><td>melanoma</td><td>0.808</td><td>C0025202</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>MST1R</td><td>ALL</td><td>DTO_03300101</td><td>2011</td></tr>\n",
       "\t<tr><th scope=row>1060</th><td>1.4300e-04</td><td>2017</td><td>79017</td><td>   Neoplasms</td><td>disease</td><td>0.552</td><td>O75223</td><td>C04</td><td>      </td><td>melanoma</td><td>0.808</td><td>C0025202</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT </td><td>ALL</td><td>            </td><td>2017</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A data.frame: 3 Ã— 20\n",
       "\\begin{tabular}{r|llllllllllllllllllll}\n",
       "  & gene\\_pli & year\\_initial & geneid & disease\\_class\\_name & disease\\_type & gene\\_dsi & uniprotid & disease\\_class & protein\\_class\\_name & disease\\_name & gene\\_dpi & diseaseid & el & ei & score & disease\\_semantic\\_type & gene\\_symbol & source & protein\\_class & year\\_final\\\\\n",
       "  & <dbl> & <int> & <int> & <chr> & <chr> & <dbl> & <chr> & <chr> & <chr> & <chr> & <dbl> & <chr> & <chr> & <dbl> & <dbl> & <chr> & <chr> & <chr> & <chr> & <int>\\\\\n",
       "\\hline\n",
       "\t628 & 9.8410e-24 & 2018 &  3949 &    Neoplasms & disease & 0.449 & P01130 & C04 &        & melanoma & 0.885 & C0025202 &  & 1 & 0.01 & Neoplastic Process & LDLR  & ALL &              & 2018\\\\\n",
       "\t768 & 7.8684e-37 & 2011 &  4486 &    Neoplasms & disease & 0.542 & Q04912 & C04 & Kinase & melanoma & 0.808 & C0025202 &  & 1 & 0.01 & Neoplastic Process & MST1R & ALL & DTO\\_03300101 & 2011\\\\\n",
       "\t1060 & 1.4300e-04 & 2017 & 79017 &    Neoplasms & disease & 0.552 & O75223 & C04 &        & melanoma & 0.808 & C0025202 &  & 1 & 0.01 & Neoplastic Process & GGCT  & ALL &              & 2017\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A data.frame: 3 Ã— 20\n",
       "\n",
       "| <!--/--> | gene_pli &lt;dbl&gt; | year_initial &lt;int&gt; | geneid &lt;int&gt; | disease_class_name &lt;chr&gt; | disease_type &lt;chr&gt; | gene_dsi &lt;dbl&gt; | uniprotid &lt;chr&gt; | disease_class &lt;chr&gt; | protein_class_name &lt;chr&gt; | disease_name &lt;chr&gt; | gene_dpi &lt;dbl&gt; | diseaseid &lt;chr&gt; | el &lt;chr&gt; | ei &lt;dbl&gt; | score &lt;dbl&gt; | disease_semantic_type &lt;chr&gt; | gene_symbol &lt;chr&gt; | source &lt;chr&gt; | protein_class &lt;chr&gt; | year_final &lt;int&gt; |\n",
       "|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n",
       "| 628 | 9.8410e-24 | 2018 |  3949 |    Neoplasms | disease | 0.449 | P01130 | C04 | <!----> | melanoma | 0.885 | C0025202 | <!----> | 1 | 0.01 | Neoplastic Process | LDLR  | ALL | <!----> | 2018 |\n",
       "| 768 | 7.8684e-37 | 2011 |  4486 |    Neoplasms | disease | 0.542 | Q04912 | C04 | Kinase | melanoma | 0.808 | C0025202 | <!----> | 1 | 0.01 | Neoplastic Process | MST1R | ALL | DTO_03300101 | 2011 |\n",
       "| 1060 | 1.4300e-04 | 2017 | 79017 |    Neoplasms | disease | 0.552 | O75223 | C04 | <!----> | melanoma | 0.808 | C0025202 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT  | ALL | <!----> | 2017 |\n",
       "\n"
      ],
      "text/plain": [
       "     gene_pli   year_initial geneid disease_class_name disease_type gene_dsi\n",
       "628  9.8410e-24 2018          3949     Neoplasms       disease      0.449   \n",
       "768  7.8684e-37 2011          4486     Neoplasms       disease      0.542   \n",
       "1060 1.4300e-04 2017         79017     Neoplasms       disease      0.552   \n",
       "     uniprotid disease_class protein_class_name disease_name gene_dpi diseaseid\n",
       "628  P01130    C04                              melanoma     0.885    C0025202 \n",
       "768  Q04912    C04           Kinase             melanoma     0.808    C0025202 \n",
       "1060 O75223    C04                              melanoma     0.808    C0025202 \n",
       "     el ei score disease_semantic_type gene_symbol source protein_class\n",
       "628     1  0.01  Neoplastic Process    LDLR        ALL                 \n",
       "768     1  0.01  Neoplastic Process    MST1R       ALL    DTO_03300101 \n",
       "1060    1  0.01  Neoplastic Process    GGCT        ALL                 \n",
       "     year_final\n",
       "628  2018      \n",
       "768  2011      \n",
       "1060 2017      "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "415 SG1 neoplasm interaction:\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "17 genes: SPI1 BCL11B MST1R PTGER4 CYB5A LDLR RBM38 GGCT OCIAD2 APBB1 CD84 GPR132 BAHD1 C1RL SPAG16 TRABD ZNF233"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A data.frame: 415 Ã— 20</caption>\n",
       "<thead>\n",
       "\t<tr><th></th><th scope=col>gene_pli</th><th scope=col>year_initial</th><th scope=col>geneid</th><th scope=col>disease_class_name</th><th scope=col>disease_type</th><th scope=col>gene_dsi</th><th scope=col>uniprotid</th><th scope=col>disease_class</th><th scope=col>protein_class_name</th><th scope=col>disease_name</th><th scope=col>gene_dpi</th><th scope=col>diseaseid</th><th scope=col>el</th><th scope=col>ei</th><th scope=col>score</th><th scope=col>disease_semantic_type</th><th scope=col>gene_symbol</th><th scope=col>source</th><th scope=col>protein_class</th><th scope=col>year_final</th></tr>\n",
       "\t<tr><th></th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><th scope=row>8</th><td>9.8206e-01</td><td>1999</td><td> 6688</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.631</td><td>P17947</td><td>C04        </td><td>Transcription factor      </td><td>Leukemia, Myelocytic, Acute                     </td><td>0.654</td><td>C0023467</td><td></td><td>1.000</td><td>0.60</td><td>Neoplastic Process </td><td>SPI1  </td><td>ALL</td><td>DTO_05007542</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>19</th><td>9.8881e-01</td><td>2003</td><td>64919</td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             </td><td>disease  </td><td>0.568</td><td>Q9C0K0</td><td>C04;C20;C15</td><td>Transcription factor      </td><td>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma</td><td>0.731</td><td>C1961099</td><td></td><td>0.938</td><td>0.40</td><td>Neoplastic Process </td><td>BCL11B</td><td>ALL</td><td>DTO_05007542</td><td>2018</td></tr>\n",
       "\t<tr><th scope=row>26</th><td>9.8881e-01</td><td>2003</td><td>64919</td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             </td><td>group    </td><td>0.568</td><td>Q9C0K0</td><td>C04;C20;C15</td><td>Transcription factor      </td><td>Lymphoma                                        </td><td>0.731</td><td>C0024299</td><td></td><td>1.000</td><td>0.33</td><td>Neoplastic Process </td><td>BCL11B</td><td>ALL</td><td>DTO_05007542</td><td>2007</td></tr>\n",
       "\t<tr><th scope=row>29</th><td>9.8206e-01</td><td>2003</td><td> 6688</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.631</td><td>P17947</td><td>C04        </td><td>Transcription factor      </td><td>Myeloid Leukemia                                </td><td>0.654</td><td>C0023470</td><td></td><td>1.000</td><td>0.32</td><td>Neoplastic Process </td><td>SPI1  </td><td>ALL</td><td>DTO_05007542</td><td>2011</td></tr>\n",
       "\t<tr><th scope=row>30</th><td>9.8206e-01</td><td>2012</td><td> 6688</td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             </td><td>disease  </td><td>0.631</td><td>P17947</td><td>C04;C20;C15</td><td>Transcription factor      </td><td>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma</td><td>0.654</td><td>C1961099</td><td></td><td>1.000</td><td>0.32</td><td>Neoplastic Process </td><td>SPI1  </td><td>ALL</td><td>DTO_05007542</td><td>2017</td></tr>\n",
       "\t<tr><th scope=row>32</th><td>7.8684e-37</td><td>2016</td><td> 4486</td><td>   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases                           </td><td>disease  </td><td>0.542</td><td>Q04912</td><td>C04;C07;C09</td><td>Kinase                    </td><td>Nasopharyngeal carcinoma                        </td><td>0.808</td><td>C2931822</td><td></td><td>1.000</td><td>0.31</td><td>Neoplastic Process </td><td>MST1R </td><td>ALL</td><td>DTO_03300101</td><td>2016</td></tr>\n",
       "\t<tr><th scope=row>51</th><td>7.8684e-37</td><td>2013</td><td> 4486</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.542</td><td>Q04912</td><td>C04        </td><td>Kinase                    </td><td>Osteosarcoma                                    </td><td>0.808</td><td>C0029463</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process </td><td>MST1R </td><td>ALL</td><td>DTO_03300101</td><td>2013</td></tr>\n",
       "\t<tr><th scope=row>58</th><td>9.7550e-01</td><td>2011</td><td> 5734</td><td>   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases</td><td>disease  </td><td>0.558</td><td>P35408</td><td>C04;C13;C19</td><td>G-protein coupled receptor</td><td>Corpus Luteum Cyst                              </td><td>0.731</td><td>C0010093</td><td></td><td>1.000</td><td>0.30</td><td>Disease or Syndrome</td><td>PTGER4</td><td>ALL</td><td>DTO_02300001</td><td>2011</td></tr>\n",
       "\t<tr><th scope=row>59</th><td>9.7550e-01</td><td>2008</td><td> 5734</td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             </td><td>group    </td><td>0.558</td><td>P35408</td><td>C04;C20;C15</td><td>G-protein coupled receptor</td><td>Lymphoma                                        </td><td>0.731</td><td>C0024299</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process </td><td>PTGER4</td><td>ALL</td><td>DTO_02300001</td><td>2008</td></tr>\n",
       "\t<tr><th scope=row>60</th><td>9.7550e-01</td><td>2011</td><td> 5734</td><td>   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases</td><td>disease  </td><td>0.558</td><td>P35408</td><td>C04;C13;C19</td><td>G-protein coupled receptor</td><td>Ovarian Cysts                                   </td><td>0.731</td><td>C0029927</td><td></td><td>1.000</td><td>0.30</td><td>Disease or Syndrome</td><td>PTGER4</td><td>ALL</td><td>DTO_02300001</td><td>2011</td></tr>\n",
       "\t<tr><th scope=row>66</th><td>9.8206e-01</td><td>2007</td><td> 6688</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.631</td><td>P17947</td><td>C04        </td><td>Transcription factor      </td><td>Leukemia, Monocytic, Chronic                    </td><td>0.654</td><td>C0023466</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process </td><td>SPI1  </td><td>ALL</td><td>DTO_05007542</td><td>2007</td></tr>\n",
       "\t<tr><th scope=row>67</th><td>9.8206e-01</td><td>2015</td><td> 6688</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.631</td><td>P17947</td><td>C04        </td><td>Transcription factor      </td><td>Acute Myeloid Leukemia, M1                      </td><td>0.654</td><td>C0026998</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process </td><td>SPI1  </td><td>ALL</td><td>DTO_05007542</td><td>2015</td></tr>\n",
       "\t<tr><th scope=row>68</th><td>9.8206e-01</td><td>2015</td><td> 6688</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.631</td><td>P17947</td><td>C04        </td><td>Transcription factor      </td><td>Acute Myeloid Leukemia (AML-M2)                 </td><td>0.654</td><td>C1879321</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process </td><td>SPI1  </td><td>ALL</td><td>DTO_05007542</td><td>2015</td></tr>\n",
       "\t<tr><th scope=row>73</th><td>9.8881e-01</td><td>  NA</td><td>64919</td><td>   Digestive System Diseases;    Neoplasms                                                           </td><td>disease  </td><td>0.568</td><td>Q9C0K0</td><td>C06;C04    </td><td>Transcription factor      </td><td>Colorectal Carcinoma                            </td><td>0.731</td><td>C0009402</td><td></td><td>   NA</td><td>0.30</td><td>Neoplastic Process </td><td>BCL11B</td><td>ALL</td><td>DTO_05007542</td><td>  NA</td></tr>\n",
       "\t<tr><th scope=row>170</th><td>1.5821e-03</td><td>  NA</td><td> 1528</td><td>   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases</td><td>disease  </td><td>0.601</td><td>P00167</td><td>C04;C13;C19</td><td>Enzyme                    </td><td>Enlarged polycystic ovaries                     </td><td>0.654</td><td>C4024641</td><td></td><td>   NA</td><td>0.10</td><td>Disease or Syndrome</td><td>CYB5A </td><td>ALL</td><td>DTO_05007624</td><td>  NA</td></tr>\n",
       "\t<tr><th scope=row>179</th><td>9.8410e-24</td><td>2012</td><td> 3949</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.449</td><td>P01130</td><td>C04        </td><td>                          </td><td>Squamous cell carcinoma                         </td><td>0.885</td><td>C0007137</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>LDLR  </td><td>ALL</td><td>            </td><td>2012</td></tr>\n",
       "\t<tr><th scope=row>184</th><td>9.8410e-24</td><td>1988</td><td> 3949</td><td>   Digestive System Diseases;    Neoplasms                                                           </td><td>group    </td><td>0.449</td><td>P01130</td><td>C06;C04    </td><td>                          </td><td>Liver neoplasms                                 </td><td>0.885</td><td>C0023903</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>LDLR  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>186</th><td>9.8410e-24</td><td>1987</td><td> 3949</td><td>   Neoplasms                                                                                         </td><td>group    </td><td>0.449</td><td>P01130</td><td>C04        </td><td>                          </td><td>Neoplasms                                       </td><td>0.885</td><td>C0027651</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>LDLR  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>204</th><td>9.8410e-24</td><td>1999</td><td> 3949</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.449</td><td>P01130</td><td>C04        </td><td>                          </td><td>Atypical Ductal Breast Hyperplasia              </td><td>0.885</td><td>C1332347</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>LDLR  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>212</th><td>9.8410e-24</td><td>1988</td><td> 3949</td><td>   Digestive System Diseases;    Neoplasms                                                           </td><td>disease  </td><td>0.449</td><td>P01130</td><td>C06;C04    </td><td>                          </td><td>Liver carcinoma                                 </td><td>0.885</td><td>C2239176</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>LDLR  </td><td>ALL</td><td>            </td><td>2018</td></tr>\n",
       "\t<tr><th scope=row>223</th><td>7.8684e-37</td><td>1996</td><td> 4486</td><td>   Neoplasms                                                                                         </td><td>group    </td><td>0.542</td><td>Q04912</td><td>C04        </td><td>Kinase                    </td><td>Malignant Neoplasms                             </td><td>0.808</td><td>C0006826</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>MST1R </td><td>ALL</td><td>DTO_03300101</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>224</th><td>7.8684e-37</td><td>  NA</td><td> 4486</td><td>   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases                           </td><td>group    </td><td>0.542</td><td>Q04912</td><td>C04;C07;C09</td><td>Kinase                    </td><td>Nasopharyngeal Neoplasms                        </td><td>0.808</td><td>C0027439</td><td></td><td>   NA</td><td>0.10</td><td>Neoplastic Process </td><td>MST1R </td><td>ALL</td><td>DTO_03300101</td><td>  NA</td></tr>\n",
       "\t<tr><th scope=row>225</th><td>7.8684e-37</td><td>2000</td><td> 4486</td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms                                         </td><td>phenotype</td><td>0.542</td><td>Q04912</td><td>C23;C04    </td><td>Kinase                    </td><td>Neoplasm Metastasis                             </td><td>0.808</td><td>C0027627</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>MST1R </td><td>ALL</td><td>DTO_03300101</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>226</th><td>7.8684e-37</td><td>1998</td><td> 4486</td><td>   Neoplasms                                                                                         </td><td>group    </td><td>0.542</td><td>Q04912</td><td>C04        </td><td>Kinase                    </td><td>Neoplasms                                       </td><td>0.808</td><td>C0027651</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>MST1R </td><td>ALL</td><td>DTO_03300101</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>228</th><td>7.8684e-37</td><td>2003</td><td> 4486</td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms                                         </td><td>phenotype</td><td>0.542</td><td>Q04912</td><td>C23;C04    </td><td>Kinase                    </td><td>Carcinogenesis                                  </td><td>0.808</td><td>C0596263</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>MST1R </td><td>ALL</td><td>DTO_03300101</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>230</th><td>7.8684e-37</td><td>1996</td><td> 4486</td><td>   Neoplasms                                                                                         </td><td>group    </td><td>0.542</td><td>Q04912</td><td>C04        </td><td>Kinase                    </td><td>Primary malignant neoplasm                      </td><td>0.808</td><td>C1306459</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>MST1R </td><td>ALL</td><td>DTO_03300101</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>233</th><td>9.8206e-01</td><td>1990</td><td> 6688</td><td>   Neoplasms;    Hemic and Lymphatic Diseases                                                        </td><td>disease  </td><td>0.631</td><td>P17947</td><td>C04;C15    </td><td>Transcription factor      </td><td>Acute Erythroblastic Leukemia                   </td><td>0.654</td><td>C0023440</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>SPI1  </td><td>ALL</td><td>DTO_05007542</td><td>2017</td></tr>\n",
       "\t<tr><th scope=row>244</th><td>7.1583e-01</td><td>2012</td><td>55544</td><td>   Neoplasms                                                                                         </td><td>group    </td><td>0.670</td><td>Q9H0Z9</td><td>C04        </td><td>                          </td><td>Neoplasms                                       </td><td>0.500</td><td>C0027651</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process </td><td>RBM38 </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>263</th><td>9.8881e-01</td><td>2000</td><td>64919</td><td>   Neoplasms                                                                                         </td><td>group    </td><td>0.568</td><td>Q9C0K0</td><td>C04        </td><td>Transcription factor      </td><td>Neoplasms                                       </td><td>0.731</td><td>C0027651</td><td></td><td>0.923</td><td>0.10</td><td>Neoplastic Process </td><td>BCL11B</td><td>ALL</td><td>DTO_05007542</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>294</th><td>1.4300e-04</td><td>2003</td><td>79017</td><td>   Neoplasms                                                                                         </td><td>group    </td><td>0.552</td><td>O75223</td><td>C04        </td><td>                          </td><td>Malignant Neoplasms                             </td><td>0.808</td><td>C0006826</td><td></td><td>0.929</td><td>0.10</td><td>Neoplastic Process </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2020</td></tr>\n",
       "\t<tr><th scope=row>â‹®</th><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td></tr>\n",
       "\t<tr><th scope=row>1087</th><td>1.4300e-04</td><td>2017</td><td> 79017</td><td>   Digestive System Diseases;    Neoplasms                              </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C06;C04    </td><td>                  </td><td>Squamous cell carcinoma of esophagus        </td><td>0.808</td><td>C0279626</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>2017</td></tr>\n",
       "\t<tr><th scope=row>1088</th><td>1.4300e-04</td><td>2019</td><td> 79017</td><td>   Neoplasms                                                            </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>                  </td><td>Childhood Glioblastoma                      </td><td>0.808</td><td>C0280474</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>1090</th><td>1.4300e-04</td><td>2015</td><td> 79017</td><td>   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases</td><td>disease  </td><td>0.552</td><td>O75223</td><td>C06;C04;C19</td><td>                  </td><td>Malignant neoplasm of pancreas              </td><td>0.808</td><td>C0346647</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>2015</td></tr>\n",
       "\t<tr><th scope=row>1091</th><td>1.4300e-04</td><td>2019</td><td> 79017</td><td>   Digestive System Diseases;    Neoplasms                              </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C06;C04    </td><td>                  </td><td>Early gastric cancer                        </td><td>0.808</td><td>C0349530</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>1094</th><td>1.4300e-04</td><td>2019</td><td> 79017</td><td>   Neoplasms;    Endocrine System Diseases                              </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04;C19    </td><td>                  </td><td>Thyroid carcinoma                           </td><td>0.808</td><td>C0549473</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>1095</th><td>1.4300e-04</td><td>2010</td><td> 79017</td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms            </td><td>phenotype</td><td>0.552</td><td>O75223</td><td>C23;C04    </td><td>                  </td><td>Carcinogenesis                              </td><td>0.808</td><td>C0596263</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>2010</td></tr>\n",
       "\t<tr><th scope=row>1096</th><td>1.4300e-04</td><td>1993</td><td> 79017</td><td>   Digestive System Diseases;    Neoplasms                              </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C06;C04    </td><td>                  </td><td>Villous adenoma of rectum                   </td><td>0.808</td><td>C0730199</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>1993</td></tr>\n",
       "\t<tr><th scope=row>1097</th><td>1.4300e-04</td><td>2005</td><td> 79017</td><td>   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04;C12;C19</td><td>                  </td><td>Malignant Testicular Germ Cell Tumor        </td><td>0.808</td><td>C0855197</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>2005</td></tr>\n",
       "\t<tr><th scope=row>1098</th><td>1.4300e-04</td><td>2007</td><td> 79017</td><td>   Neoplasms                                                            </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>                  </td><td>Squamous cell carcinoma of the head and neck</td><td>0.808</td><td>C1168401</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>2007</td></tr>\n",
       "\t<tr><th scope=row>1100</th><td>1.4300e-04</td><td>2010</td><td> 79017</td><td>   Neoplasms;    Skin and Connective Tissue Diseases                    </td><td>group    </td><td>0.552</td><td>O75223</td><td>C04;C17    </td><td>                  </td><td>Mammary Neoplasms                           </td><td>0.808</td><td>C1458155</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>2010</td></tr>\n",
       "\t<tr><th scope=row>1102</th><td>1.4300e-04</td><td>2019</td><td> 79017</td><td>   Neoplasms                                                            </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>                  </td><td>Glioblastoma Multiforme                     </td><td>0.808</td><td>C1621958</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>1113</th><td>1.4037e-34</td><td>2011</td><td> 79582</td><td>   Neoplasms                                                            </td><td>group    </td><td>0.760</td><td>Q8N0X2</td><td>C04        </td><td>Cellular structure</td><td>Neoplasms                                   </td><td>0.385</td><td>C0027651</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>SPAG16</td><td>ALL</td><td>DTO_05007530</td><td>2011</td></tr>\n",
       "\t<tr><th scope=row>1118</th><td>1.4037e-34</td><td>2013</td><td> 79582</td><td>   Neoplasms                                                            </td><td>disease  </td><td>0.760</td><td>Q8N0X2</td><td>C04        </td><td>Cellular structure</td><td>High-Risk Neuroblastoma                     </td><td>0.385</td><td>C4725671</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>SPAG16</td><td>ALL</td><td>DTO_05007530</td><td>2013</td></tr>\n",
       "\t<tr><th scope=row>1120</th><td>2.2862e-02</td><td>2018</td><td> 80305</td><td>   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases</td><td>disease  </td><td>0.839</td><td>Q9H4I3</td><td>C06;C04;C19</td><td>                  </td><td>insulinoma                                  </td><td>0.308</td><td>C0021670</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>TRABD </td><td>ALL</td><td>            </td><td>2018</td></tr>\n",
       "\t<tr><th scope=row>1121</th><td>2.2862e-02</td><td>1991</td><td> 80305</td><td>   Neoplasms                                                            </td><td>disease  </td><td>0.839</td><td>Q9H4I3</td><td>C04        </td><td>                  </td><td>leukemia                                    </td><td>0.308</td><td>C0023418</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>TRABD </td><td>ALL</td><td>            </td><td>1991</td></tr>\n",
       "\t<tr><th scope=row>1122</th><td>2.2862e-02</td><td>1993</td><td> 80305</td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases</td><td>disease  </td><td>0.839</td><td>Q9H4I3</td><td>C04;C20;C15</td><td>                  </td><td>Acute lymphocytic leukemia                  </td><td>0.308</td><td>C0023449</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>TRABD </td><td>ALL</td><td>            </td><td>1993</td></tr>\n",
       "\t<tr><th scope=row>1123</th><td>2.2862e-02</td><td>2014</td><td> 80305</td><td>   Neoplasms                                                            </td><td>group    </td><td>0.839</td><td>Q9H4I3</td><td>C04        </td><td>                  </td><td>Neoplasms                                   </td><td>0.308</td><td>C0027651</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>TRABD </td><td>ALL</td><td>            </td><td>2014</td></tr>\n",
       "\t<tr><th scope=row>1127</th><td>3.5288e-05</td><td>2014</td><td>132299</td><td>   Neoplasms                                                            </td><td>group    </td><td>0.821</td><td>Q56VL3</td><td>C04        </td><td>Immune response   </td><td>Malignant Neoplasms                         </td><td>0.346</td><td>C0006826</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>OCIAD2</td><td>ALL</td><td>DTO_05007608</td><td>2014</td></tr>\n",
       "\t<tr><th scope=row>1128</th><td>3.5288e-05</td><td>2007</td><td>132299</td><td>   Neoplasms                                                            </td><td>disease  </td><td>0.821</td><td>Q56VL3</td><td>C04        </td><td>Immune response   </td><td>Bronchioloalveolar Adenocarcinoma           </td><td>0.346</td><td>C0007120</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>OCIAD2</td><td>ALL</td><td>DTO_05007608</td><td>2007</td></tr>\n",
       "\t<tr><th scope=row>1129</th><td>3.5288e-05</td><td>2018</td><td>132299</td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms            </td><td>phenotype</td><td>0.821</td><td>Q56VL3</td><td>C23;C04    </td><td>Immune response   </td><td>Neoplasm Metastasis                         </td><td>0.346</td><td>C0027627</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>OCIAD2</td><td>ALL</td><td>DTO_05007608</td><td>2018</td></tr>\n",
       "\t<tr><th scope=row>1131</th><td>3.5288e-05</td><td>2018</td><td>132299</td><td>   Neoplasms                                                            </td><td>disease  </td><td>0.821</td><td>Q56VL3</td><td>C04        </td><td>Immune response   </td><td>Adenocarcinoma of lung (disorder)           </td><td>0.346</td><td>C0152013</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>OCIAD2</td><td>ALL</td><td>DTO_05007608</td><td>2018</td></tr>\n",
       "\t<tr><th scope=row>1132</th><td>3.5288e-05</td><td>2018</td><td>132299</td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms            </td><td>phenotype</td><td>0.821</td><td>Q56VL3</td><td>C23;C04    </td><td>Immune response   </td><td>Adenocarcinoma in Situ                      </td><td>0.346</td><td>C0334276</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>OCIAD2</td><td>ALL</td><td>DTO_05007608</td><td>2018</td></tr>\n",
       "\t<tr><th scope=row>1134</th><td>3.5288e-05</td><td>2007</td><td>132299</td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms            </td><td>disease  </td><td>0.821</td><td>Q56VL3</td><td>C23;C04    </td><td>Immune response   </td><td>Secondary malignant neoplasm of lymph node  </td><td>0.346</td><td>C0686619</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>OCIAD2</td><td>ALL</td><td>DTO_05007608</td><td>2007</td></tr>\n",
       "\t<tr><th scope=row>1135</th><td>3.5288e-05</td><td>2014</td><td>132299</td><td>   Neoplasms                                                            </td><td>group    </td><td>0.821</td><td>Q56VL3</td><td>C04        </td><td>Immune response   </td><td>Primary malignant neoplasm                  </td><td>0.346</td><td>C1306459</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>OCIAD2</td><td>ALL</td><td>DTO_05007608</td><td>2014</td></tr>\n",
       "\t<tr><th scope=row>1136</th><td>3.5288e-05</td><td>2007</td><td>132299</td><td>   Neoplasms                                                            </td><td>phenotype</td><td>0.821</td><td>Q56VL3</td><td>C04        </td><td>Immune response   </td><td>Invasive Carcinoma                          </td><td>0.346</td><td>C1334274</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>OCIAD2</td><td>ALL</td><td>DTO_05007608</td><td>2007</td></tr>\n",
       "\t<tr><th scope=row>1137</th><td>3.5288e-05</td><td>2017</td><td>132299</td><td>   Digestive System Diseases;    Neoplasms                              </td><td>disease  </td><td>0.821</td><td>Q56VL3</td><td>C06;C04    </td><td>Immune response   </td><td>Liver carcinoma                             </td><td>0.346</td><td>C2239176</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>OCIAD2</td><td>ALL</td><td>DTO_05007608</td><td>2017</td></tr>\n",
       "\t<tr><th scope=row>1138</th><td>3.5288e-05</td><td>2018</td><td>132299</td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms            </td><td>group    </td><td>0.821</td><td>Q56VL3</td><td>C23;C04    </td><td>Immune response   </td><td>Secondary Neoplasm                          </td><td>0.346</td><td>C2939419</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>OCIAD2</td><td>ALL</td><td>DTO_05007608</td><td>2018</td></tr>\n",
       "\t<tr><th scope=row>1139</th><td>1.8665e-04</td><td>2018</td><td>353355</td><td>   Neoplasms                                                            </td><td>group    </td><td>1.000</td><td>A6NK53</td><td>C04        </td><td>                  </td><td>Neoplasms                                   </td><td>0.077</td><td>C0027651</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>ZNF233</td><td>ALL</td><td>            </td><td>2018</td></tr>\n",
       "\t<tr><th scope=row>1141</th><td>1.8665e-04</td><td>2018</td><td>353355</td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms            </td><td>phenotype</td><td>1.000</td><td>A6NK53</td><td>C23;C04    </td><td>                  </td><td>Carcinogenesis                              </td><td>0.077</td><td>C0596263</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>ZNF233</td><td>ALL</td><td>            </td><td>2018</td></tr>\n",
       "\t<tr><th scope=row>1142</th><td>1.8665e-04</td><td>2018</td><td>353355</td><td>   Digestive System Diseases;    Neoplasms                              </td><td>disease  </td><td>1.000</td><td>A6NK53</td><td>C06;C04    </td><td>                  </td><td>Liver carcinoma                             </td><td>0.077</td><td>C2239176</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process</td><td>ZNF233</td><td>ALL</td><td>            </td><td>2018</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A data.frame: 415 Ã— 20\n",
       "\\begin{tabular}{r|llllllllllllllllllll}\n",
       "  & gene\\_pli & year\\_initial & geneid & disease\\_class\\_name & disease\\_type & gene\\_dsi & uniprotid & disease\\_class & protein\\_class\\_name & disease\\_name & gene\\_dpi & diseaseid & el & ei & score & disease\\_semantic\\_type & gene\\_symbol & source & protein\\_class & year\\_final\\\\\n",
       "  & <dbl> & <int> & <int> & <chr> & <chr> & <dbl> & <chr> & <chr> & <chr> & <chr> & <dbl> & <chr> & <chr> & <dbl> & <dbl> & <chr> & <chr> & <chr> & <chr> & <int>\\\\\n",
       "\\hline\n",
       "\t8 & 9.8206e-01 & 1999 &  6688 &    Neoplasms                                                                                          & disease   & 0.631 & P17947 & C04         & Transcription factor       & Leukemia, Myelocytic, Acute                      & 0.654 & C0023467 &  & 1.000 & 0.60 & Neoplastic Process  & SPI1   & ALL & DTO\\_05007542 & 2019\\\\\n",
       "\t19 & 9.8881e-01 & 2003 & 64919 &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              & disease   & 0.568 & Q9C0K0 & C04;C20;C15 & Transcription factor       & Precursor T-Cell Lymphoblastic Leukemia-Lymphoma & 0.731 & C1961099 &  & 0.938 & 0.40 & Neoplastic Process  & BCL11B & ALL & DTO\\_05007542 & 2018\\\\\n",
       "\t26 & 9.8881e-01 & 2003 & 64919 &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              & group     & 0.568 & Q9C0K0 & C04;C20;C15 & Transcription factor       & Lymphoma                                         & 0.731 & C0024299 &  & 1.000 & 0.33 & Neoplastic Process  & BCL11B & ALL & DTO\\_05007542 & 2007\\\\\n",
       "\t29 & 9.8206e-01 & 2003 &  6688 &    Neoplasms                                                                                          & disease   & 0.631 & P17947 & C04         & Transcription factor       & Myeloid Leukemia                                 & 0.654 & C0023470 &  & 1.000 & 0.32 & Neoplastic Process  & SPI1   & ALL & DTO\\_05007542 & 2011\\\\\n",
       "\t30 & 9.8206e-01 & 2012 &  6688 &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              & disease   & 0.631 & P17947 & C04;C20;C15 & Transcription factor       & Precursor T-Cell Lymphoblastic Leukemia-Lymphoma & 0.654 & C1961099 &  & 1.000 & 0.32 & Neoplastic Process  & SPI1   & ALL & DTO\\_05007542 & 2017\\\\\n",
       "\t32 & 7.8684e-37 & 2016 &  4486 &    Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases                            & disease   & 0.542 & Q04912 & C04;C07;C09 & Kinase                     & Nasopharyngeal carcinoma                         & 0.808 & C2931822 &  & 1.000 & 0.31 & Neoplastic Process  & MST1R  & ALL & DTO\\_03300101 & 2016\\\\\n",
       "\t51 & 7.8684e-37 & 2013 &  4486 &    Neoplasms                                                                                          & disease   & 0.542 & Q04912 & C04         & Kinase                     & Osteosarcoma                                     & 0.808 & C0029463 &  & 1.000 & 0.30 & Neoplastic Process  & MST1R  & ALL & DTO\\_03300101 & 2013\\\\\n",
       "\t58 & 9.7550e-01 & 2011 &  5734 &    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases & disease   & 0.558 & P35408 & C04;C13;C19 & G-protein coupled receptor & Corpus Luteum Cyst                               & 0.731 & C0010093 &  & 1.000 & 0.30 & Disease or Syndrome & PTGER4 & ALL & DTO\\_02300001 & 2011\\\\\n",
       "\t59 & 9.7550e-01 & 2008 &  5734 &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              & group     & 0.558 & P35408 & C04;C20;C15 & G-protein coupled receptor & Lymphoma                                         & 0.731 & C0024299 &  & 1.000 & 0.30 & Neoplastic Process  & PTGER4 & ALL & DTO\\_02300001 & 2008\\\\\n",
       "\t60 & 9.7550e-01 & 2011 &  5734 &    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases & disease   & 0.558 & P35408 & C04;C13;C19 & G-protein coupled receptor & Ovarian Cysts                                    & 0.731 & C0029927 &  & 1.000 & 0.30 & Disease or Syndrome & PTGER4 & ALL & DTO\\_02300001 & 2011\\\\\n",
       "\t66 & 9.8206e-01 & 2007 &  6688 &    Neoplasms                                                                                          & disease   & 0.631 & P17947 & C04         & Transcription factor       & Leukemia, Monocytic, Chronic                     & 0.654 & C0023466 &  & 1.000 & 0.30 & Neoplastic Process  & SPI1   & ALL & DTO\\_05007542 & 2007\\\\\n",
       "\t67 & 9.8206e-01 & 2015 &  6688 &    Neoplasms                                                                                          & disease   & 0.631 & P17947 & C04         & Transcription factor       & Acute Myeloid Leukemia, M1                       & 0.654 & C0026998 &  & 1.000 & 0.30 & Neoplastic Process  & SPI1   & ALL & DTO\\_05007542 & 2015\\\\\n",
       "\t68 & 9.8206e-01 & 2015 &  6688 &    Neoplasms                                                                                          & disease   & 0.631 & P17947 & C04         & Transcription factor       & Acute Myeloid Leukemia (AML-M2)                  & 0.654 & C1879321 &  & 1.000 & 0.30 & Neoplastic Process  & SPI1   & ALL & DTO\\_05007542 & 2015\\\\\n",
       "\t73 & 9.8881e-01 &   NA & 64919 &    Digestive System Diseases;    Neoplasms                                                            & disease   & 0.568 & Q9C0K0 & C06;C04     & Transcription factor       & Colorectal Carcinoma                             & 0.731 & C0009402 &  &    NA & 0.30 & Neoplastic Process  & BCL11B & ALL & DTO\\_05007542 &   NA\\\\\n",
       "\t170 & 1.5821e-03 &   NA &  1528 &    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases & disease   & 0.601 & P00167 & C04;C13;C19 & Enzyme                     & Enlarged polycystic ovaries                      & 0.654 & C4024641 &  &    NA & 0.10 & Disease or Syndrome & CYB5A  & ALL & DTO\\_05007624 &   NA\\\\\n",
       "\t179 & 9.8410e-24 & 2012 &  3949 &    Neoplasms                                                                                          & disease   & 0.449 & P01130 & C04         &                            & Squamous cell carcinoma                          & 0.885 & C0007137 &  & 1.000 & 0.10 & Neoplastic Process  & LDLR   & ALL &              & 2012\\\\\n",
       "\t184 & 9.8410e-24 & 1988 &  3949 &    Digestive System Diseases;    Neoplasms                                                            & group     & 0.449 & P01130 & C06;C04     &                            & Liver neoplasms                                  & 0.885 & C0023903 &  & 1.000 & 0.10 & Neoplastic Process  & LDLR   & ALL &              & 2019\\\\\n",
       "\t186 & 9.8410e-24 & 1987 &  3949 &    Neoplasms                                                                                          & group     & 0.449 & P01130 & C04         &                            & Neoplasms                                        & 0.885 & C0027651 &  & 1.000 & 0.10 & Neoplastic Process  & LDLR   & ALL &              & 2019\\\\\n",
       "\t204 & 9.8410e-24 & 1999 &  3949 &    Neoplasms                                                                                          & disease   & 0.449 & P01130 & C04         &                            & Atypical Ductal Breast Hyperplasia               & 0.885 & C1332347 &  & 1.000 & 0.10 & Neoplastic Process  & LDLR   & ALL &              & 2019\\\\\n",
       "\t212 & 9.8410e-24 & 1988 &  3949 &    Digestive System Diseases;    Neoplasms                                                            & disease   & 0.449 & P01130 & C06;C04     &                            & Liver carcinoma                                  & 0.885 & C2239176 &  & 1.000 & 0.10 & Neoplastic Process  & LDLR   & ALL &              & 2018\\\\\n",
       "\t223 & 7.8684e-37 & 1996 &  4486 &    Neoplasms                                                                                          & group     & 0.542 & Q04912 & C04         & Kinase                     & Malignant Neoplasms                              & 0.808 & C0006826 &  & 1.000 & 0.10 & Neoplastic Process  & MST1R  & ALL & DTO\\_03300101 & 2019\\\\\n",
       "\t224 & 7.8684e-37 &   NA &  4486 &    Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases                            & group     & 0.542 & Q04912 & C04;C07;C09 & Kinase                     & Nasopharyngeal Neoplasms                         & 0.808 & C0027439 &  &    NA & 0.10 & Neoplastic Process  & MST1R  & ALL & DTO\\_03300101 &   NA\\\\\n",
       "\t225 & 7.8684e-37 & 2000 &  4486 &    Pathological Conditions, Signs and Symptoms;    Neoplasms                                          & phenotype & 0.542 & Q04912 & C23;C04     & Kinase                     & Neoplasm Metastasis                              & 0.808 & C0027627 &  & 1.000 & 0.10 & Neoplastic Process  & MST1R  & ALL & DTO\\_03300101 & 2019\\\\\n",
       "\t226 & 7.8684e-37 & 1998 &  4486 &    Neoplasms                                                                                          & group     & 0.542 & Q04912 & C04         & Kinase                     & Neoplasms                                        & 0.808 & C0027651 &  & 1.000 & 0.10 & Neoplastic Process  & MST1R  & ALL & DTO\\_03300101 & 2019\\\\\n",
       "\t228 & 7.8684e-37 & 2003 &  4486 &    Pathological Conditions, Signs and Symptoms;    Neoplasms                                          & phenotype & 0.542 & Q04912 & C23;C04     & Kinase                     & Carcinogenesis                                   & 0.808 & C0596263 &  & 1.000 & 0.10 & Neoplastic Process  & MST1R  & ALL & DTO\\_03300101 & 2019\\\\\n",
       "\t230 & 7.8684e-37 & 1996 &  4486 &    Neoplasms                                                                                          & group     & 0.542 & Q04912 & C04         & Kinase                     & Primary malignant neoplasm                       & 0.808 & C1306459 &  & 1.000 & 0.10 & Neoplastic Process  & MST1R  & ALL & DTO\\_03300101 & 2019\\\\\n",
       "\t233 & 9.8206e-01 & 1990 &  6688 &    Neoplasms;    Hemic and Lymphatic Diseases                                                         & disease   & 0.631 & P17947 & C04;C15     & Transcription factor       & Acute Erythroblastic Leukemia                    & 0.654 & C0023440 &  & 1.000 & 0.10 & Neoplastic Process  & SPI1   & ALL & DTO\\_05007542 & 2017\\\\\n",
       "\t244 & 7.1583e-01 & 2012 & 55544 &    Neoplasms                                                                                          & group     & 0.670 & Q9H0Z9 & C04         &                            & Neoplasms                                        & 0.500 & C0027651 &  & 1.000 & 0.10 & Neoplastic Process  & RBM38  & ALL &              & 2019\\\\\n",
       "\t263 & 9.8881e-01 & 2000 & 64919 &    Neoplasms                                                                                          & group     & 0.568 & Q9C0K0 & C04         & Transcription factor       & Neoplasms                                        & 0.731 & C0027651 &  & 0.923 & 0.10 & Neoplastic Process  & BCL11B & ALL & DTO\\_05007542 & 2019\\\\\n",
       "\t294 & 1.4300e-04 & 2003 & 79017 &    Neoplasms                                                                                          & group     & 0.552 & O75223 & C04         &                            & Malignant Neoplasms                              & 0.808 & C0006826 &  & 0.929 & 0.10 & Neoplastic Process  & GGCT   & ALL &              & 2020\\\\\n",
       "\tâ‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹®\\\\\n",
       "\t1087 & 1.4300e-04 & 2017 &  79017 &    Digestive System Diseases;    Neoplasms                               & disease   & 0.552 & O75223 & C06;C04     &                    & Squamous cell carcinoma of esophagus         & 0.808 & C0279626 &  & 1 & 0.01 & Neoplastic Process & GGCT   & ALL &              & 2017\\\\\n",
       "\t1088 & 1.4300e-04 & 2019 &  79017 &    Neoplasms                                                             & disease   & 0.552 & O75223 & C04         &                    & Childhood Glioblastoma                       & 0.808 & C0280474 &  & 1 & 0.01 & Neoplastic Process & GGCT   & ALL &              & 2019\\\\\n",
       "\t1090 & 1.4300e-04 & 2015 &  79017 &    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases & disease   & 0.552 & O75223 & C06;C04;C19 &                    & Malignant neoplasm of pancreas               & 0.808 & C0346647 &  & 1 & 0.01 & Neoplastic Process & GGCT   & ALL &              & 2015\\\\\n",
       "\t1091 & 1.4300e-04 & 2019 &  79017 &    Digestive System Diseases;    Neoplasms                               & disease   & 0.552 & O75223 & C06;C04     &                    & Early gastric cancer                         & 0.808 & C0349530 &  & 1 & 0.01 & Neoplastic Process & GGCT   & ALL &              & 2019\\\\\n",
       "\t1094 & 1.4300e-04 & 2019 &  79017 &    Neoplasms;    Endocrine System Diseases                               & disease   & 0.552 & O75223 & C04;C19     &                    & Thyroid carcinoma                            & 0.808 & C0549473 &  & 1 & 0.01 & Neoplastic Process & GGCT   & ALL &              & 2019\\\\\n",
       "\t1095 & 1.4300e-04 & 2010 &  79017 &    Pathological Conditions, Signs and Symptoms;    Neoplasms             & phenotype & 0.552 & O75223 & C23;C04     &                    & Carcinogenesis                               & 0.808 & C0596263 &  & 1 & 0.01 & Neoplastic Process & GGCT   & ALL &              & 2010\\\\\n",
       "\t1096 & 1.4300e-04 & 1993 &  79017 &    Digestive System Diseases;    Neoplasms                               & disease   & 0.552 & O75223 & C06;C04     &                    & Villous adenoma of rectum                    & 0.808 & C0730199 &  & 1 & 0.01 & Neoplastic Process & GGCT   & ALL &              & 1993\\\\\n",
       "\t1097 & 1.4300e-04 & 2005 &  79017 &    Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases  & disease   & 0.552 & O75223 & C04;C12;C19 &                    & Malignant Testicular Germ Cell Tumor         & 0.808 & C0855197 &  & 1 & 0.01 & Neoplastic Process & GGCT   & ALL &              & 2005\\\\\n",
       "\t1098 & 1.4300e-04 & 2007 &  79017 &    Neoplasms                                                             & disease   & 0.552 & O75223 & C04         &                    & Squamous cell carcinoma of the head and neck & 0.808 & C1168401 &  & 1 & 0.01 & Neoplastic Process & GGCT   & ALL &              & 2007\\\\\n",
       "\t1100 & 1.4300e-04 & 2010 &  79017 &    Neoplasms;    Skin and Connective Tissue Diseases                     & group     & 0.552 & O75223 & C04;C17     &                    & Mammary Neoplasms                            & 0.808 & C1458155 &  & 1 & 0.01 & Neoplastic Process & GGCT   & ALL &              & 2010\\\\\n",
       "\t1102 & 1.4300e-04 & 2019 &  79017 &    Neoplasms                                                             & disease   & 0.552 & O75223 & C04         &                    & Glioblastoma Multiforme                      & 0.808 & C1621958 &  & 1 & 0.01 & Neoplastic Process & GGCT   & ALL &              & 2019\\\\\n",
       "\t1113 & 1.4037e-34 & 2011 &  79582 &    Neoplasms                                                             & group     & 0.760 & Q8N0X2 & C04         & Cellular structure & Neoplasms                                    & 0.385 & C0027651 &  & 1 & 0.01 & Neoplastic Process & SPAG16 & ALL & DTO\\_05007530 & 2011\\\\\n",
       "\t1118 & 1.4037e-34 & 2013 &  79582 &    Neoplasms                                                             & disease   & 0.760 & Q8N0X2 & C04         & Cellular structure & High-Risk Neuroblastoma                      & 0.385 & C4725671 &  & 1 & 0.01 & Neoplastic Process & SPAG16 & ALL & DTO\\_05007530 & 2013\\\\\n",
       "\t1120 & 2.2862e-02 & 2018 &  80305 &    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases & disease   & 0.839 & Q9H4I3 & C06;C04;C19 &                    & insulinoma                                   & 0.308 & C0021670 &  & 1 & 0.01 & Neoplastic Process & TRABD  & ALL &              & 2018\\\\\n",
       "\t1121 & 2.2862e-02 & 1991 &  80305 &    Neoplasms                                                             & disease   & 0.839 & Q9H4I3 & C04         &                    & leukemia                                     & 0.308 & C0023418 &  & 1 & 0.01 & Neoplastic Process & TRABD  & ALL &              & 1991\\\\\n",
       "\t1122 & 2.2862e-02 & 1993 &  80305 &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases & disease   & 0.839 & Q9H4I3 & C04;C20;C15 &                    & Acute lymphocytic leukemia                   & 0.308 & C0023449 &  & 1 & 0.01 & Neoplastic Process & TRABD  & ALL &              & 1993\\\\\n",
       "\t1123 & 2.2862e-02 & 2014 &  80305 &    Neoplasms                                                             & group     & 0.839 & Q9H4I3 & C04         &                    & Neoplasms                                    & 0.308 & C0027651 &  & 1 & 0.01 & Neoplastic Process & TRABD  & ALL &              & 2014\\\\\n",
       "\t1127 & 3.5288e-05 & 2014 & 132299 &    Neoplasms                                                             & group     & 0.821 & Q56VL3 & C04         & Immune response    & Malignant Neoplasms                          & 0.346 & C0006826 &  & 1 & 0.01 & Neoplastic Process & OCIAD2 & ALL & DTO\\_05007608 & 2014\\\\\n",
       "\t1128 & 3.5288e-05 & 2007 & 132299 &    Neoplasms                                                             & disease   & 0.821 & Q56VL3 & C04         & Immune response    & Bronchioloalveolar Adenocarcinoma            & 0.346 & C0007120 &  & 1 & 0.01 & Neoplastic Process & OCIAD2 & ALL & DTO\\_05007608 & 2007\\\\\n",
       "\t1129 & 3.5288e-05 & 2018 & 132299 &    Pathological Conditions, Signs and Symptoms;    Neoplasms             & phenotype & 0.821 & Q56VL3 & C23;C04     & Immune response    & Neoplasm Metastasis                          & 0.346 & C0027627 &  & 1 & 0.01 & Neoplastic Process & OCIAD2 & ALL & DTO\\_05007608 & 2018\\\\\n",
       "\t1131 & 3.5288e-05 & 2018 & 132299 &    Neoplasms                                                             & disease   & 0.821 & Q56VL3 & C04         & Immune response    & Adenocarcinoma of lung (disorder)            & 0.346 & C0152013 &  & 1 & 0.01 & Neoplastic Process & OCIAD2 & ALL & DTO\\_05007608 & 2018\\\\\n",
       "\t1132 & 3.5288e-05 & 2018 & 132299 &    Pathological Conditions, Signs and Symptoms;    Neoplasms             & phenotype & 0.821 & Q56VL3 & C23;C04     & Immune response    & Adenocarcinoma in Situ                       & 0.346 & C0334276 &  & 1 & 0.01 & Neoplastic Process & OCIAD2 & ALL & DTO\\_05007608 & 2018\\\\\n",
       "\t1134 & 3.5288e-05 & 2007 & 132299 &    Pathological Conditions, Signs and Symptoms;    Neoplasms             & disease   & 0.821 & Q56VL3 & C23;C04     & Immune response    & Secondary malignant neoplasm of lymph node   & 0.346 & C0686619 &  & 1 & 0.01 & Neoplastic Process & OCIAD2 & ALL & DTO\\_05007608 & 2007\\\\\n",
       "\t1135 & 3.5288e-05 & 2014 & 132299 &    Neoplasms                                                             & group     & 0.821 & Q56VL3 & C04         & Immune response    & Primary malignant neoplasm                   & 0.346 & C1306459 &  & 1 & 0.01 & Neoplastic Process & OCIAD2 & ALL & DTO\\_05007608 & 2014\\\\\n",
       "\t1136 & 3.5288e-05 & 2007 & 132299 &    Neoplasms                                                             & phenotype & 0.821 & Q56VL3 & C04         & Immune response    & Invasive Carcinoma                           & 0.346 & C1334274 &  & 1 & 0.01 & Neoplastic Process & OCIAD2 & ALL & DTO\\_05007608 & 2007\\\\\n",
       "\t1137 & 3.5288e-05 & 2017 & 132299 &    Digestive System Diseases;    Neoplasms                               & disease   & 0.821 & Q56VL3 & C06;C04     & Immune response    & Liver carcinoma                              & 0.346 & C2239176 &  & 1 & 0.01 & Neoplastic Process & OCIAD2 & ALL & DTO\\_05007608 & 2017\\\\\n",
       "\t1138 & 3.5288e-05 & 2018 & 132299 &    Pathological Conditions, Signs and Symptoms;    Neoplasms             & group     & 0.821 & Q56VL3 & C23;C04     & Immune response    & Secondary Neoplasm                           & 0.346 & C2939419 &  & 1 & 0.01 & Neoplastic Process & OCIAD2 & ALL & DTO\\_05007608 & 2018\\\\\n",
       "\t1139 & 1.8665e-04 & 2018 & 353355 &    Neoplasms                                                             & group     & 1.000 & A6NK53 & C04         &                    & Neoplasms                                    & 0.077 & C0027651 &  & 1 & 0.01 & Neoplastic Process & ZNF233 & ALL &              & 2018\\\\\n",
       "\t1141 & 1.8665e-04 & 2018 & 353355 &    Pathological Conditions, Signs and Symptoms;    Neoplasms             & phenotype & 1.000 & A6NK53 & C23;C04     &                    & Carcinogenesis                               & 0.077 & C0596263 &  & 1 & 0.01 & Neoplastic Process & ZNF233 & ALL &              & 2018\\\\\n",
       "\t1142 & 1.8665e-04 & 2018 & 353355 &    Digestive System Diseases;    Neoplasms                               & disease   & 1.000 & A6NK53 & C06;C04     &                    & Liver carcinoma                              & 0.077 & C2239176 &  & 1 & 0.01 & Neoplastic Process & ZNF233 & ALL &              & 2018\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A data.frame: 415 Ã— 20\n",
       "\n",
       "| <!--/--> | gene_pli &lt;dbl&gt; | year_initial &lt;int&gt; | geneid &lt;int&gt; | disease_class_name &lt;chr&gt; | disease_type &lt;chr&gt; | gene_dsi &lt;dbl&gt; | uniprotid &lt;chr&gt; | disease_class &lt;chr&gt; | protein_class_name &lt;chr&gt; | disease_name &lt;chr&gt; | gene_dpi &lt;dbl&gt; | diseaseid &lt;chr&gt; | el &lt;chr&gt; | ei &lt;dbl&gt; | score &lt;dbl&gt; | disease_semantic_type &lt;chr&gt; | gene_symbol &lt;chr&gt; | source &lt;chr&gt; | protein_class &lt;chr&gt; | year_final &lt;int&gt; |\n",
       "|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n",
       "| 8 | 9.8206e-01 | 1999 |  6688 |    Neoplasms                                                                                          | disease   | 0.631 | P17947 | C04         | Transcription factor       | Leukemia, Myelocytic, Acute                      | 0.654 | C0023467 | <!----> | 1.000 | 0.60 | Neoplastic Process  | SPI1   | ALL | DTO_05007542 | 2019 |\n",
       "| 19 | 9.8881e-01 | 2003 | 64919 |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              | disease   | 0.568 | Q9C0K0 | C04;C20;C15 | Transcription factor       | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.731 | C1961099 | <!----> | 0.938 | 0.40 | Neoplastic Process  | BCL11B | ALL | DTO_05007542 | 2018 |\n",
       "| 26 | 9.8881e-01 | 2003 | 64919 |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              | group     | 0.568 | Q9C0K0 | C04;C20;C15 | Transcription factor       | Lymphoma                                         | 0.731 | C0024299 | <!----> | 1.000 | 0.33 | Neoplastic Process  | BCL11B | ALL | DTO_05007542 | 2007 |\n",
       "| 29 | 9.8206e-01 | 2003 |  6688 |    Neoplasms                                                                                          | disease   | 0.631 | P17947 | C04         | Transcription factor       | Myeloid Leukemia                                 | 0.654 | C0023470 | <!----> | 1.000 | 0.32 | Neoplastic Process  | SPI1   | ALL | DTO_05007542 | 2011 |\n",
       "| 30 | 9.8206e-01 | 2012 |  6688 |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              | disease   | 0.631 | P17947 | C04;C20;C15 | Transcription factor       | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.654 | C1961099 | <!----> | 1.000 | 0.32 | Neoplastic Process  | SPI1   | ALL | DTO_05007542 | 2017 |\n",
       "| 32 | 7.8684e-37 | 2016 |  4486 |    Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases                            | disease   | 0.542 | Q04912 | C04;C07;C09 | Kinase                     | Nasopharyngeal carcinoma                         | 0.808 | C2931822 | <!----> | 1.000 | 0.31 | Neoplastic Process  | MST1R  | ALL | DTO_03300101 | 2016 |\n",
       "| 51 | 7.8684e-37 | 2013 |  4486 |    Neoplasms                                                                                          | disease   | 0.542 | Q04912 | C04         | Kinase                     | Osteosarcoma                                     | 0.808 | C0029463 | <!----> | 1.000 | 0.30 | Neoplastic Process  | MST1R  | ALL | DTO_03300101 | 2013 |\n",
       "| 58 | 9.7550e-01 | 2011 |  5734 |    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases | disease   | 0.558 | P35408 | C04;C13;C19 | G-protein coupled receptor | Corpus Luteum Cyst                               | 0.731 | C0010093 | <!----> | 1.000 | 0.30 | Disease or Syndrome | PTGER4 | ALL | DTO_02300001 | 2011 |\n",
       "| 59 | 9.7550e-01 | 2008 |  5734 |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              | group     | 0.558 | P35408 | C04;C20;C15 | G-protein coupled receptor | Lymphoma                                         | 0.731 | C0024299 | <!----> | 1.000 | 0.30 | Neoplastic Process  | PTGER4 | ALL | DTO_02300001 | 2008 |\n",
       "| 60 | 9.7550e-01 | 2011 |  5734 |    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases | disease   | 0.558 | P35408 | C04;C13;C19 | G-protein coupled receptor | Ovarian Cysts                                    | 0.731 | C0029927 | <!----> | 1.000 | 0.30 | Disease or Syndrome | PTGER4 | ALL | DTO_02300001 | 2011 |\n",
       "| 66 | 9.8206e-01 | 2007 |  6688 |    Neoplasms                                                                                          | disease   | 0.631 | P17947 | C04         | Transcription factor       | Leukemia, Monocytic, Chronic                     | 0.654 | C0023466 | <!----> | 1.000 | 0.30 | Neoplastic Process  | SPI1   | ALL | DTO_05007542 | 2007 |\n",
       "| 67 | 9.8206e-01 | 2015 |  6688 |    Neoplasms                                                                                          | disease   | 0.631 | P17947 | C04         | Transcription factor       | Acute Myeloid Leukemia, M1                       | 0.654 | C0026998 | <!----> | 1.000 | 0.30 | Neoplastic Process  | SPI1   | ALL | DTO_05007542 | 2015 |\n",
       "| 68 | 9.8206e-01 | 2015 |  6688 |    Neoplasms                                                                                          | disease   | 0.631 | P17947 | C04         | Transcription factor       | Acute Myeloid Leukemia (AML-M2)                  | 0.654 | C1879321 | <!----> | 1.000 | 0.30 | Neoplastic Process  | SPI1   | ALL | DTO_05007542 | 2015 |\n",
       "| 73 | 9.8881e-01 |   NA | 64919 |    Digestive System Diseases;    Neoplasms                                                            | disease   | 0.568 | Q9C0K0 | C06;C04     | Transcription factor       | Colorectal Carcinoma                             | 0.731 | C0009402 | <!----> |    NA | 0.30 | Neoplastic Process  | BCL11B | ALL | DTO_05007542 |   NA |\n",
       "| 170 | 1.5821e-03 |   NA |  1528 |    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases | disease   | 0.601 | P00167 | C04;C13;C19 | Enzyme                     | Enlarged polycystic ovaries                      | 0.654 | C4024641 | <!----> |    NA | 0.10 | Disease or Syndrome | CYB5A  | ALL | DTO_05007624 |   NA |\n",
       "| 179 | 9.8410e-24 | 2012 |  3949 |    Neoplasms                                                                                          | disease   | 0.449 | P01130 | C04         | <!----> | Squamous cell carcinoma                          | 0.885 | C0007137 | <!----> | 1.000 | 0.10 | Neoplastic Process  | LDLR   | ALL | <!----> | 2012 |\n",
       "| 184 | 9.8410e-24 | 1988 |  3949 |    Digestive System Diseases;    Neoplasms                                                            | group     | 0.449 | P01130 | C06;C04     | <!----> | Liver neoplasms                                  | 0.885 | C0023903 | <!----> | 1.000 | 0.10 | Neoplastic Process  | LDLR   | ALL | <!----> | 2019 |\n",
       "| 186 | 9.8410e-24 | 1987 |  3949 |    Neoplasms                                                                                          | group     | 0.449 | P01130 | C04         | <!----> | Neoplasms                                        | 0.885 | C0027651 | <!----> | 1.000 | 0.10 | Neoplastic Process  | LDLR   | ALL | <!----> | 2019 |\n",
       "| 204 | 9.8410e-24 | 1999 |  3949 |    Neoplasms                                                                                          | disease   | 0.449 | P01130 | C04         | <!----> | Atypical Ductal Breast Hyperplasia               | 0.885 | C1332347 | <!----> | 1.000 | 0.10 | Neoplastic Process  | LDLR   | ALL | <!----> | 2019 |\n",
       "| 212 | 9.8410e-24 | 1988 |  3949 |    Digestive System Diseases;    Neoplasms                                                            | disease   | 0.449 | P01130 | C06;C04     | <!----> | Liver carcinoma                                  | 0.885 | C2239176 | <!----> | 1.000 | 0.10 | Neoplastic Process  | LDLR   | ALL | <!----> | 2018 |\n",
       "| 223 | 7.8684e-37 | 1996 |  4486 |    Neoplasms                                                                                          | group     | 0.542 | Q04912 | C04         | Kinase                     | Malignant Neoplasms                              | 0.808 | C0006826 | <!----> | 1.000 | 0.10 | Neoplastic Process  | MST1R  | ALL | DTO_03300101 | 2019 |\n",
       "| 224 | 7.8684e-37 |   NA |  4486 |    Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases                            | group     | 0.542 | Q04912 | C04;C07;C09 | Kinase                     | Nasopharyngeal Neoplasms                         | 0.808 | C0027439 | <!----> |    NA | 0.10 | Neoplastic Process  | MST1R  | ALL | DTO_03300101 |   NA |\n",
       "| 225 | 7.8684e-37 | 2000 |  4486 |    Pathological Conditions, Signs and Symptoms;    Neoplasms                                          | phenotype | 0.542 | Q04912 | C23;C04     | Kinase                     | Neoplasm Metastasis                              | 0.808 | C0027627 | <!----> | 1.000 | 0.10 | Neoplastic Process  | MST1R  | ALL | DTO_03300101 | 2019 |\n",
       "| 226 | 7.8684e-37 | 1998 |  4486 |    Neoplasms                                                                                          | group     | 0.542 | Q04912 | C04         | Kinase                     | Neoplasms                                        | 0.808 | C0027651 | <!----> | 1.000 | 0.10 | Neoplastic Process  | MST1R  | ALL | DTO_03300101 | 2019 |\n",
       "| 228 | 7.8684e-37 | 2003 |  4486 |    Pathological Conditions, Signs and Symptoms;    Neoplasms                                          | phenotype | 0.542 | Q04912 | C23;C04     | Kinase                     | Carcinogenesis                                   | 0.808 | C0596263 | <!----> | 1.000 | 0.10 | Neoplastic Process  | MST1R  | ALL | DTO_03300101 | 2019 |\n",
       "| 230 | 7.8684e-37 | 1996 |  4486 |    Neoplasms                                                                                          | group     | 0.542 | Q04912 | C04         | Kinase                     | Primary malignant neoplasm                       | 0.808 | C1306459 | <!----> | 1.000 | 0.10 | Neoplastic Process  | MST1R  | ALL | DTO_03300101 | 2019 |\n",
       "| 233 | 9.8206e-01 | 1990 |  6688 |    Neoplasms;    Hemic and Lymphatic Diseases                                                         | disease   | 0.631 | P17947 | C04;C15     | Transcription factor       | Acute Erythroblastic Leukemia                    | 0.654 | C0023440 | <!----> | 1.000 | 0.10 | Neoplastic Process  | SPI1   | ALL | DTO_05007542 | 2017 |\n",
       "| 244 | 7.1583e-01 | 2012 | 55544 |    Neoplasms                                                                                          | group     | 0.670 | Q9H0Z9 | C04         | <!----> | Neoplasms                                        | 0.500 | C0027651 | <!----> | 1.000 | 0.10 | Neoplastic Process  | RBM38  | ALL | <!----> | 2019 |\n",
       "| 263 | 9.8881e-01 | 2000 | 64919 |    Neoplasms                                                                                          | group     | 0.568 | Q9C0K0 | C04         | Transcription factor       | Neoplasms                                        | 0.731 | C0027651 | <!----> | 0.923 | 0.10 | Neoplastic Process  | BCL11B | ALL | DTO_05007542 | 2019 |\n",
       "| 294 | 1.4300e-04 | 2003 | 79017 |    Neoplasms                                                                                          | group     | 0.552 | O75223 | C04         | <!----> | Malignant Neoplasms                              | 0.808 | C0006826 | <!----> | 0.929 | 0.10 | Neoplastic Process  | GGCT   | ALL | <!----> | 2020 |\n",
       "| â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® |\n",
       "| 1087 | 1.4300e-04 | 2017 |  79017 |    Digestive System Diseases;    Neoplasms                               | disease   | 0.552 | O75223 | C06;C04     | <!----> | Squamous cell carcinoma of esophagus         | 0.808 | C0279626 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT   | ALL | <!----> | 2017 |\n",
       "| 1088 | 1.4300e-04 | 2019 |  79017 |    Neoplasms                                                             | disease   | 0.552 | O75223 | C04         | <!----> | Childhood Glioblastoma                       | 0.808 | C0280474 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT   | ALL | <!----> | 2019 |\n",
       "| 1090 | 1.4300e-04 | 2015 |  79017 |    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases | disease   | 0.552 | O75223 | C06;C04;C19 | <!----> | Malignant neoplasm of pancreas               | 0.808 | C0346647 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT   | ALL | <!----> | 2015 |\n",
       "| 1091 | 1.4300e-04 | 2019 |  79017 |    Digestive System Diseases;    Neoplasms                               | disease   | 0.552 | O75223 | C06;C04     | <!----> | Early gastric cancer                         | 0.808 | C0349530 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT   | ALL | <!----> | 2019 |\n",
       "| 1094 | 1.4300e-04 | 2019 |  79017 |    Neoplasms;    Endocrine System Diseases                               | disease   | 0.552 | O75223 | C04;C19     | <!----> | Thyroid carcinoma                            | 0.808 | C0549473 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT   | ALL | <!----> | 2019 |\n",
       "| 1095 | 1.4300e-04 | 2010 |  79017 |    Pathological Conditions, Signs and Symptoms;    Neoplasms             | phenotype | 0.552 | O75223 | C23;C04     | <!----> | Carcinogenesis                               | 0.808 | C0596263 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT   | ALL | <!----> | 2010 |\n",
       "| 1096 | 1.4300e-04 | 1993 |  79017 |    Digestive System Diseases;    Neoplasms                               | disease   | 0.552 | O75223 | C06;C04     | <!----> | Villous adenoma of rectum                    | 0.808 | C0730199 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT   | ALL | <!----> | 1993 |\n",
       "| 1097 | 1.4300e-04 | 2005 |  79017 |    Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases  | disease   | 0.552 | O75223 | C04;C12;C19 | <!----> | Malignant Testicular Germ Cell Tumor         | 0.808 | C0855197 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT   | ALL | <!----> | 2005 |\n",
       "| 1098 | 1.4300e-04 | 2007 |  79017 |    Neoplasms                                                             | disease   | 0.552 | O75223 | C04         | <!----> | Squamous cell carcinoma of the head and neck | 0.808 | C1168401 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT   | ALL | <!----> | 2007 |\n",
       "| 1100 | 1.4300e-04 | 2010 |  79017 |    Neoplasms;    Skin and Connective Tissue Diseases                     | group     | 0.552 | O75223 | C04;C17     | <!----> | Mammary Neoplasms                            | 0.808 | C1458155 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT   | ALL | <!----> | 2010 |\n",
       "| 1102 | 1.4300e-04 | 2019 |  79017 |    Neoplasms                                                             | disease   | 0.552 | O75223 | C04         | <!----> | Glioblastoma Multiforme                      | 0.808 | C1621958 | <!----> | 1 | 0.01 | Neoplastic Process | GGCT   | ALL | <!----> | 2019 |\n",
       "| 1113 | 1.4037e-34 | 2011 |  79582 |    Neoplasms                                                             | group     | 0.760 | Q8N0X2 | C04         | Cellular structure | Neoplasms                                    | 0.385 | C0027651 | <!----> | 1 | 0.01 | Neoplastic Process | SPAG16 | ALL | DTO_05007530 | 2011 |\n",
       "| 1118 | 1.4037e-34 | 2013 |  79582 |    Neoplasms                                                             | disease   | 0.760 | Q8N0X2 | C04         | Cellular structure | High-Risk Neuroblastoma                      | 0.385 | C4725671 | <!----> | 1 | 0.01 | Neoplastic Process | SPAG16 | ALL | DTO_05007530 | 2013 |\n",
       "| 1120 | 2.2862e-02 | 2018 |  80305 |    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases | disease   | 0.839 | Q9H4I3 | C06;C04;C19 | <!----> | insulinoma                                   | 0.308 | C0021670 | <!----> | 1 | 0.01 | Neoplastic Process | TRABD  | ALL | <!----> | 2018 |\n",
       "| 1121 | 2.2862e-02 | 1991 |  80305 |    Neoplasms                                                             | disease   | 0.839 | Q9H4I3 | C04         | <!----> | leukemia                                     | 0.308 | C0023418 | <!----> | 1 | 0.01 | Neoplastic Process | TRABD  | ALL | <!----> | 1991 |\n",
       "| 1122 | 2.2862e-02 | 1993 |  80305 |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases | disease   | 0.839 | Q9H4I3 | C04;C20;C15 | <!----> | Acute lymphocytic leukemia                   | 0.308 | C0023449 | <!----> | 1 | 0.01 | Neoplastic Process | TRABD  | ALL | <!----> | 1993 |\n",
       "| 1123 | 2.2862e-02 | 2014 |  80305 |    Neoplasms                                                             | group     | 0.839 | Q9H4I3 | C04         | <!----> | Neoplasms                                    | 0.308 | C0027651 | <!----> | 1 | 0.01 | Neoplastic Process | TRABD  | ALL | <!----> | 2014 |\n",
       "| 1127 | 3.5288e-05 | 2014 | 132299 |    Neoplasms                                                             | group     | 0.821 | Q56VL3 | C04         | Immune response    | Malignant Neoplasms                          | 0.346 | C0006826 | <!----> | 1 | 0.01 | Neoplastic Process | OCIAD2 | ALL | DTO_05007608 | 2014 |\n",
       "| 1128 | 3.5288e-05 | 2007 | 132299 |    Neoplasms                                                             | disease   | 0.821 | Q56VL3 | C04         | Immune response    | Bronchioloalveolar Adenocarcinoma            | 0.346 | C0007120 | <!----> | 1 | 0.01 | Neoplastic Process | OCIAD2 | ALL | DTO_05007608 | 2007 |\n",
       "| 1129 | 3.5288e-05 | 2018 | 132299 |    Pathological Conditions, Signs and Symptoms;    Neoplasms             | phenotype | 0.821 | Q56VL3 | C23;C04     | Immune response    | Neoplasm Metastasis                          | 0.346 | C0027627 | <!----> | 1 | 0.01 | Neoplastic Process | OCIAD2 | ALL | DTO_05007608 | 2018 |\n",
       "| 1131 | 3.5288e-05 | 2018 | 132299 |    Neoplasms                                                             | disease   | 0.821 | Q56VL3 | C04         | Immune response    | Adenocarcinoma of lung (disorder)            | 0.346 | C0152013 | <!----> | 1 | 0.01 | Neoplastic Process | OCIAD2 | ALL | DTO_05007608 | 2018 |\n",
       "| 1132 | 3.5288e-05 | 2018 | 132299 |    Pathological Conditions, Signs and Symptoms;    Neoplasms             | phenotype | 0.821 | Q56VL3 | C23;C04     | Immune response    | Adenocarcinoma in Situ                       | 0.346 | C0334276 | <!----> | 1 | 0.01 | Neoplastic Process | OCIAD2 | ALL | DTO_05007608 | 2018 |\n",
       "| 1134 | 3.5288e-05 | 2007 | 132299 |    Pathological Conditions, Signs and Symptoms;    Neoplasms             | disease   | 0.821 | Q56VL3 | C23;C04     | Immune response    | Secondary malignant neoplasm of lymph node   | 0.346 | C0686619 | <!----> | 1 | 0.01 | Neoplastic Process | OCIAD2 | ALL | DTO_05007608 | 2007 |\n",
       "| 1135 | 3.5288e-05 | 2014 | 132299 |    Neoplasms                                                             | group     | 0.821 | Q56VL3 | C04         | Immune response    | Primary malignant neoplasm                   | 0.346 | C1306459 | <!----> | 1 | 0.01 | Neoplastic Process | OCIAD2 | ALL | DTO_05007608 | 2014 |\n",
       "| 1136 | 3.5288e-05 | 2007 | 132299 |    Neoplasms                                                             | phenotype | 0.821 | Q56VL3 | C04         | Immune response    | Invasive Carcinoma                           | 0.346 | C1334274 | <!----> | 1 | 0.01 | Neoplastic Process | OCIAD2 | ALL | DTO_05007608 | 2007 |\n",
       "| 1137 | 3.5288e-05 | 2017 | 132299 |    Digestive System Diseases;    Neoplasms                               | disease   | 0.821 | Q56VL3 | C06;C04     | Immune response    | Liver carcinoma                              | 0.346 | C2239176 | <!----> | 1 | 0.01 | Neoplastic Process | OCIAD2 | ALL | DTO_05007608 | 2017 |\n",
       "| 1138 | 3.5288e-05 | 2018 | 132299 |    Pathological Conditions, Signs and Symptoms;    Neoplasms             | group     | 0.821 | Q56VL3 | C23;C04     | Immune response    | Secondary Neoplasm                           | 0.346 | C2939419 | <!----> | 1 | 0.01 | Neoplastic Process | OCIAD2 | ALL | DTO_05007608 | 2018 |\n",
       "| 1139 | 1.8665e-04 | 2018 | 353355 |    Neoplasms                                                             | group     | 1.000 | A6NK53 | C04         | <!----> | Neoplasms                                    | 0.077 | C0027651 | <!----> | 1 | 0.01 | Neoplastic Process | ZNF233 | ALL | <!----> | 2018 |\n",
       "| 1141 | 1.8665e-04 | 2018 | 353355 |    Pathological Conditions, Signs and Symptoms;    Neoplasms             | phenotype | 1.000 | A6NK53 | C23;C04     | <!----> | Carcinogenesis                               | 0.077 | C0596263 | <!----> | 1 | 0.01 | Neoplastic Process | ZNF233 | ALL | <!----> | 2018 |\n",
       "| 1142 | 1.8665e-04 | 2018 | 353355 |    Digestive System Diseases;    Neoplasms                               | disease   | 1.000 | A6NK53 | C06;C04     | <!----> | Liver carcinoma                              | 0.077 | C2239176 | <!----> | 1 | 0.01 | Neoplastic Process | ZNF233 | ALL | <!----> | 2018 |\n",
       "\n"
      ],
      "text/plain": [
       "     gene_pli   year_initial geneid\n",
       "8    9.8206e-01 1999          6688 \n",
       "19   9.8881e-01 2003         64919 \n",
       "26   9.8881e-01 2003         64919 \n",
       "29   9.8206e-01 2003          6688 \n",
       "30   9.8206e-01 2012          6688 \n",
       "32   7.8684e-37 2016          4486 \n",
       "51   7.8684e-37 2013          4486 \n",
       "58   9.7550e-01 2011          5734 \n",
       "59   9.7550e-01 2008          5734 \n",
       "60   9.7550e-01 2011          5734 \n",
       "66   9.8206e-01 2007          6688 \n",
       "67   9.8206e-01 2015          6688 \n",
       "68   9.8206e-01 2015          6688 \n",
       "73   9.8881e-01   NA         64919 \n",
       "170  1.5821e-03   NA          1528 \n",
       "179  9.8410e-24 2012          3949 \n",
       "184  9.8410e-24 1988          3949 \n",
       "186  9.8410e-24 1987          3949 \n",
       "204  9.8410e-24 1999          3949 \n",
       "212  9.8410e-24 1988          3949 \n",
       "223  7.8684e-37 1996          4486 \n",
       "224  7.8684e-37   NA          4486 \n",
       "225  7.8684e-37 2000          4486 \n",
       "226  7.8684e-37 1998          4486 \n",
       "228  7.8684e-37 2003          4486 \n",
       "230  7.8684e-37 1996          4486 \n",
       "233  9.8206e-01 1990          6688 \n",
       "244  7.1583e-01 2012         55544 \n",
       "263  9.8881e-01 2000         64919 \n",
       "294  1.4300e-04 2003         79017 \n",
       "â‹®    â‹®          â‹®            â‹®     \n",
       "1087 1.4300e-04 2017          79017\n",
       "1088 1.4300e-04 2019          79017\n",
       "1090 1.4300e-04 2015          79017\n",
       "1091 1.4300e-04 2019          79017\n",
       "1094 1.4300e-04 2019          79017\n",
       "1095 1.4300e-04 2010          79017\n",
       "1096 1.4300e-04 1993          79017\n",
       "1097 1.4300e-04 2005          79017\n",
       "1098 1.4300e-04 2007          79017\n",
       "1100 1.4300e-04 2010          79017\n",
       "1102 1.4300e-04 2019          79017\n",
       "1113 1.4037e-34 2011          79582\n",
       "1118 1.4037e-34 2013          79582\n",
       "1120 2.2862e-02 2018          80305\n",
       "1121 2.2862e-02 1991          80305\n",
       "1122 2.2862e-02 1993          80305\n",
       "1123 2.2862e-02 2014          80305\n",
       "1127 3.5288e-05 2014         132299\n",
       "1128 3.5288e-05 2007         132299\n",
       "1129 3.5288e-05 2018         132299\n",
       "1131 3.5288e-05 2018         132299\n",
       "1132 3.5288e-05 2018         132299\n",
       "1134 3.5288e-05 2007         132299\n",
       "1135 3.5288e-05 2014         132299\n",
       "1136 3.5288e-05 2007         132299\n",
       "1137 3.5288e-05 2017         132299\n",
       "1138 3.5288e-05 2018         132299\n",
       "1139 1.8665e-04 2018         353355\n",
       "1141 1.8665e-04 2018         353355\n",
       "1142 1.8665e-04 2018         353355\n",
       "     disease_class_name                                                                                   \n",
       "8       Neoplasms                                                                                         \n",
       "19      Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             \n",
       "26      Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             \n",
       "29      Neoplasms                                                                                         \n",
       "30      Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             \n",
       "32      Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases                           \n",
       "51      Neoplasms                                                                                         \n",
       "58      Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases\n",
       "59      Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             \n",
       "60      Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases\n",
       "66      Neoplasms                                                                                         \n",
       "67      Neoplasms                                                                                         \n",
       "68      Neoplasms                                                                                         \n",
       "73      Digestive System Diseases;    Neoplasms                                                           \n",
       "170     Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases\n",
       "179     Neoplasms                                                                                         \n",
       "184     Digestive System Diseases;    Neoplasms                                                           \n",
       "186     Neoplasms                                                                                         \n",
       "204     Neoplasms                                                                                         \n",
       "212     Digestive System Diseases;    Neoplasms                                                           \n",
       "223     Neoplasms                                                                                         \n",
       "224     Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases                           \n",
       "225     Pathological Conditions, Signs and Symptoms;    Neoplasms                                         \n",
       "226     Neoplasms                                                                                         \n",
       "228     Pathological Conditions, Signs and Symptoms;    Neoplasms                                         \n",
       "230     Neoplasms                                                                                         \n",
       "233     Neoplasms;    Hemic and Lymphatic Diseases                                                        \n",
       "244     Neoplasms                                                                                         \n",
       "263     Neoplasms                                                                                         \n",
       "294     Neoplasms                                                                                         \n",
       "â‹®    â‹®                                                                                                    \n",
       "1087    Digestive System Diseases;    Neoplasms                                                           \n",
       "1088    Neoplasms                                                                                         \n",
       "1090    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                             \n",
       "1091    Digestive System Diseases;    Neoplasms                                                           \n",
       "1094    Neoplasms;    Endocrine System Diseases                                                           \n",
       "1095    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         \n",
       "1096    Digestive System Diseases;    Neoplasms                                                           \n",
       "1097    Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases                              \n",
       "1098    Neoplasms                                                                                         \n",
       "1100    Neoplasms;    Skin and Connective Tissue Diseases                                                 \n",
       "1102    Neoplasms                                                                                         \n",
       "1113    Neoplasms                                                                                         \n",
       "1118    Neoplasms                                                                                         \n",
       "1120    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                             \n",
       "1121    Neoplasms                                                                                         \n",
       "1122    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             \n",
       "1123    Neoplasms                                                                                         \n",
       "1127    Neoplasms                                                                                         \n",
       "1128    Neoplasms                                                                                         \n",
       "1129    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         \n",
       "1131    Neoplasms                                                                                         \n",
       "1132    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         \n",
       "1134    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         \n",
       "1135    Neoplasms                                                                                         \n",
       "1136    Neoplasms                                                                                         \n",
       "1137    Digestive System Diseases;    Neoplasms                                                           \n",
       "1138    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         \n",
       "1139    Neoplasms                                                                                         \n",
       "1141    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         \n",
       "1142    Digestive System Diseases;    Neoplasms                                                           \n",
       "     disease_type gene_dsi uniprotid disease_class protein_class_name        \n",
       "8    disease      0.631    P17947    C04           Transcription factor      \n",
       "19   disease      0.568    Q9C0K0    C04;C20;C15   Transcription factor      \n",
       "26   group        0.568    Q9C0K0    C04;C20;C15   Transcription factor      \n",
       "29   disease      0.631    P17947    C04           Transcription factor      \n",
       "30   disease      0.631    P17947    C04;C20;C15   Transcription factor      \n",
       "32   disease      0.542    Q04912    C04;C07;C09   Kinase                    \n",
       "51   disease      0.542    Q04912    C04           Kinase                    \n",
       "58   disease      0.558    P35408    C04;C13;C19   G-protein coupled receptor\n",
       "59   group        0.558    P35408    C04;C20;C15   G-protein coupled receptor\n",
       "60   disease      0.558    P35408    C04;C13;C19   G-protein coupled receptor\n",
       "66   disease      0.631    P17947    C04           Transcription factor      \n",
       "67   disease      0.631    P17947    C04           Transcription factor      \n",
       "68   disease      0.631    P17947    C04           Transcription factor      \n",
       "73   disease      0.568    Q9C0K0    C06;C04       Transcription factor      \n",
       "170  disease      0.601    P00167    C04;C13;C19   Enzyme                    \n",
       "179  disease      0.449    P01130    C04                                     \n",
       "184  group        0.449    P01130    C06;C04                                 \n",
       "186  group        0.449    P01130    C04                                     \n",
       "204  disease      0.449    P01130    C04                                     \n",
       "212  disease      0.449    P01130    C06;C04                                 \n",
       "223  group        0.542    Q04912    C04           Kinase                    \n",
       "224  group        0.542    Q04912    C04;C07;C09   Kinase                    \n",
       "225  phenotype    0.542    Q04912    C23;C04       Kinase                    \n",
       "226  group        0.542    Q04912    C04           Kinase                    \n",
       "228  phenotype    0.542    Q04912    C23;C04       Kinase                    \n",
       "230  group        0.542    Q04912    C04           Kinase                    \n",
       "233  disease      0.631    P17947    C04;C15       Transcription factor      \n",
       "244  group        0.670    Q9H0Z9    C04                                     \n",
       "263  group        0.568    Q9C0K0    C04           Transcription factor      \n",
       "294  group        0.552    O75223    C04                                     \n",
       "â‹®    â‹®            â‹®        â‹®         â‹®             â‹®                         \n",
       "1087 disease      0.552    O75223    C06;C04                                 \n",
       "1088 disease      0.552    O75223    C04                                     \n",
       "1090 disease      0.552    O75223    C06;C04;C19                             \n",
       "1091 disease      0.552    O75223    C06;C04                                 \n",
       "1094 disease      0.552    O75223    C04;C19                                 \n",
       "1095 phenotype    0.552    O75223    C23;C04                                 \n",
       "1096 disease      0.552    O75223    C06;C04                                 \n",
       "1097 disease      0.552    O75223    C04;C12;C19                             \n",
       "1098 disease      0.552    O75223    C04                                     \n",
       "1100 group        0.552    O75223    C04;C17                                 \n",
       "1102 disease      0.552    O75223    C04                                     \n",
       "1113 group        0.760    Q8N0X2    C04           Cellular structure        \n",
       "1118 disease      0.760    Q8N0X2    C04           Cellular structure        \n",
       "1120 disease      0.839    Q9H4I3    C06;C04;C19                             \n",
       "1121 disease      0.839    Q9H4I3    C04                                     \n",
       "1122 disease      0.839    Q9H4I3    C04;C20;C15                             \n",
       "1123 group        0.839    Q9H4I3    C04                                     \n",
       "1127 group        0.821    Q56VL3    C04           Immune response           \n",
       "1128 disease      0.821    Q56VL3    C04           Immune response           \n",
       "1129 phenotype    0.821    Q56VL3    C23;C04       Immune response           \n",
       "1131 disease      0.821    Q56VL3    C04           Immune response           \n",
       "1132 phenotype    0.821    Q56VL3    C23;C04       Immune response           \n",
       "1134 disease      0.821    Q56VL3    C23;C04       Immune response           \n",
       "1135 group        0.821    Q56VL3    C04           Immune response           \n",
       "1136 phenotype    0.821    Q56VL3    C04           Immune response           \n",
       "1137 disease      0.821    Q56VL3    C06;C04       Immune response           \n",
       "1138 group        0.821    Q56VL3    C23;C04       Immune response           \n",
       "1139 group        1.000    A6NK53    C04                                     \n",
       "1141 phenotype    1.000    A6NK53    C23;C04                                 \n",
       "1142 disease      1.000    A6NK53    C06;C04                                 \n",
       "     disease_name                                     gene_dpi diseaseid el\n",
       "8    Leukemia, Myelocytic, Acute                      0.654    C0023467    \n",
       "19   Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 0.731    C1961099    \n",
       "26   Lymphoma                                         0.731    C0024299    \n",
       "29   Myeloid Leukemia                                 0.654    C0023470    \n",
       "30   Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 0.654    C1961099    \n",
       "32   Nasopharyngeal carcinoma                         0.808    C2931822    \n",
       "51   Osteosarcoma                                     0.808    C0029463    \n",
       "58   Corpus Luteum Cyst                               0.731    C0010093    \n",
       "59   Lymphoma                                         0.731    C0024299    \n",
       "60   Ovarian Cysts                                    0.731    C0029927    \n",
       "66   Leukemia, Monocytic, Chronic                     0.654    C0023466    \n",
       "67   Acute Myeloid Leukemia, M1                       0.654    C0026998    \n",
       "68   Acute Myeloid Leukemia (AML-M2)                  0.654    C1879321    \n",
       "73   Colorectal Carcinoma                             0.731    C0009402    \n",
       "170  Enlarged polycystic ovaries                      0.654    C4024641    \n",
       "179  Squamous cell carcinoma                          0.885    C0007137    \n",
       "184  Liver neoplasms                                  0.885    C0023903    \n",
       "186  Neoplasms                                        0.885    C0027651    \n",
       "204  Atypical Ductal Breast Hyperplasia               0.885    C1332347    \n",
       "212  Liver carcinoma                                  0.885    C2239176    \n",
       "223  Malignant Neoplasms                              0.808    C0006826    \n",
       "224  Nasopharyngeal Neoplasms                         0.808    C0027439    \n",
       "225  Neoplasm Metastasis                              0.808    C0027627    \n",
       "226  Neoplasms                                        0.808    C0027651    \n",
       "228  Carcinogenesis                                   0.808    C0596263    \n",
       "230  Primary malignant neoplasm                       0.808    C1306459    \n",
       "233  Acute Erythroblastic Leukemia                    0.654    C0023440    \n",
       "244  Neoplasms                                        0.500    C0027651    \n",
       "263  Neoplasms                                        0.731    C0027651    \n",
       "294  Malignant Neoplasms                              0.808    C0006826    \n",
       "â‹®    â‹®                                                â‹®        â‹®         â‹® \n",
       "1087 Squamous cell carcinoma of esophagus             0.808    C0279626    \n",
       "1088 Childhood Glioblastoma                           0.808    C0280474    \n",
       "1090 Malignant neoplasm of pancreas                   0.808    C0346647    \n",
       "1091 Early gastric cancer                             0.808    C0349530    \n",
       "1094 Thyroid carcinoma                                0.808    C0549473    \n",
       "1095 Carcinogenesis                                   0.808    C0596263    \n",
       "1096 Villous adenoma of rectum                        0.808    C0730199    \n",
       "1097 Malignant Testicular Germ Cell Tumor             0.808    C0855197    \n",
       "1098 Squamous cell carcinoma of the head and neck     0.808    C1168401    \n",
       "1100 Mammary Neoplasms                                0.808    C1458155    \n",
       "1102 Glioblastoma Multiforme                          0.808    C1621958    \n",
       "1113 Neoplasms                                        0.385    C0027651    \n",
       "1118 High-Risk Neuroblastoma                          0.385    C4725671    \n",
       "1120 insulinoma                                       0.308    C0021670    \n",
       "1121 leukemia                                         0.308    C0023418    \n",
       "1122 Acute lymphocytic leukemia                       0.308    C0023449    \n",
       "1123 Neoplasms                                        0.308    C0027651    \n",
       "1127 Malignant Neoplasms                              0.346    C0006826    \n",
       "1128 Bronchioloalveolar Adenocarcinoma                0.346    C0007120    \n",
       "1129 Neoplasm Metastasis                              0.346    C0027627    \n",
       "1131 Adenocarcinoma of lung (disorder)                0.346    C0152013    \n",
       "1132 Adenocarcinoma in Situ                           0.346    C0334276    \n",
       "1134 Secondary malignant neoplasm of lymph node       0.346    C0686619    \n",
       "1135 Primary malignant neoplasm                       0.346    C1306459    \n",
       "1136 Invasive Carcinoma                               0.346    C1334274    \n",
       "1137 Liver carcinoma                                  0.346    C2239176    \n",
       "1138 Secondary Neoplasm                               0.346    C2939419    \n",
       "1139 Neoplasms                                        0.077    C0027651    \n",
       "1141 Carcinogenesis                                   0.077    C0596263    \n",
       "1142 Liver carcinoma                                  0.077    C2239176    \n",
       "     ei    score disease_semantic_type gene_symbol source protein_class\n",
       "8    1.000 0.60  Neoplastic Process    SPI1        ALL    DTO_05007542 \n",
       "19   0.938 0.40  Neoplastic Process    BCL11B      ALL    DTO_05007542 \n",
       "26   1.000 0.33  Neoplastic Process    BCL11B      ALL    DTO_05007542 \n",
       "29   1.000 0.32  Neoplastic Process    SPI1        ALL    DTO_05007542 \n",
       "30   1.000 0.32  Neoplastic Process    SPI1        ALL    DTO_05007542 \n",
       "32   1.000 0.31  Neoplastic Process    MST1R       ALL    DTO_03300101 \n",
       "51   1.000 0.30  Neoplastic Process    MST1R       ALL    DTO_03300101 \n",
       "58   1.000 0.30  Disease or Syndrome   PTGER4      ALL    DTO_02300001 \n",
       "59   1.000 0.30  Neoplastic Process    PTGER4      ALL    DTO_02300001 \n",
       "60   1.000 0.30  Disease or Syndrome   PTGER4      ALL    DTO_02300001 \n",
       "66   1.000 0.30  Neoplastic Process    SPI1        ALL    DTO_05007542 \n",
       "67   1.000 0.30  Neoplastic Process    SPI1        ALL    DTO_05007542 \n",
       "68   1.000 0.30  Neoplastic Process    SPI1        ALL    DTO_05007542 \n",
       "73      NA 0.30  Neoplastic Process    BCL11B      ALL    DTO_05007542 \n",
       "170     NA 0.10  Disease or Syndrome   CYB5A       ALL    DTO_05007624 \n",
       "179  1.000 0.10  Neoplastic Process    LDLR        ALL                 \n",
       "184  1.000 0.10  Neoplastic Process    LDLR        ALL                 \n",
       "186  1.000 0.10  Neoplastic Process    LDLR        ALL                 \n",
       "204  1.000 0.10  Neoplastic Process    LDLR        ALL                 \n",
       "212  1.000 0.10  Neoplastic Process    LDLR        ALL                 \n",
       "223  1.000 0.10  Neoplastic Process    MST1R       ALL    DTO_03300101 \n",
       "224     NA 0.10  Neoplastic Process    MST1R       ALL    DTO_03300101 \n",
       "225  1.000 0.10  Neoplastic Process    MST1R       ALL    DTO_03300101 \n",
       "226  1.000 0.10  Neoplastic Process    MST1R       ALL    DTO_03300101 \n",
       "228  1.000 0.10  Neoplastic Process    MST1R       ALL    DTO_03300101 \n",
       "230  1.000 0.10  Neoplastic Process    MST1R       ALL    DTO_03300101 \n",
       "233  1.000 0.10  Neoplastic Process    SPI1        ALL    DTO_05007542 \n",
       "244  1.000 0.10  Neoplastic Process    RBM38       ALL                 \n",
       "263  0.923 0.10  Neoplastic Process    BCL11B      ALL    DTO_05007542 \n",
       "294  0.929 0.10  Neoplastic Process    GGCT        ALL                 \n",
       "â‹®    â‹®     â‹®     â‹®                     â‹®           â‹®      â‹®            \n",
       "1087 1     0.01  Neoplastic Process    GGCT        ALL                 \n",
       "1088 1     0.01  Neoplastic Process    GGCT        ALL                 \n",
       "1090 1     0.01  Neoplastic Process    GGCT        ALL                 \n",
       "1091 1     0.01  Neoplastic Process    GGCT        ALL                 \n",
       "1094 1     0.01  Neoplastic Process    GGCT        ALL                 \n",
       "1095 1     0.01  Neoplastic Process    GGCT        ALL                 \n",
       "1096 1     0.01  Neoplastic Process    GGCT        ALL                 \n",
       "1097 1     0.01  Neoplastic Process    GGCT        ALL                 \n",
       "1098 1     0.01  Neoplastic Process    GGCT        ALL                 \n",
       "1100 1     0.01  Neoplastic Process    GGCT        ALL                 \n",
       "1102 1     0.01  Neoplastic Process    GGCT        ALL                 \n",
       "1113 1     0.01  Neoplastic Process    SPAG16      ALL    DTO_05007530 \n",
       "1118 1     0.01  Neoplastic Process    SPAG16      ALL    DTO_05007530 \n",
       "1120 1     0.01  Neoplastic Process    TRABD       ALL                 \n",
       "1121 1     0.01  Neoplastic Process    TRABD       ALL                 \n",
       "1122 1     0.01  Neoplastic Process    TRABD       ALL                 \n",
       "1123 1     0.01  Neoplastic Process    TRABD       ALL                 \n",
       "1127 1     0.01  Neoplastic Process    OCIAD2      ALL    DTO_05007608 \n",
       "1128 1     0.01  Neoplastic Process    OCIAD2      ALL    DTO_05007608 \n",
       "1129 1     0.01  Neoplastic Process    OCIAD2      ALL    DTO_05007608 \n",
       "1131 1     0.01  Neoplastic Process    OCIAD2      ALL    DTO_05007608 \n",
       "1132 1     0.01  Neoplastic Process    OCIAD2      ALL    DTO_05007608 \n",
       "1134 1     0.01  Neoplastic Process    OCIAD2      ALL    DTO_05007608 \n",
       "1135 1     0.01  Neoplastic Process    OCIAD2      ALL    DTO_05007608 \n",
       "1136 1     0.01  Neoplastic Process    OCIAD2      ALL    DTO_05007608 \n",
       "1137 1     0.01  Neoplastic Process    OCIAD2      ALL    DTO_05007608 \n",
       "1138 1     0.01  Neoplastic Process    OCIAD2      ALL    DTO_05007608 \n",
       "1139 1     0.01  Neoplastic Process    ZNF233      ALL                 \n",
       "1141 1     0.01  Neoplastic Process    ZNF233      ALL                 \n",
       "1142 1     0.01  Neoplastic Process    ZNF233      ALL                 \n",
       "     year_final\n",
       "8    2019      \n",
       "19   2018      \n",
       "26   2007      \n",
       "29   2011      \n",
       "30   2017      \n",
       "32   2016      \n",
       "51   2013      \n",
       "58   2011      \n",
       "59   2008      \n",
       "60   2011      \n",
       "66   2007      \n",
       "67   2015      \n",
       "68   2015      \n",
       "73     NA      \n",
       "170    NA      \n",
       "179  2012      \n",
       "184  2019      \n",
       "186  2019      \n",
       "204  2019      \n",
       "212  2018      \n",
       "223  2019      \n",
       "224    NA      \n",
       "225  2019      \n",
       "226  2019      \n",
       "228  2019      \n",
       "230  2019      \n",
       "233  2017      \n",
       "244  2019      \n",
       "263  2019      \n",
       "294  2020      \n",
       "â‹®    â‹®         \n",
       "1087 2017      \n",
       "1088 2019      \n",
       "1090 2015      \n",
       "1091 2019      \n",
       "1094 2019      \n",
       "1095 2010      \n",
       "1096 1993      \n",
       "1097 2005      \n",
       "1098 2007      \n",
       "1100 2010      \n",
       "1102 2019      \n",
       "1113 2011      \n",
       "1118 2013      \n",
       "1120 2018      \n",
       "1121 1991      \n",
       "1122 1993      \n",
       "1123 2014      \n",
       "1127 2014      \n",
       "1128 2007      \n",
       "1129 2018      \n",
       "1131 2018      \n",
       "1132 2018      \n",
       "1134 2007      \n",
       "1135 2014      \n",
       "1136 2007      \n",
       "1137 2017      \n",
       "1138 2018      \n",
       "1139 2018      \n",
       "1141 2018      \n",
       "1142 2018      "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "res1 = extract(gene2disease( gene = genesSG1, vocabulary = \"HGNC\",\n",
    "                     database = \"ALL\" , score =c(minScore, 1), warnings = F))\n",
    "nrow(res1)\n",
    "# filter disease_class_name on neoplasm (beign/malign), and optionally disease_name on melanoma, count\n",
    "wh =  grep(\"neoplasm\",res1$disease_class_name,ignore.case = T)\n",
    "res1 = res1[wh,]\n",
    "\n",
    "wh = grep(\"melanoma\",res1$disease_name, ignore.case = T)\n",
    "message(nrow(res1[wh,]), \" SG1 melanoma interaction:\") # 3 interactions, 3 genes: LDLR MST1R GGCT\n",
    "cat(length(unique(res1$gene_symbol[wh])), \"genes:\", unique(res1$gene_symbol[wh]))\n",
    "res1[wh,]\n",
    "message(nrow(res1), \" SG1 neoplasm interaction:\")\n",
    "cat(length(unique(res1$gene_symbol)), \"genes:\", unique(res1$gene_symbol))\n",
    "res1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "42a5c348",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "916"
      ],
      "text/latex": [
       "916"
      ],
      "text/markdown": [
       "916"
      ],
      "text/plain": [
       "[1] 916"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "4 SG2 melanoma interaction:\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4 genes: AIM2 RGS1 FES GATA3"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A data.frame: 4 Ã— 20</caption>\n",
       "<thead>\n",
       "\t<tr><th></th><th scope=col>diseaseid</th><th scope=col>score</th><th scope=col>protein_class_name</th><th scope=col>disease_class</th><th scope=col>disease_name</th><th scope=col>el</th><th scope=col>disease_class_name</th><th scope=col>gene_pli</th><th scope=col>gene_symbol</th><th scope=col>disease_semantic_type</th><th scope=col>ei</th><th scope=col>source</th><th scope=col>year_final</th><th scope=col>gene_dpi</th><th scope=col>protein_class</th><th scope=col>year_initial</th><th scope=col>gene_dsi</th><th scope=col>geneid</th><th scope=col>uniprotid</th><th scope=col>disease_type</th></tr>\n",
       "\t<tr><th></th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><th scope=row>262</th><td>C0025202</td><td>0.04</td><td>                </td><td>C04</td><td>melanoma</td><td></td><td>   Neoplasms</td><td>2.1942e-09</td><td>AIM2 </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2014</td><td>0.769</td><td>            </td><td>1997</td><td>0.521</td><td>9447</td><td>O14862</td><td>disease</td></tr>\n",
       "\t<tr><th scope=row>302</th><td>C0025202</td><td>0.03</td><td>Enzyme modulator</td><td>C04</td><td>melanoma</td><td></td><td>   Neoplasms</td><td>7.8178e-01</td><td>RGS1 </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2018</td><td>0.731</td><td>DTO_05007584</td><td>2008</td><td>0.653</td><td>5996</td><td>Q08116</td><td>disease</td></tr>\n",
       "\t<tr><th scope=row>457</th><td>C0025202</td><td>0.01</td><td>Kinase          </td><td>C04</td><td>melanoma</td><td></td><td>   Neoplasms</td><td>3.7916e-15</td><td>FES  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2017</td><td>0.769</td><td>DTO_03300101</td><td>2017</td><td>0.593</td><td>2242</td><td>P07332</td><td>disease</td></tr>\n",
       "\t<tr><th scope=row>547</th><td>C0025202</td><td>0.01</td><td>                </td><td>C04</td><td>melanoma</td><td></td><td>   Neoplasms</td><td>8.9887e-01</td><td>GATA3</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2019</td><td>0.846</td><td>            </td><td>2019</td><td>0.415</td><td>2625</td><td>P23771</td><td>disease</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A data.frame: 4 Ã— 20\n",
       "\\begin{tabular}{r|llllllllllllllllllll}\n",
       "  & diseaseid & score & protein\\_class\\_name & disease\\_class & disease\\_name & el & disease\\_class\\_name & gene\\_pli & gene\\_symbol & disease\\_semantic\\_type & ei & source & year\\_final & gene\\_dpi & protein\\_class & year\\_initial & gene\\_dsi & geneid & uniprotid & disease\\_type\\\\\n",
       "  & <chr> & <dbl> & <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <chr> & <chr> & <dbl> & <chr> & <int> & <dbl> & <chr> & <int> & <dbl> & <int> & <chr> & <chr>\\\\\n",
       "\\hline\n",
       "\t262 & C0025202 & 0.04 &                  & C04 & melanoma &  &    Neoplasms & 2.1942e-09 & AIM2  & Neoplastic Process & 1 & ALL & 2014 & 0.769 &              & 1997 & 0.521 & 9447 & O14862 & disease\\\\\n",
       "\t302 & C0025202 & 0.03 & Enzyme modulator & C04 & melanoma &  &    Neoplasms & 7.8178e-01 & RGS1  & Neoplastic Process & 1 & ALL & 2018 & 0.731 & DTO\\_05007584 & 2008 & 0.653 & 5996 & Q08116 & disease\\\\\n",
       "\t457 & C0025202 & 0.01 & Kinase           & C04 & melanoma &  &    Neoplasms & 3.7916e-15 & FES   & Neoplastic Process & 1 & ALL & 2017 & 0.769 & DTO\\_03300101 & 2017 & 0.593 & 2242 & P07332 & disease\\\\\n",
       "\t547 & C0025202 & 0.01 &                  & C04 & melanoma &  &    Neoplasms & 8.9887e-01 & GATA3 & Neoplastic Process & 1 & ALL & 2019 & 0.846 &              & 2019 & 0.415 & 2625 & P23771 & disease\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A data.frame: 4 Ã— 20\n",
       "\n",
       "| <!--/--> | diseaseid &lt;chr&gt; | score &lt;dbl&gt; | protein_class_name &lt;chr&gt; | disease_class &lt;chr&gt; | disease_name &lt;chr&gt; | el &lt;chr&gt; | disease_class_name &lt;chr&gt; | gene_pli &lt;dbl&gt; | gene_symbol &lt;chr&gt; | disease_semantic_type &lt;chr&gt; | ei &lt;dbl&gt; | source &lt;chr&gt; | year_final &lt;int&gt; | gene_dpi &lt;dbl&gt; | protein_class &lt;chr&gt; | year_initial &lt;int&gt; | gene_dsi &lt;dbl&gt; | geneid &lt;int&gt; | uniprotid &lt;chr&gt; | disease_type &lt;chr&gt; |\n",
       "|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n",
       "| 262 | C0025202 | 0.04 | <!----> | C04 | melanoma | <!----> |    Neoplasms | 2.1942e-09 | AIM2  | Neoplastic Process | 1 | ALL | 2014 | 0.769 | <!----> | 1997 | 0.521 | 9447 | O14862 | disease |\n",
       "| 302 | C0025202 | 0.03 | Enzyme modulator | C04 | melanoma | <!----> |    Neoplasms | 7.8178e-01 | RGS1  | Neoplastic Process | 1 | ALL | 2018 | 0.731 | DTO_05007584 | 2008 | 0.653 | 5996 | Q08116 | disease |\n",
       "| 457 | C0025202 | 0.01 | Kinase           | C04 | melanoma | <!----> |    Neoplasms | 3.7916e-15 | FES   | Neoplastic Process | 1 | ALL | 2017 | 0.769 | DTO_03300101 | 2017 | 0.593 | 2242 | P07332 | disease |\n",
       "| 547 | C0025202 | 0.01 | <!----> | C04 | melanoma | <!----> |    Neoplasms | 8.9887e-01 | GATA3 | Neoplastic Process | 1 | ALL | 2019 | 0.846 | <!----> | 2019 | 0.415 | 2625 | P23771 | disease |\n",
       "\n"
      ],
      "text/plain": [
       "    diseaseid score protein_class_name disease_class disease_name el\n",
       "262 C0025202  0.04                     C04           melanoma       \n",
       "302 C0025202  0.03  Enzyme modulator   C04           melanoma       \n",
       "457 C0025202  0.01  Kinase             C04           melanoma       \n",
       "547 C0025202  0.01                     C04           melanoma       \n",
       "    disease_class_name gene_pli   gene_symbol disease_semantic_type ei source\n",
       "262    Neoplasms       2.1942e-09 AIM2        Neoplastic Process    1  ALL   \n",
       "302    Neoplasms       7.8178e-01 RGS1        Neoplastic Process    1  ALL   \n",
       "457    Neoplasms       3.7916e-15 FES         Neoplastic Process    1  ALL   \n",
       "547    Neoplasms       8.9887e-01 GATA3       Neoplastic Process    1  ALL   \n",
       "    year_final gene_dpi protein_class year_initial gene_dsi geneid uniprotid\n",
       "262 2014       0.769                  1997         0.521    9447   O14862   \n",
       "302 2018       0.731    DTO_05007584  2008         0.653    5996   Q08116   \n",
       "457 2017       0.769    DTO_03300101  2017         0.593    2242   P07332   \n",
       "547 2019       0.846                  2019         0.415    2625   P23771   \n",
       "    disease_type\n",
       "262 disease     \n",
       "302 disease     \n",
       "457 disease     \n",
       "547 disease     "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "338 SG2 neoplasm interaction:\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "7 genes: GATA3 BCL11B RGS1 FES AIM2 TC2N SPAG16"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A data.frame: 338 Ã— 20</caption>\n",
       "<thead>\n",
       "\t<tr><th></th><th scope=col>diseaseid</th><th scope=col>score</th><th scope=col>protein_class_name</th><th scope=col>disease_class</th><th scope=col>disease_name</th><th scope=col>el</th><th scope=col>disease_class_name</th><th scope=col>gene_pli</th><th scope=col>gene_symbol</th><th scope=col>disease_semantic_type</th><th scope=col>ei</th><th scope=col>source</th><th scope=col>year_final</th><th scope=col>gene_dpi</th><th scope=col>protein_class</th><th scope=col>year_initial</th><th scope=col>gene_dsi</th><th scope=col>geneid</th><th scope=col>uniprotid</th><th scope=col>disease_type</th></tr>\n",
       "\t<tr><th></th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><th scope=row>3</th><td>C0006142</td><td>0.60</td><td>                    </td><td>C04;C17        </td><td>Malignant neoplasm of breast                       </td><td></td><td>   Neoplasms;    Skin and Connective Tissue Diseases                                                </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>0.950</td><td>ALL</td><td>2020</td><td>0.846</td><td>            </td><td>1999</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>4</th><td>C0019829</td><td>0.46</td><td>                    </td><td>C04;C20;C15    </td><td>Hodgkin Disease                                    </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2019</td><td>0.846</td><td>            </td><td>2005</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>7</th><td>C0007097</td><td>0.40</td><td>                    </td><td>C04            </td><td>Carcinoma                                          </td><td></td><td>   Neoplasms                                                                                        </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2019</td><td>0.846</td><td>            </td><td>2005</td><td>0.415</td><td> 2625</td><td>P23771</td><td>group    </td></tr>\n",
       "\t<tr><th scope=row>8</th><td>C0023485</td><td>0.40</td><td>                    </td><td>C04;C20;C15    </td><td>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma   </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2018</td><td>0.846</td><td>            </td><td>2013</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>9</th><td>C0678222</td><td>0.40</td><td>                    </td><td>C04;C17        </td><td>Breast Carcinoma                                   </td><td></td><td>   Neoplasms;    Skin and Connective Tissue Diseases                                                </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>0.940</td><td>ALL</td><td>2020</td><td>0.846</td><td>            </td><td>1999</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>10</th><td>C1961099</td><td>0.40</td><td>Transcription factor</td><td>C04;C20;C15    </td><td>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma   </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.98881</td><td>BCL11B</td><td>Neoplastic Process                               </td><td>0.938</td><td>ALL</td><td>2018</td><td>0.731</td><td>DTO_05007542</td><td>2003</td><td>0.568</td><td>64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>13</th><td>C0027819</td><td>0.36</td><td>                    </td><td>C04            </td><td>Neuroblastoma                                      </td><td></td><td>   Neoplasms                                                                                        </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2019</td><td>0.846</td><td>            </td><td>2010</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>14</th><td>C0220597</td><td>0.36</td><td>                    </td><td>C04;C20;C15    </td><td>Adult Hodgkin Lymphoma                             </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2019</td><td>0.846</td><td>            </td><td>2005</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>16</th><td>C0024299</td><td>0.33</td><td>Transcription factor</td><td>C04;C20;C15    </td><td>Lymphoma                                           </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.98881</td><td>BCL11B</td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2007</td><td>0.731</td><td>DTO_05007542</td><td>2003</td><td>0.568</td><td>64919</td><td>Q9C0K0</td><td>group    </td></tr>\n",
       "\t<tr><th scope=row>18</th><td>C0023493</td><td>0.31</td><td>                    </td><td>C04;C20;C15    </td><td>Adult T-Cell Lymphoma/Leukemia                     </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2015</td><td>0.846</td><td>            </td><td>2000</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>19</th><td>C0858252</td><td>0.31</td><td>                    </td><td>C04;C17        </td><td>Breast adenocarcinoma                              </td><td></td><td>   Neoplasms;    Skin and Connective Tissue Diseases                                                </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2016</td><td>0.846</td><td>            </td><td>2016</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>20</th><td>C1334968</td><td>0.31</td><td>                    </td><td>C04;C20;C15    </td><td>Nodular Lymphocyte Predominant Hodgkin Lymphoma    </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2019</td><td>0.846</td><td>            </td><td>2010</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>23</th><td>C0006413</td><td>0.30</td><td>                    </td><td>C04;C01;C20;C15</td><td>Burkitt Lymphoma                                   </td><td></td><td>   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases             </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2013</td><td>0.846</td><td>            </td><td>2013</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>26</th><td>C0024667</td><td>0.30</td><td>                    </td><td>C04;C22        </td><td>Animal Mammary Neoplasms                           </td><td></td><td>   Neoplasms;    Animal Diseases                                                                    </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2005</td><td>0.846</td><td>            </td><td>2005</td><td>0.415</td><td> 2625</td><td>P23771</td><td>phenotype</td></tr>\n",
       "\t<tr><th scope=row>27</th><td>C0024668</td><td>0.30</td><td>                    </td><td>C04            </td><td>Mammary Neoplasms, Experimental                    </td><td></td><td>   Neoplasms                                                                                        </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process; Experimental Model of Disease</td><td>1.000</td><td>ALL</td><td>2005</td><td>0.846</td><td>            </td><td>2005</td><td>0.415</td><td> 2625</td><td>P23771</td><td>phenotype</td></tr>\n",
       "\t<tr><th scope=row>29</th><td>C0152266</td><td>0.30</td><td>                    </td><td>C04;C20;C15    </td><td>Mixed Cellularity Hodgkin Lymphoma                 </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2010</td><td>0.846</td><td>            </td><td>2010</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>30</th><td>C0152267</td><td>0.30</td><td>                    </td><td>C04;C20;C15    </td><td>Hodgkin lymphoma, lymphocyte depletion             </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2010</td><td>0.846</td><td>            </td><td>2010</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>31</th><td>C0205696</td><td>0.30</td><td>                    </td><td>C04            </td><td>Anaplastic carcinoma                               </td><td></td><td>   Neoplasms                                                                                        </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2005</td><td>0.846</td><td>            </td><td>2005</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>32</th><td>C0205697</td><td>0.30</td><td>                    </td><td>C04            </td><td>Carcinoma, Spindle-Cell                            </td><td></td><td>   Neoplasms                                                                                        </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2005</td><td>0.846</td><td>            </td><td>2005</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>33</th><td>C0205698</td><td>0.30</td><td>                    </td><td>C04            </td><td>Undifferentiated carcinoma                         </td><td></td><td>   Neoplasms                                                                                        </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2005</td><td>0.846</td><td>            </td><td>2005</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>34</th><td>C0205699</td><td>0.30</td><td>                    </td><td>C04            </td><td>Carcinomatosis                                     </td><td></td><td>   Neoplasms                                                                                        </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2005</td><td>0.846</td><td>            </td><td>2005</td><td>0.415</td><td> 2625</td><td>P23771</td><td>phenotype</td></tr>\n",
       "\t<tr><th scope=row>35</th><td>C0496956</td><td>0.30</td><td>                    </td><td>C04;C17        </td><td>Neoplasm of uncertain or unknown behavior of breast</td><td></td><td>   Neoplasms;    Skin and Connective Tissue Diseases                                                </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>   NA</td><td>ALL</td><td>  NA</td><td>0.846</td><td>            </td><td>  NA</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>36</th><td>C1257925</td><td>0.30</td><td>                    </td><td>C04;C22        </td><td>Mammary Carcinoma, Animal                          </td><td></td><td>   Neoplasms;    Animal Diseases                                                                    </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2005</td><td>0.846</td><td>            </td><td>2005</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>37</th><td>C1266194</td><td>0.30</td><td>                    </td><td>C04;C20;C15    </td><td>Lymphocyte Rich Classical Hodgkin Lymphoma         </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2010</td><td>0.846</td><td>            </td><td>2010</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>38</th><td>C1292769</td><td>0.30</td><td>                    </td><td>C04;C20;C15    </td><td>Precursor B-cell lymphoblastic leukemia            </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2013</td><td>0.846</td><td>            </td><td>2013</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>39</th><td>C2930967</td><td>0.30</td><td>                    </td><td>C06;C04;C19    </td><td>Gastro-enteropancreatic neuroendocrine tumor       </td><td></td><td>   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                            </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2018</td><td>0.846</td><td>            </td><td>2018</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>40</th><td>C0029463</td><td>0.30</td><td>Enzyme modulator    </td><td>C04            </td><td>Osteosarcoma                                       </td><td></td><td>   Neoplasms                                                                                        </td><td>0.78178</td><td>RGS1  </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2004</td><td>0.731</td><td>DTO_05007584</td><td>2004</td><td>0.653</td><td> 5996</td><td>Q08116</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>48</th><td>C0009402</td><td>0.30</td><td>Transcription factor</td><td>C06;C04        </td><td>Colorectal Carcinoma                               </td><td></td><td>   Digestive System Diseases;    Neoplasms                                                          </td><td>0.98881</td><td>BCL11B</td><td>Neoplastic Process                               </td><td>   NA</td><td>ALL</td><td>  NA</td><td>0.731</td><td>DTO_05007542</td><td>  NA</td><td>0.568</td><td>64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>54</th><td>C0235831</td><td>0.20</td><td>                    </td><td>C04;C13;C12    </td><td>Renal Cell Dysplasia                               </td><td></td><td>   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases</td><td>0.89887</td><td>GATA3 </td><td>Disease or Syndrome                              </td><td>1.000</td><td>ALL</td><td>2018</td><td>0.846</td><td>            </td><td>2000</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>60</th><td>C1961102</td><td>0.13</td><td>                    </td><td>C04;C20;C15    </td><td>Precursor Cell Lymphoblastic Leukemia Lymphoma     </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>0.89887</td><td>GATA3 </td><td>Neoplastic Process                               </td><td>1.000</td><td>ALL</td><td>2019</td><td>0.846</td><td>            </td><td>2013</td><td>0.415</td><td> 2625</td><td>P23771</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>â‹®</th><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td></tr>\n",
       "\t<tr><th scope=row>833</th><td>C1168401</td><td>0.01</td><td>                    </td><td>C04        </td><td>Squamous cell carcinoma of the head and neck  </td><td></td><td>   Neoplasms                                                                                        </td><td>2.1942e-09</td><td>AIM2  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2019</td><td>0.769</td><td>            </td><td>2019</td><td>0.521</td><td>  9447</td><td>O14862</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>835</th><td>C1378703</td><td>0.01</td><td>                    </td><td>C04;C13;C12</td><td>Renal carcinoma                               </td><td></td><td>   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases</td><td>2.1942e-09</td><td>AIM2  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2018</td><td>0.769</td><td>            </td><td>2018</td><td>0.521</td><td>  9447</td><td>O14862</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>839</th><td>C1458155</td><td>0.01</td><td>                    </td><td>C04;C17    </td><td>Mammary Neoplasms                             </td><td></td><td>   Neoplasms;    Skin and Connective Tissue Diseases                                                </td><td>2.1942e-09</td><td>AIM2  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2006</td><td>0.769</td><td>            </td><td>2006</td><td>0.521</td><td>  9447</td><td>O14862</td><td>group    </td></tr>\n",
       "\t<tr><th scope=row>848</th><td>C1997217</td><td>0.01</td><td>                    </td><td>C04        </td><td>Low grade glioma                              </td><td></td><td>   Neoplasms                                                                                        </td><td>2.1942e-09</td><td>AIM2  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2019</td><td>0.769</td><td>            </td><td>2019</td><td>0.521</td><td>  9447</td><td>O14862</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>851</th><td>C2939419</td><td>0.01</td><td>                    </td><td>C23;C04    </td><td>Secondary Neoplasm                            </td><td></td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms                                        </td><td>2.1942e-09</td><td>AIM2  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2017</td><td>0.769</td><td>            </td><td>2017</td><td>0.521</td><td>  9447</td><td>O14862</td><td>group    </td></tr>\n",
       "\t<tr><th scope=row>856</th><td>C4086152</td><td>0.01</td><td>                    </td><td>C04        </td><td>Childhood Astrocytoma                         </td><td></td><td>   Neoplasms                                                                                        </td><td>2.1942e-09</td><td>AIM2  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2019</td><td>0.769</td><td>            </td><td>2019</td><td>0.521</td><td>  9447</td><td>O14862</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>862</th><td>C0005699</td><td>0.01</td><td>Transcription factor</td><td>C23;C04;C15</td><td>Blast Phase                                   </td><td></td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases       </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2009</td><td>0.731</td><td>DTO_05007542</td><td>2009</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>863</th><td>C0007102</td><td>0.01</td><td>Transcription factor</td><td>C06;C04    </td><td>Malignant tumor of colon                      </td><td></td><td>   Digestive System Diseases;    Neoplasms                                                          </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2015</td><td>0.731</td><td>DTO_05007542</td><td>2015</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>870</th><td>C0017638</td><td>0.01</td><td>Transcription factor</td><td>C04        </td><td>Glioma                                        </td><td></td><td>   Neoplasms                                                                                        </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2016</td><td>0.731</td><td>DTO_05007542</td><td>2016</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>875</th><td>C0023418</td><td>0.01</td><td>Transcription factor</td><td>C04        </td><td>leukemia                                      </td><td></td><td>   Neoplasms                                                                                        </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2004</td><td>0.731</td><td>DTO_05007542</td><td>2004</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>876</th><td>C0023449</td><td>0.01</td><td>Transcription factor</td><td>C04;C20;C15</td><td>Acute lymphocytic leukemia                    </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2018</td><td>0.731</td><td>DTO_05007542</td><td>2018</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>877</th><td>C0023452</td><td>0.01</td><td>Transcription factor</td><td>C04;C20;C15</td><td>Childhood Acute Lymphoblastic Leukemia        </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2003</td><td>0.731</td><td>DTO_05007542</td><td>2003</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>878</th><td>C0023473</td><td>0.01</td><td>Transcription factor</td><td>C04;C15    </td><td>Myeloid Leukemia, Chronic                     </td><td></td><td>   Neoplasms;    Hemic and Lymphatic Diseases                                                       </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2009</td><td>0.731</td><td>DTO_05007542</td><td>2009</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>881</th><td>C0026948</td><td>0.01</td><td>Transcription factor</td><td>C04;C20;C15</td><td>Mycosis Fungoides                             </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2017</td><td>0.731</td><td>DTO_05007542</td><td>2017</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>group    </td></tr>\n",
       "\t<tr><th scope=row>882</th><td>C0027533</td><td>0.01</td><td>Transcription factor</td><td>C04        </td><td>Neck Neoplasms                                </td><td></td><td>   Neoplasms                                                                                        </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2009</td><td>0.731</td><td>DTO_05007542</td><td>2009</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>group    </td></tr>\n",
       "\t<tr><th scope=row>883</th><td>C0027819</td><td>0.01</td><td>Transcription factor</td><td>C04        </td><td>Neuroblastoma                                 </td><td></td><td>   Neoplasms                                                                                        </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2006</td><td>0.731</td><td>DTO_05007542</td><td>2006</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>885</th><td>C0079772</td><td>0.01</td><td>Transcription factor</td><td>C04;C20;C15</td><td>T-Cell Lymphoma                               </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2012</td><td>0.731</td><td>DTO_05007542</td><td>2012</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>886</th><td>C0079773</td><td>0.01</td><td>Transcription factor</td><td>C04;C20;C15</td><td>Lymphoma, T-Cell, Cutaneous                   </td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2017</td><td>0.731</td><td>DTO_05007542</td><td>2017</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>888</th><td>C0376544</td><td>0.01</td><td>Transcription factor</td><td>C04;C15    </td><td>Hematopoietic Neoplasms                       </td><td></td><td>   Neoplasms;    Hemic and Lymphatic Diseases                                                       </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2007</td><td>0.731</td><td>DTO_05007542</td><td>2007</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>group    </td></tr>\n",
       "\t<tr><th scope=row>891</th><td>C0700095</td><td>0.01</td><td>Transcription factor</td><td>C04;C10    </td><td>Central neuroblastoma                         </td><td></td><td>   Neoplasms;    Nervous System Diseases                                                            </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2006</td><td>0.731</td><td>DTO_05007542</td><td>2006</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>892</th><td>C1168401</td><td>0.01</td><td>Transcription factor</td><td>C04        </td><td>Squamous cell carcinoma of the head and neck  </td><td></td><td>   Neoplasms                                                                                        </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2009</td><td>0.731</td><td>DTO_05007542</td><td>2009</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>894</th><td>C1961102</td><td>0.01</td><td>Transcription factor</td><td>C04;C20;C15</td><td>Precursor Cell Lymphoblastic Leukemia Lymphoma</td><td></td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2018</td><td>0.731</td><td>DTO_05007542</td><td>2018</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>899</th><td>C4086165</td><td>0.01</td><td>Transcription factor</td><td>C04        </td><td>Childhood Neuroblastoma                       </td><td></td><td>   Neoplasms                                                                                        </td><td>9.8881e-01</td><td>BCL11B</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2006</td><td>0.731</td><td>DTO_05007542</td><td>2006</td><td>0.568</td><td> 64919</td><td>Q9C0K0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>903</th><td>C0027651</td><td>0.01</td><td>Cellular structure  </td><td>C04        </td><td>Neoplasms                                     </td><td></td><td>   Neoplasms                                                                                        </td><td>1.4037e-34</td><td>SPAG16</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2011</td><td>0.385</td><td>DTO_05007530</td><td>2011</td><td>0.760</td><td> 79582</td><td>Q8N0X2</td><td>group    </td></tr>\n",
       "\t<tr><th scope=row>908</th><td>C4725671</td><td>0.01</td><td>Cellular structure  </td><td>C04        </td><td>High-Risk Neuroblastoma                       </td><td></td><td>   Neoplasms                                                                                        </td><td>1.4037e-34</td><td>SPAG16</td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2013</td><td>0.385</td><td>DTO_05007530</td><td>2013</td><td>0.760</td><td> 79582</td><td>Q8N0X2</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>911</th><td>C0006826</td><td>0.01</td><td>                    </td><td>C04        </td><td>Malignant Neoplasms                           </td><td></td><td>   Neoplasms                                                                                        </td><td>1.1879e-09</td><td>TC2N  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2019</td><td>0.154</td><td>            </td><td>2019</td><td>0.805</td><td>123036</td><td>Q8N9U0</td><td>group    </td></tr>\n",
       "\t<tr><th scope=row>912</th><td>C0024232</td><td>0.01</td><td>                    </td><td>C23;C04    </td><td>Lymphatic Metastasis                          </td><td></td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms                                        </td><td>1.1879e-09</td><td>TC2N  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2019</td><td>0.154</td><td>            </td><td>2019</td><td>0.805</td><td>123036</td><td>Q8N9U0</td><td>disease  </td></tr>\n",
       "\t<tr><th scope=row>913</th><td>C0027651</td><td>0.01</td><td>                    </td><td>C04        </td><td>Neoplasms                                     </td><td></td><td>   Neoplasms                                                                                        </td><td>1.1879e-09</td><td>TC2N  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2019</td><td>0.154</td><td>            </td><td>2019</td><td>0.805</td><td>123036</td><td>Q8N9U0</td><td>group    </td></tr>\n",
       "\t<tr><th scope=row>915</th><td>C0596263</td><td>0.01</td><td>                    </td><td>C23;C04    </td><td>Carcinogenesis                                </td><td></td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms                                        </td><td>1.1879e-09</td><td>TC2N  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2019</td><td>0.154</td><td>            </td><td>2019</td><td>0.805</td><td>123036</td><td>Q8N9U0</td><td>phenotype</td></tr>\n",
       "\t<tr><th scope=row>916</th><td>C1306459</td><td>0.01</td><td>                    </td><td>C04        </td><td>Primary malignant neoplasm                    </td><td></td><td>   Neoplasms                                                                                        </td><td>1.1879e-09</td><td>TC2N  </td><td>Neoplastic Process</td><td>1</td><td>ALL</td><td>2019</td><td>0.154</td><td>            </td><td>2019</td><td>0.805</td><td>123036</td><td>Q8N9U0</td><td>group    </td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A data.frame: 338 Ã— 20\n",
       "\\begin{tabular}{r|llllllllllllllllllll}\n",
       "  & diseaseid & score & protein\\_class\\_name & disease\\_class & disease\\_name & el & disease\\_class\\_name & gene\\_pli & gene\\_symbol & disease\\_semantic\\_type & ei & source & year\\_final & gene\\_dpi & protein\\_class & year\\_initial & gene\\_dsi & geneid & uniprotid & disease\\_type\\\\\n",
       "  & <chr> & <dbl> & <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <chr> & <chr> & <dbl> & <chr> & <int> & <dbl> & <chr> & <int> & <dbl> & <int> & <chr> & <chr>\\\\\n",
       "\\hline\n",
       "\t3 & C0006142 & 0.60 &                      & C04;C17         & Malignant neoplasm of breast                        &  &    Neoplasms;    Skin and Connective Tissue Diseases                                                 & 0.89887 & GATA3  & Neoplastic Process                                & 0.950 & ALL & 2020 & 0.846 &              & 1999 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t4 & C0019829 & 0.46 &                      & C04;C20;C15     & Hodgkin Disease                                     &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2019 & 0.846 &              & 2005 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t7 & C0007097 & 0.40 &                      & C04             & Carcinoma                                           &  &    Neoplasms                                                                                         & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2019 & 0.846 &              & 2005 & 0.415 &  2625 & P23771 & group    \\\\\n",
       "\t8 & C0023485 & 0.40 &                      & C04;C20;C15     & Precursor B-Cell Lymphoblastic Leukemia-Lymphoma    &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2018 & 0.846 &              & 2013 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t9 & C0678222 & 0.40 &                      & C04;C17         & Breast Carcinoma                                    &  &    Neoplasms;    Skin and Connective Tissue Diseases                                                 & 0.89887 & GATA3  & Neoplastic Process                                & 0.940 & ALL & 2020 & 0.846 &              & 1999 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t10 & C1961099 & 0.40 & Transcription factor & C04;C20;C15     & Precursor T-Cell Lymphoblastic Leukemia-Lymphoma    &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.98881 & BCL11B & Neoplastic Process                                & 0.938 & ALL & 2018 & 0.731 & DTO\\_05007542 & 2003 & 0.568 & 64919 & Q9C0K0 & disease  \\\\\n",
       "\t13 & C0027819 & 0.36 &                      & C04             & Neuroblastoma                                       &  &    Neoplasms                                                                                         & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2019 & 0.846 &              & 2010 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t14 & C0220597 & 0.36 &                      & C04;C20;C15     & Adult Hodgkin Lymphoma                              &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2019 & 0.846 &              & 2005 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t16 & C0024299 & 0.33 & Transcription factor & C04;C20;C15     & Lymphoma                                            &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.98881 & BCL11B & Neoplastic Process                                & 1.000 & ALL & 2007 & 0.731 & DTO\\_05007542 & 2003 & 0.568 & 64919 & Q9C0K0 & group    \\\\\n",
       "\t18 & C0023493 & 0.31 &                      & C04;C20;C15     & Adult T-Cell Lymphoma/Leukemia                      &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2015 & 0.846 &              & 2000 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t19 & C0858252 & 0.31 &                      & C04;C17         & Breast adenocarcinoma                               &  &    Neoplasms;    Skin and Connective Tissue Diseases                                                 & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2016 & 0.846 &              & 2016 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t20 & C1334968 & 0.31 &                      & C04;C20;C15     & Nodular Lymphocyte Predominant Hodgkin Lymphoma     &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2019 & 0.846 &              & 2010 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t23 & C0006413 & 0.30 &                      & C04;C01;C20;C15 & Burkitt Lymphoma                                    &  &    Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases              & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2013 & 0.846 &              & 2013 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t26 & C0024667 & 0.30 &                      & C04;C22         & Animal Mammary Neoplasms                            &  &    Neoplasms;    Animal Diseases                                                                     & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2005 & 0.846 &              & 2005 & 0.415 &  2625 & P23771 & phenotype\\\\\n",
       "\t27 & C0024668 & 0.30 &                      & C04             & Mammary Neoplasms, Experimental                     &  &    Neoplasms                                                                                         & 0.89887 & GATA3  & Neoplastic Process; Experimental Model of Disease & 1.000 & ALL & 2005 & 0.846 &              & 2005 & 0.415 &  2625 & P23771 & phenotype\\\\\n",
       "\t29 & C0152266 & 0.30 &                      & C04;C20;C15     & Mixed Cellularity Hodgkin Lymphoma                  &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2010 & 0.846 &              & 2010 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t30 & C0152267 & 0.30 &                      & C04;C20;C15     & Hodgkin lymphoma, lymphocyte depletion              &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2010 & 0.846 &              & 2010 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t31 & C0205696 & 0.30 &                      & C04             & Anaplastic carcinoma                                &  &    Neoplasms                                                                                         & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2005 & 0.846 &              & 2005 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t32 & C0205697 & 0.30 &                      & C04             & Carcinoma, Spindle-Cell                             &  &    Neoplasms                                                                                         & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2005 & 0.846 &              & 2005 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t33 & C0205698 & 0.30 &                      & C04             & Undifferentiated carcinoma                          &  &    Neoplasms                                                                                         & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2005 & 0.846 &              & 2005 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t34 & C0205699 & 0.30 &                      & C04             & Carcinomatosis                                      &  &    Neoplasms                                                                                         & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2005 & 0.846 &              & 2005 & 0.415 &  2625 & P23771 & phenotype\\\\\n",
       "\t35 & C0496956 & 0.30 &                      & C04;C17         & Neoplasm of uncertain or unknown behavior of breast &  &    Neoplasms;    Skin and Connective Tissue Diseases                                                 & 0.89887 & GATA3  & Neoplastic Process                                &    NA & ALL &   NA & 0.846 &              &   NA & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t36 & C1257925 & 0.30 &                      & C04;C22         & Mammary Carcinoma, Animal                           &  &    Neoplasms;    Animal Diseases                                                                     & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2005 & 0.846 &              & 2005 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t37 & C1266194 & 0.30 &                      & C04;C20;C15     & Lymphocyte Rich Classical Hodgkin Lymphoma          &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2010 & 0.846 &              & 2010 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t38 & C1292769 & 0.30 &                      & C04;C20;C15     & Precursor B-cell lymphoblastic leukemia             &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2013 & 0.846 &              & 2013 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t39 & C2930967 & 0.30 &                      & C06;C04;C19     & Gastro-enteropancreatic neuroendocrine tumor        &  &    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                             & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2018 & 0.846 &              & 2018 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t40 & C0029463 & 0.30 & Enzyme modulator     & C04             & Osteosarcoma                                        &  &    Neoplasms                                                                                         & 0.78178 & RGS1   & Neoplastic Process                                & 1.000 & ALL & 2004 & 0.731 & DTO\\_05007584 & 2004 & 0.653 &  5996 & Q08116 & disease  \\\\\n",
       "\t48 & C0009402 & 0.30 & Transcription factor & C06;C04         & Colorectal Carcinoma                                &  &    Digestive System Diseases;    Neoplasms                                                           & 0.98881 & BCL11B & Neoplastic Process                                &    NA & ALL &   NA & 0.731 & DTO\\_05007542 &   NA & 0.568 & 64919 & Q9C0K0 & disease  \\\\\n",
       "\t54 & C0235831 & 0.20 &                      & C04;C13;C12     & Renal Cell Dysplasia                                &  &    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases & 0.89887 & GATA3  & Disease or Syndrome                               & 1.000 & ALL & 2018 & 0.846 &              & 2000 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\t60 & C1961102 & 0.13 &                      & C04;C20;C15     & Precursor Cell Lymphoblastic Leukemia Lymphoma      &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 0.89887 & GATA3  & Neoplastic Process                                & 1.000 & ALL & 2019 & 0.846 &              & 2013 & 0.415 &  2625 & P23771 & disease  \\\\\n",
       "\tâ‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹®\\\\\n",
       "\t833 & C1168401 & 0.01 &                      & C04         & Squamous cell carcinoma of the head and neck   &  &    Neoplasms                                                                                         & 2.1942e-09 & AIM2   & Neoplastic Process & 1 & ALL & 2019 & 0.769 &              & 2019 & 0.521 &   9447 & O14862 & disease  \\\\\n",
       "\t835 & C1378703 & 0.01 &                      & C04;C13;C12 & Renal carcinoma                                &  &    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases & 2.1942e-09 & AIM2   & Neoplastic Process & 1 & ALL & 2018 & 0.769 &              & 2018 & 0.521 &   9447 & O14862 & disease  \\\\\n",
       "\t839 & C1458155 & 0.01 &                      & C04;C17     & Mammary Neoplasms                              &  &    Neoplasms;    Skin and Connective Tissue Diseases                                                 & 2.1942e-09 & AIM2   & Neoplastic Process & 1 & ALL & 2006 & 0.769 &              & 2006 & 0.521 &   9447 & O14862 & group    \\\\\n",
       "\t848 & C1997217 & 0.01 &                      & C04         & Low grade glioma                               &  &    Neoplasms                                                                                         & 2.1942e-09 & AIM2   & Neoplastic Process & 1 & ALL & 2019 & 0.769 &              & 2019 & 0.521 &   9447 & O14862 & disease  \\\\\n",
       "\t851 & C2939419 & 0.01 &                      & C23;C04     & Secondary Neoplasm                             &  &    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         & 2.1942e-09 & AIM2   & Neoplastic Process & 1 & ALL & 2017 & 0.769 &              & 2017 & 0.521 &   9447 & O14862 & group    \\\\\n",
       "\t856 & C4086152 & 0.01 &                      & C04         & Childhood Astrocytoma                          &  &    Neoplasms                                                                                         & 2.1942e-09 & AIM2   & Neoplastic Process & 1 & ALL & 2019 & 0.769 &              & 2019 & 0.521 &   9447 & O14862 & disease  \\\\\n",
       "\t862 & C0005699 & 0.01 & Transcription factor & C23;C04;C15 & Blast Phase                                    &  &    Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases        & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2009 & 0.731 & DTO\\_05007542 & 2009 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t863 & C0007102 & 0.01 & Transcription factor & C06;C04     & Malignant tumor of colon                       &  &    Digestive System Diseases;    Neoplasms                                                           & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2015 & 0.731 & DTO\\_05007542 & 2015 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t870 & C0017638 & 0.01 & Transcription factor & C04         & Glioma                                         &  &    Neoplasms                                                                                         & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2016 & 0.731 & DTO\\_05007542 & 2016 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t875 & C0023418 & 0.01 & Transcription factor & C04         & leukemia                                       &  &    Neoplasms                                                                                         & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2004 & 0.731 & DTO\\_05007542 & 2004 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t876 & C0023449 & 0.01 & Transcription factor & C04;C20;C15 & Acute lymphocytic leukemia                     &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2018 & 0.731 & DTO\\_05007542 & 2018 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t877 & C0023452 & 0.01 & Transcription factor & C04;C20;C15 & Childhood Acute Lymphoblastic Leukemia         &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2003 & 0.731 & DTO\\_05007542 & 2003 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t878 & C0023473 & 0.01 & Transcription factor & C04;C15     & Myeloid Leukemia, Chronic                      &  &    Neoplasms;    Hemic and Lymphatic Diseases                                                        & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2009 & 0.731 & DTO\\_05007542 & 2009 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t881 & C0026948 & 0.01 & Transcription factor & C04;C20;C15 & Mycosis Fungoides                              &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2017 & 0.731 & DTO\\_05007542 & 2017 & 0.568 &  64919 & Q9C0K0 & group    \\\\\n",
       "\t882 & C0027533 & 0.01 & Transcription factor & C04         & Neck Neoplasms                                 &  &    Neoplasms                                                                                         & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2009 & 0.731 & DTO\\_05007542 & 2009 & 0.568 &  64919 & Q9C0K0 & group    \\\\\n",
       "\t883 & C0027819 & 0.01 & Transcription factor & C04         & Neuroblastoma                                  &  &    Neoplasms                                                                                         & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2006 & 0.731 & DTO\\_05007542 & 2006 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t885 & C0079772 & 0.01 & Transcription factor & C04;C20;C15 & T-Cell Lymphoma                                &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2012 & 0.731 & DTO\\_05007542 & 2012 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t886 & C0079773 & 0.01 & Transcription factor & C04;C20;C15 & Lymphoma, T-Cell, Cutaneous                    &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2017 & 0.731 & DTO\\_05007542 & 2017 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t888 & C0376544 & 0.01 & Transcription factor & C04;C15     & Hematopoietic Neoplasms                        &  &    Neoplasms;    Hemic and Lymphatic Diseases                                                        & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2007 & 0.731 & DTO\\_05007542 & 2007 & 0.568 &  64919 & Q9C0K0 & group    \\\\\n",
       "\t891 & C0700095 & 0.01 & Transcription factor & C04;C10     & Central neuroblastoma                          &  &    Neoplasms;    Nervous System Diseases                                                             & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2006 & 0.731 & DTO\\_05007542 & 2006 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t892 & C1168401 & 0.01 & Transcription factor & C04         & Squamous cell carcinoma of the head and neck   &  &    Neoplasms                                                                                         & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2009 & 0.731 & DTO\\_05007542 & 2009 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t894 & C1961102 & 0.01 & Transcription factor & C04;C20;C15 & Precursor Cell Lymphoblastic Leukemia Lymphoma &  &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2018 & 0.731 & DTO\\_05007542 & 2018 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t899 & C4086165 & 0.01 & Transcription factor & C04         & Childhood Neuroblastoma                        &  &    Neoplasms                                                                                         & 9.8881e-01 & BCL11B & Neoplastic Process & 1 & ALL & 2006 & 0.731 & DTO\\_05007542 & 2006 & 0.568 &  64919 & Q9C0K0 & disease  \\\\\n",
       "\t903 & C0027651 & 0.01 & Cellular structure   & C04         & Neoplasms                                      &  &    Neoplasms                                                                                         & 1.4037e-34 & SPAG16 & Neoplastic Process & 1 & ALL & 2011 & 0.385 & DTO\\_05007530 & 2011 & 0.760 &  79582 & Q8N0X2 & group    \\\\\n",
       "\t908 & C4725671 & 0.01 & Cellular structure   & C04         & High-Risk Neuroblastoma                        &  &    Neoplasms                                                                                         & 1.4037e-34 & SPAG16 & Neoplastic Process & 1 & ALL & 2013 & 0.385 & DTO\\_05007530 & 2013 & 0.760 &  79582 & Q8N0X2 & disease  \\\\\n",
       "\t911 & C0006826 & 0.01 &                      & C04         & Malignant Neoplasms                            &  &    Neoplasms                                                                                         & 1.1879e-09 & TC2N   & Neoplastic Process & 1 & ALL & 2019 & 0.154 &              & 2019 & 0.805 & 123036 & Q8N9U0 & group    \\\\\n",
       "\t912 & C0024232 & 0.01 &                      & C23;C04     & Lymphatic Metastasis                           &  &    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         & 1.1879e-09 & TC2N   & Neoplastic Process & 1 & ALL & 2019 & 0.154 &              & 2019 & 0.805 & 123036 & Q8N9U0 & disease  \\\\\n",
       "\t913 & C0027651 & 0.01 &                      & C04         & Neoplasms                                      &  &    Neoplasms                                                                                         & 1.1879e-09 & TC2N   & Neoplastic Process & 1 & ALL & 2019 & 0.154 &              & 2019 & 0.805 & 123036 & Q8N9U0 & group    \\\\\n",
       "\t915 & C0596263 & 0.01 &                      & C23;C04     & Carcinogenesis                                 &  &    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         & 1.1879e-09 & TC2N   & Neoplastic Process & 1 & ALL & 2019 & 0.154 &              & 2019 & 0.805 & 123036 & Q8N9U0 & phenotype\\\\\n",
       "\t916 & C1306459 & 0.01 &                      & C04         & Primary malignant neoplasm                     &  &    Neoplasms                                                                                         & 1.1879e-09 & TC2N   & Neoplastic Process & 1 & ALL & 2019 & 0.154 &              & 2019 & 0.805 & 123036 & Q8N9U0 & group    \\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A data.frame: 338 Ã— 20\n",
       "\n",
       "| <!--/--> | diseaseid &lt;chr&gt; | score &lt;dbl&gt; | protein_class_name &lt;chr&gt; | disease_class &lt;chr&gt; | disease_name &lt;chr&gt; | el &lt;chr&gt; | disease_class_name &lt;chr&gt; | gene_pli &lt;dbl&gt; | gene_symbol &lt;chr&gt; | disease_semantic_type &lt;chr&gt; | ei &lt;dbl&gt; | source &lt;chr&gt; | year_final &lt;int&gt; | gene_dpi &lt;dbl&gt; | protein_class &lt;chr&gt; | year_initial &lt;int&gt; | gene_dsi &lt;dbl&gt; | geneid &lt;int&gt; | uniprotid &lt;chr&gt; | disease_type &lt;chr&gt; |\n",
       "|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n",
       "| 3 | C0006142 | 0.60 | <!----> | C04;C17         | Malignant neoplasm of breast                        | <!----> |    Neoplasms;    Skin and Connective Tissue Diseases                                                 | 0.89887 | GATA3  | Neoplastic Process                                | 0.950 | ALL | 2020 | 0.846 | <!----> | 1999 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 4 | C0019829 | 0.46 | <!----> | C04;C20;C15     | Hodgkin Disease                                     | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2019 | 0.846 | <!----> | 2005 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 7 | C0007097 | 0.40 | <!----> | C04             | Carcinoma                                           | <!----> |    Neoplasms                                                                                         | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2019 | 0.846 | <!----> | 2005 | 0.415 |  2625 | P23771 | group     |\n",
       "| 8 | C0023485 | 0.40 | <!----> | C04;C20;C15     | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma    | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2018 | 0.846 | <!----> | 2013 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 9 | C0678222 | 0.40 | <!----> | C04;C17         | Breast Carcinoma                                    | <!----> |    Neoplasms;    Skin and Connective Tissue Diseases                                                 | 0.89887 | GATA3  | Neoplastic Process                                | 0.940 | ALL | 2020 | 0.846 | <!----> | 1999 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 10 | C1961099 | 0.40 | Transcription factor | C04;C20;C15     | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma    | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.98881 | BCL11B | Neoplastic Process                                | 0.938 | ALL | 2018 | 0.731 | DTO_05007542 | 2003 | 0.568 | 64919 | Q9C0K0 | disease   |\n",
       "| 13 | C0027819 | 0.36 | <!----> | C04             | Neuroblastoma                                       | <!----> |    Neoplasms                                                                                         | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2019 | 0.846 | <!----> | 2010 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 14 | C0220597 | 0.36 | <!----> | C04;C20;C15     | Adult Hodgkin Lymphoma                              | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2019 | 0.846 | <!----> | 2005 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 16 | C0024299 | 0.33 | Transcription factor | C04;C20;C15     | Lymphoma                                            | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.98881 | BCL11B | Neoplastic Process                                | 1.000 | ALL | 2007 | 0.731 | DTO_05007542 | 2003 | 0.568 | 64919 | Q9C0K0 | group     |\n",
       "| 18 | C0023493 | 0.31 | <!----> | C04;C20;C15     | Adult T-Cell Lymphoma/Leukemia                      | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2015 | 0.846 | <!----> | 2000 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 19 | C0858252 | 0.31 | <!----> | C04;C17         | Breast adenocarcinoma                               | <!----> |    Neoplasms;    Skin and Connective Tissue Diseases                                                 | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2016 | 0.846 | <!----> | 2016 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 20 | C1334968 | 0.31 | <!----> | C04;C20;C15     | Nodular Lymphocyte Predominant Hodgkin Lymphoma     | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2019 | 0.846 | <!----> | 2010 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 23 | C0006413 | 0.30 | <!----> | C04;C01;C20;C15 | Burkitt Lymphoma                                    | <!----> |    Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases              | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2013 | 0.846 | <!----> | 2013 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 26 | C0024667 | 0.30 | <!----> | C04;C22         | Animal Mammary Neoplasms                            | <!----> |    Neoplasms;    Animal Diseases                                                                     | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2005 | 0.846 | <!----> | 2005 | 0.415 |  2625 | P23771 | phenotype |\n",
       "| 27 | C0024668 | 0.30 | <!----> | C04             | Mammary Neoplasms, Experimental                     | <!----> |    Neoplasms                                                                                         | 0.89887 | GATA3  | Neoplastic Process; Experimental Model of Disease | 1.000 | ALL | 2005 | 0.846 | <!----> | 2005 | 0.415 |  2625 | P23771 | phenotype |\n",
       "| 29 | C0152266 | 0.30 | <!----> | C04;C20;C15     | Mixed Cellularity Hodgkin Lymphoma                  | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2010 | 0.846 | <!----> | 2010 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 30 | C0152267 | 0.30 | <!----> | C04;C20;C15     | Hodgkin lymphoma, lymphocyte depletion              | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2010 | 0.846 | <!----> | 2010 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 31 | C0205696 | 0.30 | <!----> | C04             | Anaplastic carcinoma                                | <!----> |    Neoplasms                                                                                         | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2005 | 0.846 | <!----> | 2005 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 32 | C0205697 | 0.30 | <!----> | C04             | Carcinoma, Spindle-Cell                             | <!----> |    Neoplasms                                                                                         | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2005 | 0.846 | <!----> | 2005 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 33 | C0205698 | 0.30 | <!----> | C04             | Undifferentiated carcinoma                          | <!----> |    Neoplasms                                                                                         | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2005 | 0.846 | <!----> | 2005 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 34 | C0205699 | 0.30 | <!----> | C04             | Carcinomatosis                                      | <!----> |    Neoplasms                                                                                         | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2005 | 0.846 | <!----> | 2005 | 0.415 |  2625 | P23771 | phenotype |\n",
       "| 35 | C0496956 | 0.30 | <!----> | C04;C17         | Neoplasm of uncertain or unknown behavior of breast | <!----> |    Neoplasms;    Skin and Connective Tissue Diseases                                                 | 0.89887 | GATA3  | Neoplastic Process                                |    NA | ALL |   NA | 0.846 | <!----> |   NA | 0.415 |  2625 | P23771 | disease   |\n",
       "| 36 | C1257925 | 0.30 | <!----> | C04;C22         | Mammary Carcinoma, Animal                           | <!----> |    Neoplasms;    Animal Diseases                                                                     | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2005 | 0.846 | <!----> | 2005 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 37 | C1266194 | 0.30 | <!----> | C04;C20;C15     | Lymphocyte Rich Classical Hodgkin Lymphoma          | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2010 | 0.846 | <!----> | 2010 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 38 | C1292769 | 0.30 | <!----> | C04;C20;C15     | Precursor B-cell lymphoblastic leukemia             | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2013 | 0.846 | <!----> | 2013 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 39 | C2930967 | 0.30 | <!----> | C06;C04;C19     | Gastro-enteropancreatic neuroendocrine tumor        | <!----> |    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                             | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2018 | 0.846 | <!----> | 2018 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 40 | C0029463 | 0.30 | Enzyme modulator     | C04             | Osteosarcoma                                        | <!----> |    Neoplasms                                                                                         | 0.78178 | RGS1   | Neoplastic Process                                | 1.000 | ALL | 2004 | 0.731 | DTO_05007584 | 2004 | 0.653 |  5996 | Q08116 | disease   |\n",
       "| 48 | C0009402 | 0.30 | Transcription factor | C06;C04         | Colorectal Carcinoma                                | <!----> |    Digestive System Diseases;    Neoplasms                                                           | 0.98881 | BCL11B | Neoplastic Process                                |    NA | ALL |   NA | 0.731 | DTO_05007542 |   NA | 0.568 | 64919 | Q9C0K0 | disease   |\n",
       "| 54 | C0235831 | 0.20 | <!----> | C04;C13;C12     | Renal Cell Dysplasia                                | <!----> |    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases | 0.89887 | GATA3  | Disease or Syndrome                               | 1.000 | ALL | 2018 | 0.846 | <!----> | 2000 | 0.415 |  2625 | P23771 | disease   |\n",
       "| 60 | C1961102 | 0.13 | <!----> | C04;C20;C15     | Precursor Cell Lymphoblastic Leukemia Lymphoma      | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 0.89887 | GATA3  | Neoplastic Process                                | 1.000 | ALL | 2019 | 0.846 | <!----> | 2013 | 0.415 |  2625 | P23771 | disease   |\n",
       "| â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® |\n",
       "| 833 | C1168401 | 0.01 | <!----> | C04         | Squamous cell carcinoma of the head and neck   | <!----> |    Neoplasms                                                                                         | 2.1942e-09 | AIM2   | Neoplastic Process | 1 | ALL | 2019 | 0.769 | <!----> | 2019 | 0.521 |   9447 | O14862 | disease   |\n",
       "| 835 | C1378703 | 0.01 | <!----> | C04;C13;C12 | Renal carcinoma                                | <!----> |    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases | 2.1942e-09 | AIM2   | Neoplastic Process | 1 | ALL | 2018 | 0.769 | <!----> | 2018 | 0.521 |   9447 | O14862 | disease   |\n",
       "| 839 | C1458155 | 0.01 | <!----> | C04;C17     | Mammary Neoplasms                              | <!----> |    Neoplasms;    Skin and Connective Tissue Diseases                                                 | 2.1942e-09 | AIM2   | Neoplastic Process | 1 | ALL | 2006 | 0.769 | <!----> | 2006 | 0.521 |   9447 | O14862 | group     |\n",
       "| 848 | C1997217 | 0.01 | <!----> | C04         | Low grade glioma                               | <!----> |    Neoplasms                                                                                         | 2.1942e-09 | AIM2   | Neoplastic Process | 1 | ALL | 2019 | 0.769 | <!----> | 2019 | 0.521 |   9447 | O14862 | disease   |\n",
       "| 851 | C2939419 | 0.01 | <!----> | C23;C04     | Secondary Neoplasm                             | <!----> |    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         | 2.1942e-09 | AIM2   | Neoplastic Process | 1 | ALL | 2017 | 0.769 | <!----> | 2017 | 0.521 |   9447 | O14862 | group     |\n",
       "| 856 | C4086152 | 0.01 | <!----> | C04         | Childhood Astrocytoma                          | <!----> |    Neoplasms                                                                                         | 2.1942e-09 | AIM2   | Neoplastic Process | 1 | ALL | 2019 | 0.769 | <!----> | 2019 | 0.521 |   9447 | O14862 | disease   |\n",
       "| 862 | C0005699 | 0.01 | Transcription factor | C23;C04;C15 | Blast Phase                                    | <!----> |    Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases        | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2009 | 0.731 | DTO_05007542 | 2009 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 863 | C0007102 | 0.01 | Transcription factor | C06;C04     | Malignant tumor of colon                       | <!----> |    Digestive System Diseases;    Neoplasms                                                           | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2015 | 0.731 | DTO_05007542 | 2015 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 870 | C0017638 | 0.01 | Transcription factor | C04         | Glioma                                         | <!----> |    Neoplasms                                                                                         | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2016 | 0.731 | DTO_05007542 | 2016 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 875 | C0023418 | 0.01 | Transcription factor | C04         | leukemia                                       | <!----> |    Neoplasms                                                                                         | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2004 | 0.731 | DTO_05007542 | 2004 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 876 | C0023449 | 0.01 | Transcription factor | C04;C20;C15 | Acute lymphocytic leukemia                     | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2018 | 0.731 | DTO_05007542 | 2018 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 877 | C0023452 | 0.01 | Transcription factor | C04;C20;C15 | Childhood Acute Lymphoblastic Leukemia         | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2003 | 0.731 | DTO_05007542 | 2003 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 878 | C0023473 | 0.01 | Transcription factor | C04;C15     | Myeloid Leukemia, Chronic                      | <!----> |    Neoplasms;    Hemic and Lymphatic Diseases                                                        | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2009 | 0.731 | DTO_05007542 | 2009 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 881 | C0026948 | 0.01 | Transcription factor | C04;C20;C15 | Mycosis Fungoides                              | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2017 | 0.731 | DTO_05007542 | 2017 | 0.568 |  64919 | Q9C0K0 | group     |\n",
       "| 882 | C0027533 | 0.01 | Transcription factor | C04         | Neck Neoplasms                                 | <!----> |    Neoplasms                                                                                         | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2009 | 0.731 | DTO_05007542 | 2009 | 0.568 |  64919 | Q9C0K0 | group     |\n",
       "| 883 | C0027819 | 0.01 | Transcription factor | C04         | Neuroblastoma                                  | <!----> |    Neoplasms                                                                                         | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2006 | 0.731 | DTO_05007542 | 2006 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 885 | C0079772 | 0.01 | Transcription factor | C04;C20;C15 | T-Cell Lymphoma                                | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2012 | 0.731 | DTO_05007542 | 2012 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 886 | C0079773 | 0.01 | Transcription factor | C04;C20;C15 | Lymphoma, T-Cell, Cutaneous                    | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2017 | 0.731 | DTO_05007542 | 2017 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 888 | C0376544 | 0.01 | Transcription factor | C04;C15     | Hematopoietic Neoplasms                        | <!----> |    Neoplasms;    Hemic and Lymphatic Diseases                                                        | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2007 | 0.731 | DTO_05007542 | 2007 | 0.568 |  64919 | Q9C0K0 | group     |\n",
       "| 891 | C0700095 | 0.01 | Transcription factor | C04;C10     | Central neuroblastoma                          | <!----> |    Neoplasms;    Nervous System Diseases                                                             | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2006 | 0.731 | DTO_05007542 | 2006 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 892 | C1168401 | 0.01 | Transcription factor | C04         | Squamous cell carcinoma of the head and neck   | <!----> |    Neoplasms                                                                                         | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2009 | 0.731 | DTO_05007542 | 2009 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 894 | C1961102 | 0.01 | Transcription factor | C04;C20;C15 | Precursor Cell Lymphoblastic Leukemia Lymphoma | <!----> |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2018 | 0.731 | DTO_05007542 | 2018 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 899 | C4086165 | 0.01 | Transcription factor | C04         | Childhood Neuroblastoma                        | <!----> |    Neoplasms                                                                                         | 9.8881e-01 | BCL11B | Neoplastic Process | 1 | ALL | 2006 | 0.731 | DTO_05007542 | 2006 | 0.568 |  64919 | Q9C0K0 | disease   |\n",
       "| 903 | C0027651 | 0.01 | Cellular structure   | C04         | Neoplasms                                      | <!----> |    Neoplasms                                                                                         | 1.4037e-34 | SPAG16 | Neoplastic Process | 1 | ALL | 2011 | 0.385 | DTO_05007530 | 2011 | 0.760 |  79582 | Q8N0X2 | group     |\n",
       "| 908 | C4725671 | 0.01 | Cellular structure   | C04         | High-Risk Neuroblastoma                        | <!----> |    Neoplasms                                                                                         | 1.4037e-34 | SPAG16 | Neoplastic Process | 1 | ALL | 2013 | 0.385 | DTO_05007530 | 2013 | 0.760 |  79582 | Q8N0X2 | disease   |\n",
       "| 911 | C0006826 | 0.01 | <!----> | C04         | Malignant Neoplasms                            | <!----> |    Neoplasms                                                                                         | 1.1879e-09 | TC2N   | Neoplastic Process | 1 | ALL | 2019 | 0.154 | <!----> | 2019 | 0.805 | 123036 | Q8N9U0 | group     |\n",
       "| 912 | C0024232 | 0.01 | <!----> | C23;C04     | Lymphatic Metastasis                           | <!----> |    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         | 1.1879e-09 | TC2N   | Neoplastic Process | 1 | ALL | 2019 | 0.154 | <!----> | 2019 | 0.805 | 123036 | Q8N9U0 | disease   |\n",
       "| 913 | C0027651 | 0.01 | <!----> | C04         | Neoplasms                                      | <!----> |    Neoplasms                                                                                         | 1.1879e-09 | TC2N   | Neoplastic Process | 1 | ALL | 2019 | 0.154 | <!----> | 2019 | 0.805 | 123036 | Q8N9U0 | group     |\n",
       "| 915 | C0596263 | 0.01 | <!----> | C23;C04     | Carcinogenesis                                 | <!----> |    Pathological Conditions, Signs and Symptoms;    Neoplasms                                         | 1.1879e-09 | TC2N   | Neoplastic Process | 1 | ALL | 2019 | 0.154 | <!----> | 2019 | 0.805 | 123036 | Q8N9U0 | phenotype |\n",
       "| 916 | C1306459 | 0.01 | <!----> | C04         | Primary malignant neoplasm                     | <!----> |    Neoplasms                                                                                         | 1.1879e-09 | TC2N   | Neoplastic Process | 1 | ALL | 2019 | 0.154 | <!----> | 2019 | 0.805 | 123036 | Q8N9U0 | group     |\n",
       "\n"
      ],
      "text/plain": [
       "    diseaseid score protein_class_name   disease_class  \n",
       "3   C0006142  0.60                       C04;C17        \n",
       "4   C0019829  0.46                       C04;C20;C15    \n",
       "7   C0007097  0.40                       C04            \n",
       "8   C0023485  0.40                       C04;C20;C15    \n",
       "9   C0678222  0.40                       C04;C17        \n",
       "10  C1961099  0.40  Transcription factor C04;C20;C15    \n",
       "13  C0027819  0.36                       C04            \n",
       "14  C0220597  0.36                       C04;C20;C15    \n",
       "16  C0024299  0.33  Transcription factor C04;C20;C15    \n",
       "18  C0023493  0.31                       C04;C20;C15    \n",
       "19  C0858252  0.31                       C04;C17        \n",
       "20  C1334968  0.31                       C04;C20;C15    \n",
       "23  C0006413  0.30                       C04;C01;C20;C15\n",
       "26  C0024667  0.30                       C04;C22        \n",
       "27  C0024668  0.30                       C04            \n",
       "29  C0152266  0.30                       C04;C20;C15    \n",
       "30  C0152267  0.30                       C04;C20;C15    \n",
       "31  C0205696  0.30                       C04            \n",
       "32  C0205697  0.30                       C04            \n",
       "33  C0205698  0.30                       C04            \n",
       "34  C0205699  0.30                       C04            \n",
       "35  C0496956  0.30                       C04;C17        \n",
       "36  C1257925  0.30                       C04;C22        \n",
       "37  C1266194  0.30                       C04;C20;C15    \n",
       "38  C1292769  0.30                       C04;C20;C15    \n",
       "39  C2930967  0.30                       C06;C04;C19    \n",
       "40  C0029463  0.30  Enzyme modulator     C04            \n",
       "48  C0009402  0.30  Transcription factor C06;C04        \n",
       "54  C0235831  0.20                       C04;C13;C12    \n",
       "60  C1961102  0.13                       C04;C20;C15    \n",
       "â‹®   â‹®         â‹®     â‹®                    â‹®              \n",
       "833 C1168401  0.01                       C04            \n",
       "835 C1378703  0.01                       C04;C13;C12    \n",
       "839 C1458155  0.01                       C04;C17        \n",
       "848 C1997217  0.01                       C04            \n",
       "851 C2939419  0.01                       C23;C04        \n",
       "856 C4086152  0.01                       C04            \n",
       "862 C0005699  0.01  Transcription factor C23;C04;C15    \n",
       "863 C0007102  0.01  Transcription factor C06;C04        \n",
       "870 C0017638  0.01  Transcription factor C04            \n",
       "875 C0023418  0.01  Transcription factor C04            \n",
       "876 C0023449  0.01  Transcription factor C04;C20;C15    \n",
       "877 C0023452  0.01  Transcription factor C04;C20;C15    \n",
       "878 C0023473  0.01  Transcription factor C04;C15        \n",
       "881 C0026948  0.01  Transcription factor C04;C20;C15    \n",
       "882 C0027533  0.01  Transcription factor C04            \n",
       "883 C0027819  0.01  Transcription factor C04            \n",
       "885 C0079772  0.01  Transcription factor C04;C20;C15    \n",
       "886 C0079773  0.01  Transcription factor C04;C20;C15    \n",
       "888 C0376544  0.01  Transcription factor C04;C15        \n",
       "891 C0700095  0.01  Transcription factor C04;C10        \n",
       "892 C1168401  0.01  Transcription factor C04            \n",
       "894 C1961102  0.01  Transcription factor C04;C20;C15    \n",
       "899 C4086165  0.01  Transcription factor C04            \n",
       "903 C0027651  0.01  Cellular structure   C04            \n",
       "908 C4725671  0.01  Cellular structure   C04            \n",
       "911 C0006826  0.01                       C04            \n",
       "912 C0024232  0.01                       C23;C04        \n",
       "913 C0027651  0.01                       C04            \n",
       "915 C0596263  0.01                       C23;C04        \n",
       "916 C1306459  0.01                       C04            \n",
       "    disease_name                                        el\n",
       "3   Malignant neoplasm of breast                          \n",
       "4   Hodgkin Disease                                       \n",
       "7   Carcinoma                                             \n",
       "8   Precursor B-Cell Lymphoblastic Leukemia-Lymphoma      \n",
       "9   Breast Carcinoma                                      \n",
       "10  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma      \n",
       "13  Neuroblastoma                                         \n",
       "14  Adult Hodgkin Lymphoma                                \n",
       "16  Lymphoma                                              \n",
       "18  Adult T-Cell Lymphoma/Leukemia                        \n",
       "19  Breast adenocarcinoma                                 \n",
       "20  Nodular Lymphocyte Predominant Hodgkin Lymphoma       \n",
       "23  Burkitt Lymphoma                                      \n",
       "26  Animal Mammary Neoplasms                              \n",
       "27  Mammary Neoplasms, Experimental                       \n",
       "29  Mixed Cellularity Hodgkin Lymphoma                    \n",
       "30  Hodgkin lymphoma, lymphocyte depletion                \n",
       "31  Anaplastic carcinoma                                  \n",
       "32  Carcinoma, Spindle-Cell                               \n",
       "33  Undifferentiated carcinoma                            \n",
       "34  Carcinomatosis                                        \n",
       "35  Neoplasm of uncertain or unknown behavior of breast   \n",
       "36  Mammary Carcinoma, Animal                             \n",
       "37  Lymphocyte Rich Classical Hodgkin Lymphoma            \n",
       "38  Precursor B-cell lymphoblastic leukemia               \n",
       "39  Gastro-enteropancreatic neuroendocrine tumor          \n",
       "40  Osteosarcoma                                          \n",
       "48  Colorectal Carcinoma                                  \n",
       "54  Renal Cell Dysplasia                                  \n",
       "60  Precursor Cell Lymphoblastic Leukemia Lymphoma        \n",
       "â‹®   â‹®                                                   â‹® \n",
       "833 Squamous cell carcinoma of the head and neck          \n",
       "835 Renal carcinoma                                       \n",
       "839 Mammary Neoplasms                                     \n",
       "848 Low grade glioma                                      \n",
       "851 Secondary Neoplasm                                    \n",
       "856 Childhood Astrocytoma                                 \n",
       "862 Blast Phase                                           \n",
       "863 Malignant tumor of colon                              \n",
       "870 Glioma                                                \n",
       "875 leukemia                                              \n",
       "876 Acute lymphocytic leukemia                            \n",
       "877 Childhood Acute Lymphoblastic Leukemia                \n",
       "878 Myeloid Leukemia, Chronic                             \n",
       "881 Mycosis Fungoides                                     \n",
       "882 Neck Neoplasms                                        \n",
       "883 Neuroblastoma                                         \n",
       "885 T-Cell Lymphoma                                       \n",
       "886 Lymphoma, T-Cell, Cutaneous                           \n",
       "888 Hematopoietic Neoplasms                               \n",
       "891 Central neuroblastoma                                 \n",
       "892 Squamous cell carcinoma of the head and neck          \n",
       "894 Precursor Cell Lymphoblastic Leukemia Lymphoma        \n",
       "899 Childhood Neuroblastoma                               \n",
       "903 Neoplasms                                             \n",
       "908 High-Risk Neuroblastoma                               \n",
       "911 Malignant Neoplasms                                   \n",
       "912 Lymphatic Metastasis                                  \n",
       "913 Neoplasms                                             \n",
       "915 Carcinogenesis                                        \n",
       "916 Primary malignant neoplasm                            \n",
       "    disease_class_name                                                                                  \n",
       "3      Neoplasms;    Skin and Connective Tissue Diseases                                                \n",
       "4      Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "7      Neoplasms                                                                                        \n",
       "8      Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "9      Neoplasms;    Skin and Connective Tissue Diseases                                                \n",
       "10     Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "13     Neoplasms                                                                                        \n",
       "14     Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "16     Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "18     Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "19     Neoplasms;    Skin and Connective Tissue Diseases                                                \n",
       "20     Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "23     Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases             \n",
       "26     Neoplasms;    Animal Diseases                                                                    \n",
       "27     Neoplasms                                                                                        \n",
       "29     Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "30     Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "31     Neoplasms                                                                                        \n",
       "32     Neoplasms                                                                                        \n",
       "33     Neoplasms                                                                                        \n",
       "34     Neoplasms                                                                                        \n",
       "35     Neoplasms;    Skin and Connective Tissue Diseases                                                \n",
       "36     Neoplasms;    Animal Diseases                                                                    \n",
       "37     Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "38     Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "39     Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                            \n",
       "40     Neoplasms                                                                                        \n",
       "48     Digestive System Diseases;    Neoplasms                                                          \n",
       "54     Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases\n",
       "60     Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "â‹®   â‹®                                                                                                   \n",
       "833    Neoplasms                                                                                        \n",
       "835    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases\n",
       "839    Neoplasms;    Skin and Connective Tissue Diseases                                                \n",
       "848    Neoplasms                                                                                        \n",
       "851    Pathological Conditions, Signs and Symptoms;    Neoplasms                                        \n",
       "856    Neoplasms                                                                                        \n",
       "862    Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases       \n",
       "863    Digestive System Diseases;    Neoplasms                                                          \n",
       "870    Neoplasms                                                                                        \n",
       "875    Neoplasms                                                                                        \n",
       "876    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "877    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "878    Neoplasms;    Hemic and Lymphatic Diseases                                                       \n",
       "881    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "882    Neoplasms                                                                                        \n",
       "883    Neoplasms                                                                                        \n",
       "885    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "886    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "888    Neoplasms;    Hemic and Lymphatic Diseases                                                       \n",
       "891    Neoplasms;    Nervous System Diseases                                                            \n",
       "892    Neoplasms                                                                                        \n",
       "894    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                            \n",
       "899    Neoplasms                                                                                        \n",
       "903    Neoplasms                                                                                        \n",
       "908    Neoplasms                                                                                        \n",
       "911    Neoplasms                                                                                        \n",
       "912    Pathological Conditions, Signs and Symptoms;    Neoplasms                                        \n",
       "913    Neoplasms                                                                                        \n",
       "915    Pathological Conditions, Signs and Symptoms;    Neoplasms                                        \n",
       "916    Neoplasms                                                                                        \n",
       "    gene_pli   gene_symbol disease_semantic_type                            \n",
       "3   0.89887    GATA3       Neoplastic Process                               \n",
       "4   0.89887    GATA3       Neoplastic Process                               \n",
       "7   0.89887    GATA3       Neoplastic Process                               \n",
       "8   0.89887    GATA3       Neoplastic Process                               \n",
       "9   0.89887    GATA3       Neoplastic Process                               \n",
       "10  0.98881    BCL11B      Neoplastic Process                               \n",
       "13  0.89887    GATA3       Neoplastic Process                               \n",
       "14  0.89887    GATA3       Neoplastic Process                               \n",
       "16  0.98881    BCL11B      Neoplastic Process                               \n",
       "18  0.89887    GATA3       Neoplastic Process                               \n",
       "19  0.89887    GATA3       Neoplastic Process                               \n",
       "20  0.89887    GATA3       Neoplastic Process                               \n",
       "23  0.89887    GATA3       Neoplastic Process                               \n",
       "26  0.89887    GATA3       Neoplastic Process                               \n",
       "27  0.89887    GATA3       Neoplastic Process; Experimental Model of Disease\n",
       "29  0.89887    GATA3       Neoplastic Process                               \n",
       "30  0.89887    GATA3       Neoplastic Process                               \n",
       "31  0.89887    GATA3       Neoplastic Process                               \n",
       "32  0.89887    GATA3       Neoplastic Process                               \n",
       "33  0.89887    GATA3       Neoplastic Process                               \n",
       "34  0.89887    GATA3       Neoplastic Process                               \n",
       "35  0.89887    GATA3       Neoplastic Process                               \n",
       "36  0.89887    GATA3       Neoplastic Process                               \n",
       "37  0.89887    GATA3       Neoplastic Process                               \n",
       "38  0.89887    GATA3       Neoplastic Process                               \n",
       "39  0.89887    GATA3       Neoplastic Process                               \n",
       "40  0.78178    RGS1        Neoplastic Process                               \n",
       "48  0.98881    BCL11B      Neoplastic Process                               \n",
       "54  0.89887    GATA3       Disease or Syndrome                              \n",
       "60  0.89887    GATA3       Neoplastic Process                               \n",
       "â‹®   â‹®          â‹®           â‹®                                                \n",
       "833 2.1942e-09 AIM2        Neoplastic Process                               \n",
       "835 2.1942e-09 AIM2        Neoplastic Process                               \n",
       "839 2.1942e-09 AIM2        Neoplastic Process                               \n",
       "848 2.1942e-09 AIM2        Neoplastic Process                               \n",
       "851 2.1942e-09 AIM2        Neoplastic Process                               \n",
       "856 2.1942e-09 AIM2        Neoplastic Process                               \n",
       "862 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "863 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "870 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "875 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "876 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "877 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "878 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "881 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "882 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "883 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "885 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "886 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "888 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "891 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "892 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "894 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "899 9.8881e-01 BCL11B      Neoplastic Process                               \n",
       "903 1.4037e-34 SPAG16      Neoplastic Process                               \n",
       "908 1.4037e-34 SPAG16      Neoplastic Process                               \n",
       "911 1.1879e-09 TC2N        Neoplastic Process                               \n",
       "912 1.1879e-09 TC2N        Neoplastic Process                               \n",
       "913 1.1879e-09 TC2N        Neoplastic Process                               \n",
       "915 1.1879e-09 TC2N        Neoplastic Process                               \n",
       "916 1.1879e-09 TC2N        Neoplastic Process                               \n",
       "    ei    source year_final gene_dpi protein_class year_initial gene_dsi geneid\n",
       "3   0.950 ALL    2020       0.846                  1999         0.415     2625 \n",
       "4   1.000 ALL    2019       0.846                  2005         0.415     2625 \n",
       "7   1.000 ALL    2019       0.846                  2005         0.415     2625 \n",
       "8   1.000 ALL    2018       0.846                  2013         0.415     2625 \n",
       "9   0.940 ALL    2020       0.846                  1999         0.415     2625 \n",
       "10  0.938 ALL    2018       0.731    DTO_05007542  2003         0.568    64919 \n",
       "13  1.000 ALL    2019       0.846                  2010         0.415     2625 \n",
       "14  1.000 ALL    2019       0.846                  2005         0.415     2625 \n",
       "16  1.000 ALL    2007       0.731    DTO_05007542  2003         0.568    64919 \n",
       "18  1.000 ALL    2015       0.846                  2000         0.415     2625 \n",
       "19  1.000 ALL    2016       0.846                  2016         0.415     2625 \n",
       "20  1.000 ALL    2019       0.846                  2010         0.415     2625 \n",
       "23  1.000 ALL    2013       0.846                  2013         0.415     2625 \n",
       "26  1.000 ALL    2005       0.846                  2005         0.415     2625 \n",
       "27  1.000 ALL    2005       0.846                  2005         0.415     2625 \n",
       "29  1.000 ALL    2010       0.846                  2010         0.415     2625 \n",
       "30  1.000 ALL    2010       0.846                  2010         0.415     2625 \n",
       "31  1.000 ALL    2005       0.846                  2005         0.415     2625 \n",
       "32  1.000 ALL    2005       0.846                  2005         0.415     2625 \n",
       "33  1.000 ALL    2005       0.846                  2005         0.415     2625 \n",
       "34  1.000 ALL    2005       0.846                  2005         0.415     2625 \n",
       "35     NA ALL      NA       0.846                    NA         0.415     2625 \n",
       "36  1.000 ALL    2005       0.846                  2005         0.415     2625 \n",
       "37  1.000 ALL    2010       0.846                  2010         0.415     2625 \n",
       "38  1.000 ALL    2013       0.846                  2013         0.415     2625 \n",
       "39  1.000 ALL    2018       0.846                  2018         0.415     2625 \n",
       "40  1.000 ALL    2004       0.731    DTO_05007584  2004         0.653     5996 \n",
       "48     NA ALL      NA       0.731    DTO_05007542    NA         0.568    64919 \n",
       "54  1.000 ALL    2018       0.846                  2000         0.415     2625 \n",
       "60  1.000 ALL    2019       0.846                  2013         0.415     2625 \n",
       "â‹®   â‹®     â‹®      â‹®          â‹®        â‹®             â‹®            â‹®        â‹®     \n",
       "833 1     ALL    2019       0.769                  2019         0.521      9447\n",
       "835 1     ALL    2018       0.769                  2018         0.521      9447\n",
       "839 1     ALL    2006       0.769                  2006         0.521      9447\n",
       "848 1     ALL    2019       0.769                  2019         0.521      9447\n",
       "851 1     ALL    2017       0.769                  2017         0.521      9447\n",
       "856 1     ALL    2019       0.769                  2019         0.521      9447\n",
       "862 1     ALL    2009       0.731    DTO_05007542  2009         0.568     64919\n",
       "863 1     ALL    2015       0.731    DTO_05007542  2015         0.568     64919\n",
       "870 1     ALL    2016       0.731    DTO_05007542  2016         0.568     64919\n",
       "875 1     ALL    2004       0.731    DTO_05007542  2004         0.568     64919\n",
       "876 1     ALL    2018       0.731    DTO_05007542  2018         0.568     64919\n",
       "877 1     ALL    2003       0.731    DTO_05007542  2003         0.568     64919\n",
       "878 1     ALL    2009       0.731    DTO_05007542  2009         0.568     64919\n",
       "881 1     ALL    2017       0.731    DTO_05007542  2017         0.568     64919\n",
       "882 1     ALL    2009       0.731    DTO_05007542  2009         0.568     64919\n",
       "883 1     ALL    2006       0.731    DTO_05007542  2006         0.568     64919\n",
       "885 1     ALL    2012       0.731    DTO_05007542  2012         0.568     64919\n",
       "886 1     ALL    2017       0.731    DTO_05007542  2017         0.568     64919\n",
       "888 1     ALL    2007       0.731    DTO_05007542  2007         0.568     64919\n",
       "891 1     ALL    2006       0.731    DTO_05007542  2006         0.568     64919\n",
       "892 1     ALL    2009       0.731    DTO_05007542  2009         0.568     64919\n",
       "894 1     ALL    2018       0.731    DTO_05007542  2018         0.568     64919\n",
       "899 1     ALL    2006       0.731    DTO_05007542  2006         0.568     64919\n",
       "903 1     ALL    2011       0.385    DTO_05007530  2011         0.760     79582\n",
       "908 1     ALL    2013       0.385    DTO_05007530  2013         0.760     79582\n",
       "911 1     ALL    2019       0.154                  2019         0.805    123036\n",
       "912 1     ALL    2019       0.154                  2019         0.805    123036\n",
       "913 1     ALL    2019       0.154                  2019         0.805    123036\n",
       "915 1     ALL    2019       0.154                  2019         0.805    123036\n",
       "916 1     ALL    2019       0.154                  2019         0.805    123036\n",
       "    uniprotid disease_type\n",
       "3   P23771    disease     \n",
       "4   P23771    disease     \n",
       "7   P23771    group       \n",
       "8   P23771    disease     \n",
       "9   P23771    disease     \n",
       "10  Q9C0K0    disease     \n",
       "13  P23771    disease     \n",
       "14  P23771    disease     \n",
       "16  Q9C0K0    group       \n",
       "18  P23771    disease     \n",
       "19  P23771    disease     \n",
       "20  P23771    disease     \n",
       "23  P23771    disease     \n",
       "26  P23771    phenotype   \n",
       "27  P23771    phenotype   \n",
       "29  P23771    disease     \n",
       "30  P23771    disease     \n",
       "31  P23771    disease     \n",
       "32  P23771    disease     \n",
       "33  P23771    disease     \n",
       "34  P23771    phenotype   \n",
       "35  P23771    disease     \n",
       "36  P23771    disease     \n",
       "37  P23771    disease     \n",
       "38  P23771    disease     \n",
       "39  P23771    disease     \n",
       "40  Q08116    disease     \n",
       "48  Q9C0K0    disease     \n",
       "54  P23771    disease     \n",
       "60  P23771    disease     \n",
       "â‹®   â‹®         â‹®           \n",
       "833 O14862    disease     \n",
       "835 O14862    disease     \n",
       "839 O14862    group       \n",
       "848 O14862    disease     \n",
       "851 O14862    group       \n",
       "856 O14862    disease     \n",
       "862 Q9C0K0    disease     \n",
       "863 Q9C0K0    disease     \n",
       "870 Q9C0K0    disease     \n",
       "875 Q9C0K0    disease     \n",
       "876 Q9C0K0    disease     \n",
       "877 Q9C0K0    disease     \n",
       "878 Q9C0K0    disease     \n",
       "881 Q9C0K0    group       \n",
       "882 Q9C0K0    group       \n",
       "883 Q9C0K0    disease     \n",
       "885 Q9C0K0    disease     \n",
       "886 Q9C0K0    disease     \n",
       "888 Q9C0K0    group       \n",
       "891 Q9C0K0    disease     \n",
       "892 Q9C0K0    disease     \n",
       "894 Q9C0K0    disease     \n",
       "899 Q9C0K0    disease     \n",
       "903 Q8N0X2    group       \n",
       "908 Q8N0X2    disease     \n",
       "911 Q8N9U0    group       \n",
       "912 Q8N9U0    disease     \n",
       "913 Q8N9U0    group       \n",
       "915 Q8N9U0    phenotype   \n",
       "916 Q8N9U0    group       "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "res2 = extract(gene2disease( gene = genesSG2, vocabulary = \"HGNC\",\n",
    "                     database = \"ALL\" , score =c(minScore, 1), warnings = F))\n",
    "nrow(res2)\n",
    "# filter disease_class_name on neoplasm (beign/malign), and optionally disease_name on melanoma, count\n",
    "wh =  grep(\"neoplasm\",res2$disease_class_name,ignore.case = T)\n",
    "res2 = res2[wh,]\n",
    "\n",
    "wh = grep(\"melanoma\",res2$disease_name, ignore.case = T)\n",
    "message(nrow(res2[wh,]), \" SG2 melanoma interaction:\") # 4 interactions, 4 genes: AIM2 RGS1 FES GATA3\n",
    "cat(length(unique(res2$gene_symbol[wh])), \"genes:\", unique(res2$gene_symbol[wh]))\n",
    "res2[wh,]\n",
    "message(nrow(res2), \" SG2 neoplasm interaction:\")\n",
    "cat(length(unique(res2$gene_symbol)), \"genes:\", unique(res2$gene_symbol))\n",
    "res2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "adce25ea",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "711"
      ],
      "text/latex": [
       "711"
      ],
      "text/markdown": [
       "711"
      ],
      "text/plain": [
       "[1] 711"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "5 SG3 melanoma interaction:\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3 genes: PYCARD GGCT SLAMF6"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A data.frame: 5 Ã— 20</caption>\n",
       "<thead>\n",
       "\t<tr><th></th><th scope=col>gene_pli</th><th scope=col>year_initial</th><th scope=col>geneid</th><th scope=col>disease_class_name</th><th scope=col>disease_type</th><th scope=col>gene_dsi</th><th scope=col>uniprotid</th><th scope=col>disease_class</th><th scope=col>protein_class_name</th><th scope=col>disease_name</th><th scope=col>gene_dpi</th><th scope=col>diseaseid</th><th scope=col>el</th><th scope=col>ei</th><th scope=col>score</th><th scope=col>disease_semantic_type</th><th scope=col>gene_symbol</th><th scope=col>source</th><th scope=col>protein_class</th><th scope=col>year_final</th></tr>\n",
       "\t<tr><th></th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><th scope=row>165</th><td>0.00019768</td><td>2003</td><td> 29108</td><td>   Neoplasms</td><td>disease</td><td>0.457</td><td>Q9ULZ3</td><td>C04</td><td>Enzyme</td><td>melanoma           </td><td>0.808</td><td>C0025202</td><td></td><td>1</td><td>0.03</td><td>Neoplastic Process                               </td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2017</td></tr>\n",
       "\t<tr><th scope=row>538</th><td>0.00019768</td><td>2013</td><td> 29108</td><td>   Neoplasms</td><td>disease</td><td>0.457</td><td>Q9ULZ3</td><td>C04</td><td>Enzyme</td><td>Metastatic melanoma</td><td>0.808</td><td>C0278883</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2013</td></tr>\n",
       "\t<tr><th scope=row>639</th><td>0.00014300</td><td>2017</td><td> 79017</td><td>   Neoplasms</td><td>disease</td><td>0.552</td><td>O75223</td><td>C04</td><td>      </td><td>melanoma           </td><td>0.808</td><td>C0025202</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2017</td></tr>\n",
       "\t<tr><th scope=row>702</th><td>0.01871200</td><td>2019</td><td>114836</td><td>   Neoplasms</td><td>disease</td><td>0.751</td><td>Q96DU3</td><td>C04</td><td>Enzyme</td><td>Melanoma, B16      </td><td>0.346</td><td>C0004565</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process; Experimental Model of Disease</td><td>SLAMF6</td><td>ALL</td><td>DTO_05007624</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>709</th><td>0.01871200</td><td>2018</td><td>114836</td><td>   Neoplasms</td><td>disease</td><td>0.751</td><td>Q96DU3</td><td>C04</td><td>Enzyme</td><td>melanoma           </td><td>0.346</td><td>C0025202</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>SLAMF6</td><td>ALL</td><td>DTO_05007624</td><td>2018</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A data.frame: 5 Ã— 20\n",
       "\\begin{tabular}{r|llllllllllllllllllll}\n",
       "  & gene\\_pli & year\\_initial & geneid & disease\\_class\\_name & disease\\_type & gene\\_dsi & uniprotid & disease\\_class & protein\\_class\\_name & disease\\_name & gene\\_dpi & diseaseid & el & ei & score & disease\\_semantic\\_type & gene\\_symbol & source & protein\\_class & year\\_final\\\\\n",
       "  & <dbl> & <int> & <int> & <chr> & <chr> & <dbl> & <chr> & <chr> & <chr> & <chr> & <dbl> & <chr> & <chr> & <dbl> & <dbl> & <chr> & <chr> & <chr> & <chr> & <int>\\\\\n",
       "\\hline\n",
       "\t165 & 0.00019768 & 2003 &  29108 &    Neoplasms & disease & 0.457 & Q9ULZ3 & C04 & Enzyme & melanoma            & 0.808 & C0025202 &  & 1 & 0.03 & Neoplastic Process                                & PYCARD & ALL & DTO\\_05007624 & 2017\\\\\n",
       "\t538 & 0.00019768 & 2013 &  29108 &    Neoplasms & disease & 0.457 & Q9ULZ3 & C04 & Enzyme & Metastatic melanoma & 0.808 & C0278883 &  & 1 & 0.01 & Neoplastic Process                                & PYCARD & ALL & DTO\\_05007624 & 2013\\\\\n",
       "\t639 & 0.00014300 & 2017 &  79017 &    Neoplasms & disease & 0.552 & O75223 & C04 &        & melanoma            & 0.808 & C0025202 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2017\\\\\n",
       "\t702 & 0.01871200 & 2019 & 114836 &    Neoplasms & disease & 0.751 & Q96DU3 & C04 & Enzyme & Melanoma, B16       & 0.346 & C0004565 &  & 1 & 0.01 & Neoplastic Process; Experimental Model of Disease & SLAMF6 & ALL & DTO\\_05007624 & 2019\\\\\n",
       "\t709 & 0.01871200 & 2018 & 114836 &    Neoplasms & disease & 0.751 & Q96DU3 & C04 & Enzyme & melanoma            & 0.346 & C0025202 &  & 1 & 0.01 & Neoplastic Process                                & SLAMF6 & ALL & DTO\\_05007624 & 2018\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A data.frame: 5 Ã— 20\n",
       "\n",
       "| <!--/--> | gene_pli &lt;dbl&gt; | year_initial &lt;int&gt; | geneid &lt;int&gt; | disease_class_name &lt;chr&gt; | disease_type &lt;chr&gt; | gene_dsi &lt;dbl&gt; | uniprotid &lt;chr&gt; | disease_class &lt;chr&gt; | protein_class_name &lt;chr&gt; | disease_name &lt;chr&gt; | gene_dpi &lt;dbl&gt; | diseaseid &lt;chr&gt; | el &lt;chr&gt; | ei &lt;dbl&gt; | score &lt;dbl&gt; | disease_semantic_type &lt;chr&gt; | gene_symbol &lt;chr&gt; | source &lt;chr&gt; | protein_class &lt;chr&gt; | year_final &lt;int&gt; |\n",
       "|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n",
       "| 165 | 0.00019768 | 2003 |  29108 |    Neoplasms | disease | 0.457 | Q9ULZ3 | C04 | Enzyme | melanoma            | 0.808 | C0025202 | <!----> | 1 | 0.03 | Neoplastic Process                                | PYCARD | ALL | DTO_05007624 | 2017 |\n",
       "| 538 | 0.00019768 | 2013 |  29108 |    Neoplasms | disease | 0.457 | Q9ULZ3 | C04 | Enzyme | Metastatic melanoma | 0.808 | C0278883 | <!----> | 1 | 0.01 | Neoplastic Process                                | PYCARD | ALL | DTO_05007624 | 2013 |\n",
       "| 639 | 0.00014300 | 2017 |  79017 |    Neoplasms | disease | 0.552 | O75223 | C04 | <!----> | melanoma            | 0.808 | C0025202 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2017 |\n",
       "| 702 | 0.01871200 | 2019 | 114836 |    Neoplasms | disease | 0.751 | Q96DU3 | C04 | Enzyme | Melanoma, B16       | 0.346 | C0004565 | <!----> | 1 | 0.01 | Neoplastic Process; Experimental Model of Disease | SLAMF6 | ALL | DTO_05007624 | 2019 |\n",
       "| 709 | 0.01871200 | 2018 | 114836 |    Neoplasms | disease | 0.751 | Q96DU3 | C04 | Enzyme | melanoma            | 0.346 | C0025202 | <!----> | 1 | 0.01 | Neoplastic Process                                | SLAMF6 | ALL | DTO_05007624 | 2018 |\n",
       "\n"
      ],
      "text/plain": [
       "    gene_pli   year_initial geneid disease_class_name disease_type gene_dsi\n",
       "165 0.00019768 2003          29108    Neoplasms       disease      0.457   \n",
       "538 0.00019768 2013          29108    Neoplasms       disease      0.457   \n",
       "639 0.00014300 2017          79017    Neoplasms       disease      0.552   \n",
       "702 0.01871200 2019         114836    Neoplasms       disease      0.751   \n",
       "709 0.01871200 2018         114836    Neoplasms       disease      0.751   \n",
       "    uniprotid disease_class protein_class_name disease_name        gene_dpi\n",
       "165 Q9ULZ3    C04           Enzyme             melanoma            0.808   \n",
       "538 Q9ULZ3    C04           Enzyme             Metastatic melanoma 0.808   \n",
       "639 O75223    C04                              melanoma            0.808   \n",
       "702 Q96DU3    C04           Enzyme             Melanoma, B16       0.346   \n",
       "709 Q96DU3    C04           Enzyme             melanoma            0.346   \n",
       "    diseaseid el ei score disease_semantic_type                            \n",
       "165 C0025202     1  0.03  Neoplastic Process                               \n",
       "538 C0278883     1  0.01  Neoplastic Process                               \n",
       "639 C0025202     1  0.01  Neoplastic Process                               \n",
       "702 C0004565     1  0.01  Neoplastic Process; Experimental Model of Disease\n",
       "709 C0025202     1  0.01  Neoplastic Process                               \n",
       "    gene_symbol source protein_class year_final\n",
       "165 PYCARD      ALL    DTO_05007624  2017      \n",
       "538 PYCARD      ALL    DTO_05007624  2013      \n",
       "639 GGCT        ALL                  2017      \n",
       "702 SLAMF6      ALL    DTO_05007624  2019      \n",
       "709 SLAMF6      ALL    DTO_05007624  2018      "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "268 SG3 neoplasm interaction:\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "7 genes: PYCARD KRT10 GGCT ZNF620 CD247 APBA2 SLAMF6"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A data.frame: 268 Ã— 20</caption>\n",
       "<thead>\n",
       "\t<tr><th></th><th scope=col>gene_pli</th><th scope=col>year_initial</th><th scope=col>geneid</th><th scope=col>disease_class_name</th><th scope=col>disease_type</th><th scope=col>gene_dsi</th><th scope=col>uniprotid</th><th scope=col>disease_class</th><th scope=col>protein_class_name</th><th scope=col>disease_name</th><th scope=col>gene_dpi</th><th scope=col>diseaseid</th><th scope=col>el</th><th scope=col>ei</th><th scope=col>score</th><th scope=col>disease_semantic_type</th><th scope=col>gene_symbol</th><th scope=col>source</th><th scope=col>protein_class</th><th scope=col>year_final</th></tr>\n",
       "\t<tr><th></th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><th scope=row>8</th><td>0.00019768</td><td>2002</td><td>29108</td><td>   Neoplasms;    Respiratory Tract Diseases                                                                            </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04;C08    </td><td>Enzyme</td><td>Non-Small Cell Lung Carcinoma               </td><td>0.808</td><td>C0007131</td><td></td><td>1.000</td><td>0.35</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2014</td></tr>\n",
       "\t<tr><th scope=row>9</th><td>0.00252530</td><td>2004</td><td> 3858</td><td>   Neoplasms                                                                                                           </td><td>disease  </td><td>0.579</td><td>P13645</td><td>C04        </td><td>      </td><td>Squamous cell carcinoma                     </td><td>0.692</td><td>C0007137</td><td></td><td>1.000</td><td>0.34</td><td>Neoplastic Process</td><td>KRT10 </td><td>ALL</td><td>            </td><td>2013</td></tr>\n",
       "\t<tr><th scope=row>10</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>group    </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Adenocarcinoma                              </td><td>0.808</td><td>C0001418</td><td></td><td>1.000</td><td>0.34</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2014</td></tr>\n",
       "\t<tr><th scope=row>11</th><td>0.00019768</td><td>2003</td><td>29108</td><td>   Digestive System Diseases;    Neoplasms                                                                             </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C06;C04    </td><td>Enzyme</td><td>Colorectal Carcinoma                        </td><td>0.808</td><td>C0009402</td><td></td><td>1.000</td><td>0.33</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2007</td></tr>\n",
       "\t<tr><th scope=row>12</th><td>0.00019768</td><td>2003</td><td>29108</td><td>   Digestive System Diseases;    Neoplasms                                                                             </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C06;C04    </td><td>Enzyme</td><td>Malignant neoplasm of stomach               </td><td>0.808</td><td>C0024623</td><td></td><td>1.000</td><td>0.33</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2016</td></tr>\n",
       "\t<tr><th scope=row>13</th><td>0.00019768</td><td>2003</td><td>29108</td><td>   Digestive System Diseases;    Neoplasms                                                                             </td><td>group    </td><td>0.457</td><td>Q9ULZ3</td><td>C06;C04    </td><td>Enzyme</td><td>Colorectal Neoplasms                        </td><td>0.808</td><td>C0009404</td><td></td><td>1.000</td><td>0.32</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2007</td></tr>\n",
       "\t<tr><th scope=row>14</th><td>0.00019768</td><td>2007</td><td>29108</td><td>   Digestive System Diseases;    Neoplasms                                                                             </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C06;C04    </td><td>Enzyme</td><td>Liver carcinoma                             </td><td>0.808</td><td>C2239176</td><td></td><td>1.000</td><td>0.32</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2017</td></tr>\n",
       "\t<tr><th scope=row>16</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Squamous cell carcinoma                     </td><td>0.808</td><td>C0007137</td><td></td><td>1.000</td><td>0.31</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2018</td></tr>\n",
       "\t<tr><th scope=row>18</th><td>0.00019768</td><td>2003</td><td>29108</td><td>   Digestive System Diseases;    Neoplasms                                                                             </td><td>group    </td><td>0.457</td><td>Q9ULZ3</td><td>C06;C04    </td><td>Enzyme</td><td>Stomach Neoplasms                           </td><td>0.808</td><td>C0038356</td><td></td><td>1.000</td><td>0.31</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2006</td></tr>\n",
       "\t<tr><th scope=row>19</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Carcinoma, Large Cell                       </td><td>0.808</td><td>C0206704</td><td></td><td>1.000</td><td>0.31</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2006</td></tr>\n",
       "\t<tr><th scope=row>20</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms;    Respiratory Tract Diseases                                                                            </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04;C08    </td><td>Enzyme</td><td>Malignant neoplasm of lung                  </td><td>0.808</td><td>C0242379</td><td></td><td>1.000</td><td>0.31</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2006</td></tr>\n",
       "\t<tr><th scope=row>21</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Carcinoma, Small Cell                       </td><td>0.808</td><td>C0262584</td><td></td><td>1.000</td><td>0.31</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2006</td></tr>\n",
       "\t<tr><th scope=row>24</th><td>0.00252530</td><td>2008</td><td> 3858</td><td>   Neoplasms;    Skin and Connective Tissue Diseases                                                                   </td><td>disease  </td><td>0.579</td><td>P13645</td><td>C04;C17    </td><td>      </td><td>Malignant neoplasm of skin                  </td><td>0.692</td><td>C0007114</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process</td><td>KRT10 </td><td>ALL</td><td>            </td><td>2008</td></tr>\n",
       "\t<tr><th scope=row>26</th><td>0.00252530</td><td>2008</td><td> 3858</td><td>   Neoplasms;    Skin and Connective Tissue Diseases                                                                   </td><td>group    </td><td>0.579</td><td>P13645</td><td>C04;C17    </td><td>      </td><td>Skin Neoplasms                              </td><td>0.692</td><td>C0037286</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process</td><td>KRT10 </td><td>ALL</td><td>            </td><td>2008</td></tr>\n",
       "\t<tr><th scope=row>39</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms;    Respiratory Tract Diseases                                                                            </td><td>group    </td><td>0.457</td><td>Q9ULZ3</td><td>C04;C08    </td><td>Enzyme</td><td>Lung Neoplasms                              </td><td>0.808</td><td>C0024121</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2006</td></tr>\n",
       "\t<tr><th scope=row>41</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Adenocarcinoma, Basal Cell                  </td><td>0.808</td><td>C0205641</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2006</td></tr>\n",
       "\t<tr><th scope=row>42</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Adenocarcinoma, Oxyphilic                   </td><td>0.808</td><td>C0205642</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2006</td></tr>\n",
       "\t<tr><th scope=row>43</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Carcinoma, Cribriform                       </td><td>0.808</td><td>C0205643</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2006</td></tr>\n",
       "\t<tr><th scope=row>44</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Carcinoma, Granular Cell                    </td><td>0.808</td><td>C0205644</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2006</td></tr>\n",
       "\t<tr><th scope=row>45</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Adenocarcinoma, Tubular                     </td><td>0.808</td><td>C0205645</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2006</td></tr>\n",
       "\t<tr><th scope=row>47</th><td>0.00019768</td><td>2016</td><td>29108</td><td>   Neoplasms;    Respiratory Tract Diseases                                                                            </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04;C08    </td><td>Enzyme</td><td>Malignant mesothelioma                      </td><td>0.808</td><td>C0345967</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2016</td></tr>\n",
       "\t<tr><th scope=row>50</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Digestive System Diseases;    Neoplasms                                                                             </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C06;C04    </td><td>Enzyme</td><td>Hereditary Diffuse Gastric Cancer           </td><td>0.808</td><td>C1708349</td><td></td><td>1.000</td><td>0.30</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2006</td></tr>\n",
       "\t<tr><th scope=row>105</th><td>0.00019768</td><td>2003</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>group    </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Malignant Neoplasms                         </td><td>0.808</td><td>C0006826</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>107</th><td>0.00019768</td><td>2003</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>group    </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Neoplasms                                   </td><td>0.808</td><td>C0027651</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>108</th><td>0.00019768</td><td>2002</td><td>29108</td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications</td><td>phenotype</td><td>0.457</td><td>Q9ULZ3</td><td>C23;C04;C13</td><td>Enzyme</td><td>High-Grade Squamous Intraepithelial Lesions </td><td>0.808</td><td>C0333875</td><td></td><td>0.920</td><td>0.10</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>109</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms;    Male Urogenital Diseases                                                                              </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04;C12    </td><td>Enzyme</td><td>Malignant neoplasm of prostate              </td><td>0.808</td><td>C0376358</td><td></td><td>0.917</td><td>0.10</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>110</th><td>0.00019768</td><td>2006</td><td>29108</td><td>   Neoplasms;    Male Urogenital Diseases                                                                              </td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C04;C12    </td><td>Enzyme</td><td>Prostate carcinoma                          </td><td>0.808</td><td>C0600139</td><td></td><td>0.909</td><td>0.10</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>111</th><td>0.00019768</td><td>2003</td><td>29108</td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications</td><td>disease  </td><td>0.457</td><td>Q9ULZ3</td><td>C23;C04;C13</td><td>Enzyme</td><td>Low Grade Squamous Intraepithelial Neoplasia</td><td>0.808</td><td>C1302773</td><td></td><td>0.963</td><td>0.10</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>112</th><td>0.00019768</td><td>2004</td><td>29108</td><td>   Neoplasms                                                                                                           </td><td>group    </td><td>0.457</td><td>Q9ULZ3</td><td>C04        </td><td>Enzyme</td><td>Primary malignant neoplasm                  </td><td>0.808</td><td>C1306459</td><td></td><td>1.000</td><td>0.10</td><td>Neoplastic Process</td><td>PYCARD</td><td>ALL</td><td>DTO_05007624</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>113</th><td>0.00014300</td><td>2003</td><td>79017</td><td>   Neoplasms                                                                                                           </td><td>group    </td><td>0.552</td><td>O75223</td><td>C04        </td><td>      </td><td>Malignant Neoplasms                         </td><td>0.808</td><td>C0006826</td><td></td><td>0.929</td><td>0.10</td><td>Neoplastic Process</td><td>GGCT  </td><td>ALL</td><td>            </td><td>2020</td></tr>\n",
       "\t<tr><th scope=row>â‹®</th><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td><td>â‹®</td></tr>\n",
       "\t<tr><th scope=row>639</th><td>0.000143</td><td>2017</td><td> 79017</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>      </td><td>melanoma                                    </td><td>0.808</td><td>C0025202</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2017</td></tr>\n",
       "\t<tr><th scope=row>643</th><td>0.000143</td><td>2007</td><td> 79017</td><td>   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases</td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04;C13;C19</td><td>      </td><td>Ovarian Carcinoma                           </td><td>0.808</td><td>C0029925</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2007</td></tr>\n",
       "\t<tr><th scope=row>646</th><td>0.000143</td><td>1999</td><td> 79017</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>      </td><td>Rhabdomyosarcoma                            </td><td>0.808</td><td>C0035412</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>1999</td></tr>\n",
       "\t<tr><th scope=row>650</th><td>0.000143</td><td>2019</td><td> 79017</td><td>   Neoplasms;    Endocrine System Diseases                                                           </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04;C19    </td><td>      </td><td>Thyroid Neoplasm                            </td><td>0.808</td><td>C0040136</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>651</th><td>0.000143</td><td>2016</td><td> 79017</td><td>   Neoplasms                                                                                         </td><td>group    </td><td>0.552</td><td>O75223</td><td>C04        </td><td>      </td><td>Uterine Fibroids                            </td><td>0.808</td><td>C0042133</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2016</td></tr>\n",
       "\t<tr><th scope=row>653</th><td>0.000143</td><td>2015</td><td> 79017</td><td>   Neoplasms;    Stomatognathic Diseases                                                             </td><td>group    </td><td>0.552</td><td>O75223</td><td>C04;C07    </td><td>      </td><td>Malignant neoplasm of mouth                 </td><td>0.808</td><td>C0153381</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2015</td></tr>\n",
       "\t<tr><th scope=row>654</th><td>0.000143</td><td>2005</td><td> 79017</td><td>   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases                              </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04;C12;C19</td><td>      </td><td>Malignant neoplasm of testis                </td><td>0.808</td><td>C0153594</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2005</td></tr>\n",
       "\t<tr><th scope=row>655</th><td>0.000143</td><td>1996</td><td> 79017</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>      </td><td>Cholangiocarcinoma                          </td><td>0.808</td><td>C0206698</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>1996</td></tr>\n",
       "\t<tr><th scope=row>656</th><td>0.000143</td><td>1999</td><td> 79017</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>      </td><td>Childhood Rhabdomyosarcoma                  </td><td>0.808</td><td>C0220611</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>1999</td></tr>\n",
       "\t<tr><th scope=row>657</th><td>0.000143</td><td>2015</td><td> 79017</td><td>   Neoplasms;    Stomatognathic Diseases                                                             </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04;C07    </td><td>      </td><td>Lip and Oral Cavity Carcinoma               </td><td>0.808</td><td>C0220641</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2015</td></tr>\n",
       "\t<tr><th scope=row>658</th><td>0.000143</td><td>2015</td><td> 79017</td><td>   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                             </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C06;C04;C19</td><td>      </td><td>Pancreatic carcinoma                        </td><td>0.808</td><td>C0235974</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2015</td></tr>\n",
       "\t<tr><th scope=row>659</th><td>0.000143</td><td>2003</td><td> 79017</td><td>   Neoplasms;    Skin and Connective Tissue Diseases                                                 </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04;C17    </td><td>      </td><td>Carcinoma of Male Breast                    </td><td>0.808</td><td>C0238033</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2003</td></tr>\n",
       "\t<tr><th scope=row>660</th><td>0.000143</td><td>2003</td><td> 79017</td><td>   Neoplasms;    Skin and Connective Tissue Diseases;    Endocrine System Diseases                   </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04;C17;C19</td><td>      </td><td>Malignant neoplasm of male breast           </td><td>0.808</td><td>C0242787</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2003</td></tr>\n",
       "\t<tr><th scope=row>664</th><td>0.000143</td><td>2019</td><td> 79017</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>      </td><td>Adult Glioblastoma                          </td><td>0.808</td><td>C0278878</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>665</th><td>0.000143</td><td>1999</td><td> 79017</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>      </td><td>Adult Rhabdomyosarcoma                      </td><td>0.808</td><td>C0279550</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>1999</td></tr>\n",
       "\t<tr><th scope=row>666</th><td>0.000143</td><td>2017</td><td> 79017</td><td>   Digestive System Diseases;    Neoplasms                                                           </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C06;C04    </td><td>      </td><td>Squamous cell carcinoma of esophagus        </td><td>0.808</td><td>C0279626</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2017</td></tr>\n",
       "\t<tr><th scope=row>667</th><td>0.000143</td><td>2019</td><td> 79017</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>      </td><td>Childhood Glioblastoma                      </td><td>0.808</td><td>C0280474</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>669</th><td>0.000143</td><td>2015</td><td> 79017</td><td>   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                             </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C06;C04;C19</td><td>      </td><td>Malignant neoplasm of pancreas              </td><td>0.808</td><td>C0346647</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2015</td></tr>\n",
       "\t<tr><th scope=row>670</th><td>0.000143</td><td>2019</td><td> 79017</td><td>   Digestive System Diseases;    Neoplasms                                                           </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C06;C04    </td><td>      </td><td>Early gastric cancer                        </td><td>0.808</td><td>C0349530</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>673</th><td>0.000143</td><td>2019</td><td> 79017</td><td>   Neoplasms;    Endocrine System Diseases                                                           </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04;C19    </td><td>      </td><td>Thyroid carcinoma                           </td><td>0.808</td><td>C0549473</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>674</th><td>0.000143</td><td>2010</td><td> 79017</td><td>   Pathological Conditions, Signs and Symptoms;    Neoplasms                                         </td><td>phenotype</td><td>0.552</td><td>O75223</td><td>C23;C04    </td><td>      </td><td>Carcinogenesis                              </td><td>0.808</td><td>C0596263</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2010</td></tr>\n",
       "\t<tr><th scope=row>675</th><td>0.000143</td><td>1993</td><td> 79017</td><td>   Digestive System Diseases;    Neoplasms                                                           </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C06;C04    </td><td>      </td><td>Villous adenoma of rectum                   </td><td>0.808</td><td>C0730199</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>1993</td></tr>\n",
       "\t<tr><th scope=row>676</th><td>0.000143</td><td>2005</td><td> 79017</td><td>   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases                              </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04;C12;C19</td><td>      </td><td>Malignant Testicular Germ Cell Tumor        </td><td>0.808</td><td>C0855197</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2005</td></tr>\n",
       "\t<tr><th scope=row>677</th><td>0.000143</td><td>2007</td><td> 79017</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>      </td><td>Squamous cell carcinoma of the head and neck</td><td>0.808</td><td>C1168401</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2007</td></tr>\n",
       "\t<tr><th scope=row>679</th><td>0.000143</td><td>2010</td><td> 79017</td><td>   Neoplasms;    Skin and Connective Tissue Diseases                                                 </td><td>group    </td><td>0.552</td><td>O75223</td><td>C04;C17    </td><td>      </td><td>Mammary Neoplasms                           </td><td>0.808</td><td>C1458155</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2010</td></tr>\n",
       "\t<tr><th scope=row>681</th><td>0.000143</td><td>2019</td><td> 79017</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.552</td><td>O75223</td><td>C04        </td><td>      </td><td>Glioblastoma Multiforme                     </td><td>0.808</td><td>C1621958</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>GGCT  </td><td>ALL</td><td>            </td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>702</th><td>0.018712</td><td>2019</td><td>114836</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.751</td><td>Q96DU3</td><td>C04        </td><td>Enzyme</td><td>Melanoma, B16                               </td><td>0.346</td><td>C0004565</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process; Experimental Model of Disease</td><td>SLAMF6</td><td>ALL</td><td>DTO_05007624</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>707</th><td>0.018712</td><td>2019</td><td>114836</td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             </td><td>disease  </td><td>0.751</td><td>Q96DU3</td><td>C04;C20;C15</td><td>Enzyme</td><td>Chronic Lymphocytic Leukemia                </td><td>0.346</td><td>C0023434</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>SLAMF6</td><td>ALL</td><td>DTO_05007624</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>708</th><td>0.018712</td><td>2019</td><td>114836</td><td>   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                             </td><td>group    </td><td>0.751</td><td>Q96DU3</td><td>C04;C20;C15</td><td>Enzyme</td><td>Lymphoma                                    </td><td>0.346</td><td>C0024299</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>SLAMF6</td><td>ALL</td><td>DTO_05007624</td><td>2019</td></tr>\n",
       "\t<tr><th scope=row>709</th><td>0.018712</td><td>2018</td><td>114836</td><td>   Neoplasms                                                                                         </td><td>disease  </td><td>0.751</td><td>Q96DU3</td><td>C04        </td><td>Enzyme</td><td>melanoma                                    </td><td>0.346</td><td>C0025202</td><td></td><td>1</td><td>0.01</td><td>Neoplastic Process                               </td><td>SLAMF6</td><td>ALL</td><td>DTO_05007624</td><td>2018</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A data.frame: 268 Ã— 20\n",
       "\\begin{tabular}{r|llllllllllllllllllll}\n",
       "  & gene\\_pli & year\\_initial & geneid & disease\\_class\\_name & disease\\_type & gene\\_dsi & uniprotid & disease\\_class & protein\\_class\\_name & disease\\_name & gene\\_dpi & diseaseid & el & ei & score & disease\\_semantic\\_type & gene\\_symbol & source & protein\\_class & year\\_final\\\\\n",
       "  & <dbl> & <int> & <int> & <chr> & <chr> & <dbl> & <chr> & <chr> & <chr> & <chr> & <dbl> & <chr> & <chr> & <dbl> & <dbl> & <chr> & <chr> & <chr> & <chr> & <int>\\\\\n",
       "\\hline\n",
       "\t8 & 0.00019768 & 2002 & 29108 &    Neoplasms;    Respiratory Tract Diseases                                                                             & disease   & 0.457 & Q9ULZ3 & C04;C08     & Enzyme & Non-Small Cell Lung Carcinoma                & 0.808 & C0007131 &  & 1.000 & 0.35 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2014\\\\\n",
       "\t9 & 0.00252530 & 2004 &  3858 &    Neoplasms                                                                                                            & disease   & 0.579 & P13645 & C04         &        & Squamous cell carcinoma                      & 0.692 & C0007137 &  & 1.000 & 0.34 & Neoplastic Process & KRT10  & ALL &              & 2013\\\\\n",
       "\t10 & 0.00019768 & 2006 & 29108 &    Neoplasms                                                                                                            & group     & 0.457 & Q9ULZ3 & C04         & Enzyme & Adenocarcinoma                               & 0.808 & C0001418 &  & 1.000 & 0.34 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2014\\\\\n",
       "\t11 & 0.00019768 & 2003 & 29108 &    Digestive System Diseases;    Neoplasms                                                                              & disease   & 0.457 & Q9ULZ3 & C06;C04     & Enzyme & Colorectal Carcinoma                         & 0.808 & C0009402 &  & 1.000 & 0.33 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2007\\\\\n",
       "\t12 & 0.00019768 & 2003 & 29108 &    Digestive System Diseases;    Neoplasms                                                                              & disease   & 0.457 & Q9ULZ3 & C06;C04     & Enzyme & Malignant neoplasm of stomach                & 0.808 & C0024623 &  & 1.000 & 0.33 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2016\\\\\n",
       "\t13 & 0.00019768 & 2003 & 29108 &    Digestive System Diseases;    Neoplasms                                                                              & group     & 0.457 & Q9ULZ3 & C06;C04     & Enzyme & Colorectal Neoplasms                         & 0.808 & C0009404 &  & 1.000 & 0.32 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2007\\\\\n",
       "\t14 & 0.00019768 & 2007 & 29108 &    Digestive System Diseases;    Neoplasms                                                                              & disease   & 0.457 & Q9ULZ3 & C06;C04     & Enzyme & Liver carcinoma                              & 0.808 & C2239176 &  & 1.000 & 0.32 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2017\\\\\n",
       "\t16 & 0.00019768 & 2006 & 29108 &    Neoplasms                                                                                                            & disease   & 0.457 & Q9ULZ3 & C04         & Enzyme & Squamous cell carcinoma                      & 0.808 & C0007137 &  & 1.000 & 0.31 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2018\\\\\n",
       "\t18 & 0.00019768 & 2003 & 29108 &    Digestive System Diseases;    Neoplasms                                                                              & group     & 0.457 & Q9ULZ3 & C06;C04     & Enzyme & Stomach Neoplasms                            & 0.808 & C0038356 &  & 1.000 & 0.31 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2006\\\\\n",
       "\t19 & 0.00019768 & 2006 & 29108 &    Neoplasms                                                                                                            & disease   & 0.457 & Q9ULZ3 & C04         & Enzyme & Carcinoma, Large Cell                        & 0.808 & C0206704 &  & 1.000 & 0.31 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2006\\\\\n",
       "\t20 & 0.00019768 & 2006 & 29108 &    Neoplasms;    Respiratory Tract Diseases                                                                             & disease   & 0.457 & Q9ULZ3 & C04;C08     & Enzyme & Malignant neoplasm of lung                   & 0.808 & C0242379 &  & 1.000 & 0.31 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2006\\\\\n",
       "\t21 & 0.00019768 & 2006 & 29108 &    Neoplasms                                                                                                            & disease   & 0.457 & Q9ULZ3 & C04         & Enzyme & Carcinoma, Small Cell                        & 0.808 & C0262584 &  & 1.000 & 0.31 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2006\\\\\n",
       "\t24 & 0.00252530 & 2008 &  3858 &    Neoplasms;    Skin and Connective Tissue Diseases                                                                    & disease   & 0.579 & P13645 & C04;C17     &        & Malignant neoplasm of skin                   & 0.692 & C0007114 &  & 1.000 & 0.30 & Neoplastic Process & KRT10  & ALL &              & 2008\\\\\n",
       "\t26 & 0.00252530 & 2008 &  3858 &    Neoplasms;    Skin and Connective Tissue Diseases                                                                    & group     & 0.579 & P13645 & C04;C17     &        & Skin Neoplasms                               & 0.692 & C0037286 &  & 1.000 & 0.30 & Neoplastic Process & KRT10  & ALL &              & 2008\\\\\n",
       "\t39 & 0.00019768 & 2006 & 29108 &    Neoplasms;    Respiratory Tract Diseases                                                                             & group     & 0.457 & Q9ULZ3 & C04;C08     & Enzyme & Lung Neoplasms                               & 0.808 & C0024121 &  & 1.000 & 0.30 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2006\\\\\n",
       "\t41 & 0.00019768 & 2006 & 29108 &    Neoplasms                                                                                                            & disease   & 0.457 & Q9ULZ3 & C04         & Enzyme & Adenocarcinoma, Basal Cell                   & 0.808 & C0205641 &  & 1.000 & 0.30 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2006\\\\\n",
       "\t42 & 0.00019768 & 2006 & 29108 &    Neoplasms                                                                                                            & disease   & 0.457 & Q9ULZ3 & C04         & Enzyme & Adenocarcinoma, Oxyphilic                    & 0.808 & C0205642 &  & 1.000 & 0.30 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2006\\\\\n",
       "\t43 & 0.00019768 & 2006 & 29108 &    Neoplasms                                                                                                            & disease   & 0.457 & Q9ULZ3 & C04         & Enzyme & Carcinoma, Cribriform                        & 0.808 & C0205643 &  & 1.000 & 0.30 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2006\\\\\n",
       "\t44 & 0.00019768 & 2006 & 29108 &    Neoplasms                                                                                                            & disease   & 0.457 & Q9ULZ3 & C04         & Enzyme & Carcinoma, Granular Cell                     & 0.808 & C0205644 &  & 1.000 & 0.30 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2006\\\\\n",
       "\t45 & 0.00019768 & 2006 & 29108 &    Neoplasms                                                                                                            & disease   & 0.457 & Q9ULZ3 & C04         & Enzyme & Adenocarcinoma, Tubular                      & 0.808 & C0205645 &  & 1.000 & 0.30 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2006\\\\\n",
       "\t47 & 0.00019768 & 2016 & 29108 &    Neoplasms;    Respiratory Tract Diseases                                                                             & disease   & 0.457 & Q9ULZ3 & C04;C08     & Enzyme & Malignant mesothelioma                       & 0.808 & C0345967 &  & 1.000 & 0.30 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2016\\\\\n",
       "\t50 & 0.00019768 & 2006 & 29108 &    Digestive System Diseases;    Neoplasms                                                                              & disease   & 0.457 & Q9ULZ3 & C06;C04     & Enzyme & Hereditary Diffuse Gastric Cancer            & 0.808 & C1708349 &  & 1.000 & 0.30 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2006\\\\\n",
       "\t105 & 0.00019768 & 2003 & 29108 &    Neoplasms                                                                                                            & group     & 0.457 & Q9ULZ3 & C04         & Enzyme & Malignant Neoplasms                          & 0.808 & C0006826 &  & 1.000 & 0.10 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2019\\\\\n",
       "\t107 & 0.00019768 & 2003 & 29108 &    Neoplasms                                                                                                            & group     & 0.457 & Q9ULZ3 & C04         & Enzyme & Neoplasms                                    & 0.808 & C0027651 &  & 1.000 & 0.10 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2019\\\\\n",
       "\t108 & 0.00019768 & 2002 & 29108 &    Pathological Conditions, Signs and Symptoms;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications & phenotype & 0.457 & Q9ULZ3 & C23;C04;C13 & Enzyme & High-Grade Squamous Intraepithelial Lesions  & 0.808 & C0333875 &  & 0.920 & 0.10 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2019\\\\\n",
       "\t109 & 0.00019768 & 2006 & 29108 &    Neoplasms;    Male Urogenital Diseases                                                                               & disease   & 0.457 & Q9ULZ3 & C04;C12     & Enzyme & Malignant neoplasm of prostate               & 0.808 & C0376358 &  & 0.917 & 0.10 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2019\\\\\n",
       "\t110 & 0.00019768 & 2006 & 29108 &    Neoplasms;    Male Urogenital Diseases                                                                               & disease   & 0.457 & Q9ULZ3 & C04;C12     & Enzyme & Prostate carcinoma                           & 0.808 & C0600139 &  & 0.909 & 0.10 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2019\\\\\n",
       "\t111 & 0.00019768 & 2003 & 29108 &    Pathological Conditions, Signs and Symptoms;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications & disease   & 0.457 & Q9ULZ3 & C23;C04;C13 & Enzyme & Low Grade Squamous Intraepithelial Neoplasia & 0.808 & C1302773 &  & 0.963 & 0.10 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2019\\\\\n",
       "\t112 & 0.00019768 & 2004 & 29108 &    Neoplasms                                                                                                            & group     & 0.457 & Q9ULZ3 & C04         & Enzyme & Primary malignant neoplasm                   & 0.808 & C1306459 &  & 1.000 & 0.10 & Neoplastic Process & PYCARD & ALL & DTO\\_05007624 & 2019\\\\\n",
       "\t113 & 0.00014300 & 2003 & 79017 &    Neoplasms                                                                                                            & group     & 0.552 & O75223 & C04         &        & Malignant Neoplasms                          & 0.808 & C0006826 &  & 0.929 & 0.10 & Neoplastic Process & GGCT   & ALL &              & 2020\\\\\n",
       "\tâ‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹® & â‹®\\\\\n",
       "\t639 & 0.000143 & 2017 &  79017 &    Neoplasms                                                                                          & disease   & 0.552 & O75223 & C04         &        & melanoma                                     & 0.808 & C0025202 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2017\\\\\n",
       "\t643 & 0.000143 & 2007 &  79017 &    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases & disease   & 0.552 & O75223 & C04;C13;C19 &        & Ovarian Carcinoma                            & 0.808 & C0029925 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2007\\\\\n",
       "\t646 & 0.000143 & 1999 &  79017 &    Neoplasms                                                                                          & disease   & 0.552 & O75223 & C04         &        & Rhabdomyosarcoma                             & 0.808 & C0035412 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 1999\\\\\n",
       "\t650 & 0.000143 & 2019 &  79017 &    Neoplasms;    Endocrine System Diseases                                                            & disease   & 0.552 & O75223 & C04;C19     &        & Thyroid Neoplasm                             & 0.808 & C0040136 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2019\\\\\n",
       "\t651 & 0.000143 & 2016 &  79017 &    Neoplasms                                                                                          & group     & 0.552 & O75223 & C04         &        & Uterine Fibroids                             & 0.808 & C0042133 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2016\\\\\n",
       "\t653 & 0.000143 & 2015 &  79017 &    Neoplasms;    Stomatognathic Diseases                                                              & group     & 0.552 & O75223 & C04;C07     &        & Malignant neoplasm of mouth                  & 0.808 & C0153381 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2015\\\\\n",
       "\t654 & 0.000143 & 2005 &  79017 &    Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases                               & disease   & 0.552 & O75223 & C04;C12;C19 &        & Malignant neoplasm of testis                 & 0.808 & C0153594 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2005\\\\\n",
       "\t655 & 0.000143 & 1996 &  79017 &    Neoplasms                                                                                          & disease   & 0.552 & O75223 & C04         &        & Cholangiocarcinoma                           & 0.808 & C0206698 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 1996\\\\\n",
       "\t656 & 0.000143 & 1999 &  79017 &    Neoplasms                                                                                          & disease   & 0.552 & O75223 & C04         &        & Childhood Rhabdomyosarcoma                   & 0.808 & C0220611 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 1999\\\\\n",
       "\t657 & 0.000143 & 2015 &  79017 &    Neoplasms;    Stomatognathic Diseases                                                              & disease   & 0.552 & O75223 & C04;C07     &        & Lip and Oral Cavity Carcinoma                & 0.808 & C0220641 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2015\\\\\n",
       "\t658 & 0.000143 & 2015 &  79017 &    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                              & disease   & 0.552 & O75223 & C06;C04;C19 &        & Pancreatic carcinoma                         & 0.808 & C0235974 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2015\\\\\n",
       "\t659 & 0.000143 & 2003 &  79017 &    Neoplasms;    Skin and Connective Tissue Diseases                                                  & disease   & 0.552 & O75223 & C04;C17     &        & Carcinoma of Male Breast                     & 0.808 & C0238033 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2003\\\\\n",
       "\t660 & 0.000143 & 2003 &  79017 &    Neoplasms;    Skin and Connective Tissue Diseases;    Endocrine System Diseases                    & disease   & 0.552 & O75223 & C04;C17;C19 &        & Malignant neoplasm of male breast            & 0.808 & C0242787 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2003\\\\\n",
       "\t664 & 0.000143 & 2019 &  79017 &    Neoplasms                                                                                          & disease   & 0.552 & O75223 & C04         &        & Adult Glioblastoma                           & 0.808 & C0278878 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2019\\\\\n",
       "\t665 & 0.000143 & 1999 &  79017 &    Neoplasms                                                                                          & disease   & 0.552 & O75223 & C04         &        & Adult Rhabdomyosarcoma                       & 0.808 & C0279550 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 1999\\\\\n",
       "\t666 & 0.000143 & 2017 &  79017 &    Digestive System Diseases;    Neoplasms                                                            & disease   & 0.552 & O75223 & C06;C04     &        & Squamous cell carcinoma of esophagus         & 0.808 & C0279626 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2017\\\\\n",
       "\t667 & 0.000143 & 2019 &  79017 &    Neoplasms                                                                                          & disease   & 0.552 & O75223 & C04         &        & Childhood Glioblastoma                       & 0.808 & C0280474 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2019\\\\\n",
       "\t669 & 0.000143 & 2015 &  79017 &    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                              & disease   & 0.552 & O75223 & C06;C04;C19 &        & Malignant neoplasm of pancreas               & 0.808 & C0346647 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2015\\\\\n",
       "\t670 & 0.000143 & 2019 &  79017 &    Digestive System Diseases;    Neoplasms                                                            & disease   & 0.552 & O75223 & C06;C04     &        & Early gastric cancer                         & 0.808 & C0349530 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2019\\\\\n",
       "\t673 & 0.000143 & 2019 &  79017 &    Neoplasms;    Endocrine System Diseases                                                            & disease   & 0.552 & O75223 & C04;C19     &        & Thyroid carcinoma                            & 0.808 & C0549473 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2019\\\\\n",
       "\t674 & 0.000143 & 2010 &  79017 &    Pathological Conditions, Signs and Symptoms;    Neoplasms                                          & phenotype & 0.552 & O75223 & C23;C04     &        & Carcinogenesis                               & 0.808 & C0596263 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2010\\\\\n",
       "\t675 & 0.000143 & 1993 &  79017 &    Digestive System Diseases;    Neoplasms                                                            & disease   & 0.552 & O75223 & C06;C04     &        & Villous adenoma of rectum                    & 0.808 & C0730199 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 1993\\\\\n",
       "\t676 & 0.000143 & 2005 &  79017 &    Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases                               & disease   & 0.552 & O75223 & C04;C12;C19 &        & Malignant Testicular Germ Cell Tumor         & 0.808 & C0855197 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2005\\\\\n",
       "\t677 & 0.000143 & 2007 &  79017 &    Neoplasms                                                                                          & disease   & 0.552 & O75223 & C04         &        & Squamous cell carcinoma of the head and neck & 0.808 & C1168401 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2007\\\\\n",
       "\t679 & 0.000143 & 2010 &  79017 &    Neoplasms;    Skin and Connective Tissue Diseases                                                  & group     & 0.552 & O75223 & C04;C17     &        & Mammary Neoplasms                            & 0.808 & C1458155 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2010\\\\\n",
       "\t681 & 0.000143 & 2019 &  79017 &    Neoplasms                                                                                          & disease   & 0.552 & O75223 & C04         &        & Glioblastoma Multiforme                      & 0.808 & C1621958 &  & 1 & 0.01 & Neoplastic Process                                & GGCT   & ALL &              & 2019\\\\\n",
       "\t702 & 0.018712 & 2019 & 114836 &    Neoplasms                                                                                          & disease   & 0.751 & Q96DU3 & C04         & Enzyme & Melanoma, B16                                & 0.346 & C0004565 &  & 1 & 0.01 & Neoplastic Process; Experimental Model of Disease & SLAMF6 & ALL & DTO\\_05007624 & 2019\\\\\n",
       "\t707 & 0.018712 & 2019 & 114836 &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              & disease   & 0.751 & Q96DU3 & C04;C20;C15 & Enzyme & Chronic Lymphocytic Leukemia                 & 0.346 & C0023434 &  & 1 & 0.01 & Neoplastic Process                                & SLAMF6 & ALL & DTO\\_05007624 & 2019\\\\\n",
       "\t708 & 0.018712 & 2019 & 114836 &    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              & group     & 0.751 & Q96DU3 & C04;C20;C15 & Enzyme & Lymphoma                                     & 0.346 & C0024299 &  & 1 & 0.01 & Neoplastic Process                                & SLAMF6 & ALL & DTO\\_05007624 & 2019\\\\\n",
       "\t709 & 0.018712 & 2018 & 114836 &    Neoplasms                                                                                          & disease   & 0.751 & Q96DU3 & C04         & Enzyme & melanoma                                     & 0.346 & C0025202 &  & 1 & 0.01 & Neoplastic Process                                & SLAMF6 & ALL & DTO\\_05007624 & 2018\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A data.frame: 268 Ã— 20\n",
       "\n",
       "| <!--/--> | gene_pli &lt;dbl&gt; | year_initial &lt;int&gt; | geneid &lt;int&gt; | disease_class_name &lt;chr&gt; | disease_type &lt;chr&gt; | gene_dsi &lt;dbl&gt; | uniprotid &lt;chr&gt; | disease_class &lt;chr&gt; | protein_class_name &lt;chr&gt; | disease_name &lt;chr&gt; | gene_dpi &lt;dbl&gt; | diseaseid &lt;chr&gt; | el &lt;chr&gt; | ei &lt;dbl&gt; | score &lt;dbl&gt; | disease_semantic_type &lt;chr&gt; | gene_symbol &lt;chr&gt; | source &lt;chr&gt; | protein_class &lt;chr&gt; | year_final &lt;int&gt; |\n",
       "|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n",
       "| 8 | 0.00019768 | 2002 | 29108 |    Neoplasms;    Respiratory Tract Diseases                                                                             | disease   | 0.457 | Q9ULZ3 | C04;C08     | Enzyme | Non-Small Cell Lung Carcinoma                | 0.808 | C0007131 | <!----> | 1.000 | 0.35 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2014 |\n",
       "| 9 | 0.00252530 | 2004 |  3858 |    Neoplasms                                                                                                            | disease   | 0.579 | P13645 | C04         | <!----> | Squamous cell carcinoma                      | 0.692 | C0007137 | <!----> | 1.000 | 0.34 | Neoplastic Process | KRT10  | ALL | <!----> | 2013 |\n",
       "| 10 | 0.00019768 | 2006 | 29108 |    Neoplasms                                                                                                            | group     | 0.457 | Q9ULZ3 | C04         | Enzyme | Adenocarcinoma                               | 0.808 | C0001418 | <!----> | 1.000 | 0.34 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2014 |\n",
       "| 11 | 0.00019768 | 2003 | 29108 |    Digestive System Diseases;    Neoplasms                                                                              | disease   | 0.457 | Q9ULZ3 | C06;C04     | Enzyme | Colorectal Carcinoma                         | 0.808 | C0009402 | <!----> | 1.000 | 0.33 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2007 |\n",
       "| 12 | 0.00019768 | 2003 | 29108 |    Digestive System Diseases;    Neoplasms                                                                              | disease   | 0.457 | Q9ULZ3 | C06;C04     | Enzyme | Malignant neoplasm of stomach                | 0.808 | C0024623 | <!----> | 1.000 | 0.33 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2016 |\n",
       "| 13 | 0.00019768 | 2003 | 29108 |    Digestive System Diseases;    Neoplasms                                                                              | group     | 0.457 | Q9ULZ3 | C06;C04     | Enzyme | Colorectal Neoplasms                         | 0.808 | C0009404 | <!----> | 1.000 | 0.32 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2007 |\n",
       "| 14 | 0.00019768 | 2007 | 29108 |    Digestive System Diseases;    Neoplasms                                                                              | disease   | 0.457 | Q9ULZ3 | C06;C04     | Enzyme | Liver carcinoma                              | 0.808 | C2239176 | <!----> | 1.000 | 0.32 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2017 |\n",
       "| 16 | 0.00019768 | 2006 | 29108 |    Neoplasms                                                                                                            | disease   | 0.457 | Q9ULZ3 | C04         | Enzyme | Squamous cell carcinoma                      | 0.808 | C0007137 | <!----> | 1.000 | 0.31 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2018 |\n",
       "| 18 | 0.00019768 | 2003 | 29108 |    Digestive System Diseases;    Neoplasms                                                                              | group     | 0.457 | Q9ULZ3 | C06;C04     | Enzyme | Stomach Neoplasms                            | 0.808 | C0038356 | <!----> | 1.000 | 0.31 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2006 |\n",
       "| 19 | 0.00019768 | 2006 | 29108 |    Neoplasms                                                                                                            | disease   | 0.457 | Q9ULZ3 | C04         | Enzyme | Carcinoma, Large Cell                        | 0.808 | C0206704 | <!----> | 1.000 | 0.31 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2006 |\n",
       "| 20 | 0.00019768 | 2006 | 29108 |    Neoplasms;    Respiratory Tract Diseases                                                                             | disease   | 0.457 | Q9ULZ3 | C04;C08     | Enzyme | Malignant neoplasm of lung                   | 0.808 | C0242379 | <!----> | 1.000 | 0.31 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2006 |\n",
       "| 21 | 0.00019768 | 2006 | 29108 |    Neoplasms                                                                                                            | disease   | 0.457 | Q9ULZ3 | C04         | Enzyme | Carcinoma, Small Cell                        | 0.808 | C0262584 | <!----> | 1.000 | 0.31 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2006 |\n",
       "| 24 | 0.00252530 | 2008 |  3858 |    Neoplasms;    Skin and Connective Tissue Diseases                                                                    | disease   | 0.579 | P13645 | C04;C17     | <!----> | Malignant neoplasm of skin                   | 0.692 | C0007114 | <!----> | 1.000 | 0.30 | Neoplastic Process | KRT10  | ALL | <!----> | 2008 |\n",
       "| 26 | 0.00252530 | 2008 |  3858 |    Neoplasms;    Skin and Connective Tissue Diseases                                                                    | group     | 0.579 | P13645 | C04;C17     | <!----> | Skin Neoplasms                               | 0.692 | C0037286 | <!----> | 1.000 | 0.30 | Neoplastic Process | KRT10  | ALL | <!----> | 2008 |\n",
       "| 39 | 0.00019768 | 2006 | 29108 |    Neoplasms;    Respiratory Tract Diseases                                                                             | group     | 0.457 | Q9ULZ3 | C04;C08     | Enzyme | Lung Neoplasms                               | 0.808 | C0024121 | <!----> | 1.000 | 0.30 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2006 |\n",
       "| 41 | 0.00019768 | 2006 | 29108 |    Neoplasms                                                                                                            | disease   | 0.457 | Q9ULZ3 | C04         | Enzyme | Adenocarcinoma, Basal Cell                   | 0.808 | C0205641 | <!----> | 1.000 | 0.30 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2006 |\n",
       "| 42 | 0.00019768 | 2006 | 29108 |    Neoplasms                                                                                                            | disease   | 0.457 | Q9ULZ3 | C04         | Enzyme | Adenocarcinoma, Oxyphilic                    | 0.808 | C0205642 | <!----> | 1.000 | 0.30 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2006 |\n",
       "| 43 | 0.00019768 | 2006 | 29108 |    Neoplasms                                                                                                            | disease   | 0.457 | Q9ULZ3 | C04         | Enzyme | Carcinoma, Cribriform                        | 0.808 | C0205643 | <!----> | 1.000 | 0.30 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2006 |\n",
       "| 44 | 0.00019768 | 2006 | 29108 |    Neoplasms                                                                                                            | disease   | 0.457 | Q9ULZ3 | C04         | Enzyme | Carcinoma, Granular Cell                     | 0.808 | C0205644 | <!----> | 1.000 | 0.30 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2006 |\n",
       "| 45 | 0.00019768 | 2006 | 29108 |    Neoplasms                                                                                                            | disease   | 0.457 | Q9ULZ3 | C04         | Enzyme | Adenocarcinoma, Tubular                      | 0.808 | C0205645 | <!----> | 1.000 | 0.30 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2006 |\n",
       "| 47 | 0.00019768 | 2016 | 29108 |    Neoplasms;    Respiratory Tract Diseases                                                                             | disease   | 0.457 | Q9ULZ3 | C04;C08     | Enzyme | Malignant mesothelioma                       | 0.808 | C0345967 | <!----> | 1.000 | 0.30 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2016 |\n",
       "| 50 | 0.00019768 | 2006 | 29108 |    Digestive System Diseases;    Neoplasms                                                                              | disease   | 0.457 | Q9ULZ3 | C06;C04     | Enzyme | Hereditary Diffuse Gastric Cancer            | 0.808 | C1708349 | <!----> | 1.000 | 0.30 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2006 |\n",
       "| 105 | 0.00019768 | 2003 | 29108 |    Neoplasms                                                                                                            | group     | 0.457 | Q9ULZ3 | C04         | Enzyme | Malignant Neoplasms                          | 0.808 | C0006826 | <!----> | 1.000 | 0.10 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2019 |\n",
       "| 107 | 0.00019768 | 2003 | 29108 |    Neoplasms                                                                                                            | group     | 0.457 | Q9ULZ3 | C04         | Enzyme | Neoplasms                                    | 0.808 | C0027651 | <!----> | 1.000 | 0.10 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2019 |\n",
       "| 108 | 0.00019768 | 2002 | 29108 |    Pathological Conditions, Signs and Symptoms;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications | phenotype | 0.457 | Q9ULZ3 | C23;C04;C13 | Enzyme | High-Grade Squamous Intraepithelial Lesions  | 0.808 | C0333875 | <!----> | 0.920 | 0.10 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2019 |\n",
       "| 109 | 0.00019768 | 2006 | 29108 |    Neoplasms;    Male Urogenital Diseases                                                                               | disease   | 0.457 | Q9ULZ3 | C04;C12     | Enzyme | Malignant neoplasm of prostate               | 0.808 | C0376358 | <!----> | 0.917 | 0.10 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2019 |\n",
       "| 110 | 0.00019768 | 2006 | 29108 |    Neoplasms;    Male Urogenital Diseases                                                                               | disease   | 0.457 | Q9ULZ3 | C04;C12     | Enzyme | Prostate carcinoma                           | 0.808 | C0600139 | <!----> | 0.909 | 0.10 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2019 |\n",
       "| 111 | 0.00019768 | 2003 | 29108 |    Pathological Conditions, Signs and Symptoms;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications | disease   | 0.457 | Q9ULZ3 | C23;C04;C13 | Enzyme | Low Grade Squamous Intraepithelial Neoplasia | 0.808 | C1302773 | <!----> | 0.963 | 0.10 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2019 |\n",
       "| 112 | 0.00019768 | 2004 | 29108 |    Neoplasms                                                                                                            | group     | 0.457 | Q9ULZ3 | C04         | Enzyme | Primary malignant neoplasm                   | 0.808 | C1306459 | <!----> | 1.000 | 0.10 | Neoplastic Process | PYCARD | ALL | DTO_05007624 | 2019 |\n",
       "| 113 | 0.00014300 | 2003 | 79017 |    Neoplasms                                                                                                            | group     | 0.552 | O75223 | C04         | <!----> | Malignant Neoplasms                          | 0.808 | C0006826 | <!----> | 0.929 | 0.10 | Neoplastic Process | GGCT   | ALL | <!----> | 2020 |\n",
       "| â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® | â‹® |\n",
       "| 639 | 0.000143 | 2017 |  79017 |    Neoplasms                                                                                          | disease   | 0.552 | O75223 | C04         | <!----> | melanoma                                     | 0.808 | C0025202 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2017 |\n",
       "| 643 | 0.000143 | 2007 |  79017 |    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases | disease   | 0.552 | O75223 | C04;C13;C19 | <!----> | Ovarian Carcinoma                            | 0.808 | C0029925 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2007 |\n",
       "| 646 | 0.000143 | 1999 |  79017 |    Neoplasms                                                                                          | disease   | 0.552 | O75223 | C04         | <!----> | Rhabdomyosarcoma                             | 0.808 | C0035412 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 1999 |\n",
       "| 650 | 0.000143 | 2019 |  79017 |    Neoplasms;    Endocrine System Diseases                                                            | disease   | 0.552 | O75223 | C04;C19     | <!----> | Thyroid Neoplasm                             | 0.808 | C0040136 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2019 |\n",
       "| 651 | 0.000143 | 2016 |  79017 |    Neoplasms                                                                                          | group     | 0.552 | O75223 | C04         | <!----> | Uterine Fibroids                             | 0.808 | C0042133 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2016 |\n",
       "| 653 | 0.000143 | 2015 |  79017 |    Neoplasms;    Stomatognathic Diseases                                                              | group     | 0.552 | O75223 | C04;C07     | <!----> | Malignant neoplasm of mouth                  | 0.808 | C0153381 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2015 |\n",
       "| 654 | 0.000143 | 2005 |  79017 |    Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases                               | disease   | 0.552 | O75223 | C04;C12;C19 | <!----> | Malignant neoplasm of testis                 | 0.808 | C0153594 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2005 |\n",
       "| 655 | 0.000143 | 1996 |  79017 |    Neoplasms                                                                                          | disease   | 0.552 | O75223 | C04         | <!----> | Cholangiocarcinoma                           | 0.808 | C0206698 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 1996 |\n",
       "| 656 | 0.000143 | 1999 |  79017 |    Neoplasms                                                                                          | disease   | 0.552 | O75223 | C04         | <!----> | Childhood Rhabdomyosarcoma                   | 0.808 | C0220611 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 1999 |\n",
       "| 657 | 0.000143 | 2015 |  79017 |    Neoplasms;    Stomatognathic Diseases                                                              | disease   | 0.552 | O75223 | C04;C07     | <!----> | Lip and Oral Cavity Carcinoma                | 0.808 | C0220641 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2015 |\n",
       "| 658 | 0.000143 | 2015 |  79017 |    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                              | disease   | 0.552 | O75223 | C06;C04;C19 | <!----> | Pancreatic carcinoma                         | 0.808 | C0235974 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2015 |\n",
       "| 659 | 0.000143 | 2003 |  79017 |    Neoplasms;    Skin and Connective Tissue Diseases                                                  | disease   | 0.552 | O75223 | C04;C17     | <!----> | Carcinoma of Male Breast                     | 0.808 | C0238033 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2003 |\n",
       "| 660 | 0.000143 | 2003 |  79017 |    Neoplasms;    Skin and Connective Tissue Diseases;    Endocrine System Diseases                    | disease   | 0.552 | O75223 | C04;C17;C19 | <!----> | Malignant neoplasm of male breast            | 0.808 | C0242787 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2003 |\n",
       "| 664 | 0.000143 | 2019 |  79017 |    Neoplasms                                                                                          | disease   | 0.552 | O75223 | C04         | <!----> | Adult Glioblastoma                           | 0.808 | C0278878 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2019 |\n",
       "| 665 | 0.000143 | 1999 |  79017 |    Neoplasms                                                                                          | disease   | 0.552 | O75223 | C04         | <!----> | Adult Rhabdomyosarcoma                       | 0.808 | C0279550 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 1999 |\n",
       "| 666 | 0.000143 | 2017 |  79017 |    Digestive System Diseases;    Neoplasms                                                            | disease   | 0.552 | O75223 | C06;C04     | <!----> | Squamous cell carcinoma of esophagus         | 0.808 | C0279626 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2017 |\n",
       "| 667 | 0.000143 | 2019 |  79017 |    Neoplasms                                                                                          | disease   | 0.552 | O75223 | C04         | <!----> | Childhood Glioblastoma                       | 0.808 | C0280474 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2019 |\n",
       "| 669 | 0.000143 | 2015 |  79017 |    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                              | disease   | 0.552 | O75223 | C06;C04;C19 | <!----> | Malignant neoplasm of pancreas               | 0.808 | C0346647 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2015 |\n",
       "| 670 | 0.000143 | 2019 |  79017 |    Digestive System Diseases;    Neoplasms                                                            | disease   | 0.552 | O75223 | C06;C04     | <!----> | Early gastric cancer                         | 0.808 | C0349530 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2019 |\n",
       "| 673 | 0.000143 | 2019 |  79017 |    Neoplasms;    Endocrine System Diseases                                                            | disease   | 0.552 | O75223 | C04;C19     | <!----> | Thyroid carcinoma                            | 0.808 | C0549473 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2019 |\n",
       "| 674 | 0.000143 | 2010 |  79017 |    Pathological Conditions, Signs and Symptoms;    Neoplasms                                          | phenotype | 0.552 | O75223 | C23;C04     | <!----> | Carcinogenesis                               | 0.808 | C0596263 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2010 |\n",
       "| 675 | 0.000143 | 1993 |  79017 |    Digestive System Diseases;    Neoplasms                                                            | disease   | 0.552 | O75223 | C06;C04     | <!----> | Villous adenoma of rectum                    | 0.808 | C0730199 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 1993 |\n",
       "| 676 | 0.000143 | 2005 |  79017 |    Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases                               | disease   | 0.552 | O75223 | C04;C12;C19 | <!----> | Malignant Testicular Germ Cell Tumor         | 0.808 | C0855197 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2005 |\n",
       "| 677 | 0.000143 | 2007 |  79017 |    Neoplasms                                                                                          | disease   | 0.552 | O75223 | C04         | <!----> | Squamous cell carcinoma of the head and neck | 0.808 | C1168401 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2007 |\n",
       "| 679 | 0.000143 | 2010 |  79017 |    Neoplasms;    Skin and Connective Tissue Diseases                                                  | group     | 0.552 | O75223 | C04;C17     | <!----> | Mammary Neoplasms                            | 0.808 | C1458155 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2010 |\n",
       "| 681 | 0.000143 | 2019 |  79017 |    Neoplasms                                                                                          | disease   | 0.552 | O75223 | C04         | <!----> | Glioblastoma Multiforme                      | 0.808 | C1621958 | <!----> | 1 | 0.01 | Neoplastic Process                                | GGCT   | ALL | <!----> | 2019 |\n",
       "| 702 | 0.018712 | 2019 | 114836 |    Neoplasms                                                                                          | disease   | 0.751 | Q96DU3 | C04         | Enzyme | Melanoma, B16                                | 0.346 | C0004565 | <!----> | 1 | 0.01 | Neoplastic Process; Experimental Model of Disease | SLAMF6 | ALL | DTO_05007624 | 2019 |\n",
       "| 707 | 0.018712 | 2019 | 114836 |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              | disease   | 0.751 | Q96DU3 | C04;C20;C15 | Enzyme | Chronic Lymphocytic Leukemia                 | 0.346 | C0023434 | <!----> | 1 | 0.01 | Neoplastic Process                                | SLAMF6 | ALL | DTO_05007624 | 2019 |\n",
       "| 708 | 0.018712 | 2019 | 114836 |    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                              | group     | 0.751 | Q96DU3 | C04;C20;C15 | Enzyme | Lymphoma                                     | 0.346 | C0024299 | <!----> | 1 | 0.01 | Neoplastic Process                                | SLAMF6 | ALL | DTO_05007624 | 2019 |\n",
       "| 709 | 0.018712 | 2018 | 114836 |    Neoplasms                                                                                          | disease   | 0.751 | Q96DU3 | C04         | Enzyme | melanoma                                     | 0.346 | C0025202 | <!----> | 1 | 0.01 | Neoplastic Process                                | SLAMF6 | ALL | DTO_05007624 | 2018 |\n",
       "\n"
      ],
      "text/plain": [
       "    gene_pli   year_initial geneid\n",
       "8   0.00019768 2002         29108 \n",
       "9   0.00252530 2004          3858 \n",
       "10  0.00019768 2006         29108 \n",
       "11  0.00019768 2003         29108 \n",
       "12  0.00019768 2003         29108 \n",
       "13  0.00019768 2003         29108 \n",
       "14  0.00019768 2007         29108 \n",
       "16  0.00019768 2006         29108 \n",
       "18  0.00019768 2003         29108 \n",
       "19  0.00019768 2006         29108 \n",
       "20  0.00019768 2006         29108 \n",
       "21  0.00019768 2006         29108 \n",
       "24  0.00252530 2008          3858 \n",
       "26  0.00252530 2008          3858 \n",
       "39  0.00019768 2006         29108 \n",
       "41  0.00019768 2006         29108 \n",
       "42  0.00019768 2006         29108 \n",
       "43  0.00019768 2006         29108 \n",
       "44  0.00019768 2006         29108 \n",
       "45  0.00019768 2006         29108 \n",
       "47  0.00019768 2016         29108 \n",
       "50  0.00019768 2006         29108 \n",
       "105 0.00019768 2003         29108 \n",
       "107 0.00019768 2003         29108 \n",
       "108 0.00019768 2002         29108 \n",
       "109 0.00019768 2006         29108 \n",
       "110 0.00019768 2006         29108 \n",
       "111 0.00019768 2003         29108 \n",
       "112 0.00019768 2004         29108 \n",
       "113 0.00014300 2003         79017 \n",
       "â‹®   â‹®          â‹®            â‹®     \n",
       "639 0.000143   2017          79017\n",
       "643 0.000143   2007          79017\n",
       "646 0.000143   1999          79017\n",
       "650 0.000143   2019          79017\n",
       "651 0.000143   2016          79017\n",
       "653 0.000143   2015          79017\n",
       "654 0.000143   2005          79017\n",
       "655 0.000143   1996          79017\n",
       "656 0.000143   1999          79017\n",
       "657 0.000143   2015          79017\n",
       "658 0.000143   2015          79017\n",
       "659 0.000143   2003          79017\n",
       "660 0.000143   2003          79017\n",
       "664 0.000143   2019          79017\n",
       "665 0.000143   1999          79017\n",
       "666 0.000143   2017          79017\n",
       "667 0.000143   2019          79017\n",
       "669 0.000143   2015          79017\n",
       "670 0.000143   2019          79017\n",
       "673 0.000143   2019          79017\n",
       "674 0.000143   2010          79017\n",
       "675 0.000143   1993          79017\n",
       "676 0.000143   2005          79017\n",
       "677 0.000143   2007          79017\n",
       "679 0.000143   2010          79017\n",
       "681 0.000143   2019          79017\n",
       "702 0.018712   2019         114836\n",
       "707 0.018712   2019         114836\n",
       "708 0.018712   2019         114836\n",
       "709 0.018712   2018         114836\n",
       "    disease_class_name                                                                                                     \n",
       "8      Neoplasms;    Respiratory Tract Diseases                                                                            \n",
       "9      Neoplasms                                                                                                           \n",
       "10     Neoplasms                                                                                                           \n",
       "11     Digestive System Diseases;    Neoplasms                                                                             \n",
       "12     Digestive System Diseases;    Neoplasms                                                                             \n",
       "13     Digestive System Diseases;    Neoplasms                                                                             \n",
       "14     Digestive System Diseases;    Neoplasms                                                                             \n",
       "16     Neoplasms                                                                                                           \n",
       "18     Digestive System Diseases;    Neoplasms                                                                             \n",
       "19     Neoplasms                                                                                                           \n",
       "20     Neoplasms;    Respiratory Tract Diseases                                                                            \n",
       "21     Neoplasms                                                                                                           \n",
       "24     Neoplasms;    Skin and Connective Tissue Diseases                                                                   \n",
       "26     Neoplasms;    Skin and Connective Tissue Diseases                                                                   \n",
       "39     Neoplasms;    Respiratory Tract Diseases                                                                            \n",
       "41     Neoplasms                                                                                                           \n",
       "42     Neoplasms                                                                                                           \n",
       "43     Neoplasms                                                                                                           \n",
       "44     Neoplasms                                                                                                           \n",
       "45     Neoplasms                                                                                                           \n",
       "47     Neoplasms;    Respiratory Tract Diseases                                                                            \n",
       "50     Digestive System Diseases;    Neoplasms                                                                             \n",
       "105    Neoplasms                                                                                                           \n",
       "107    Neoplasms                                                                                                           \n",
       "108    Pathological Conditions, Signs and Symptoms;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications\n",
       "109    Neoplasms;    Male Urogenital Diseases                                                                              \n",
       "110    Neoplasms;    Male Urogenital Diseases                                                                              \n",
       "111    Pathological Conditions, Signs and Symptoms;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications\n",
       "112    Neoplasms                                                                                                           \n",
       "113    Neoplasms                                                                                                           \n",
       "â‹®   â‹®                                                                                                                      \n",
       "639    Neoplasms                                                                                                           \n",
       "643    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases                  \n",
       "646    Neoplasms                                                                                                           \n",
       "650    Neoplasms;    Endocrine System Diseases                                                                             \n",
       "651    Neoplasms                                                                                                           \n",
       "653    Neoplasms;    Stomatognathic Diseases                                                                               \n",
       "654    Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases                                                \n",
       "655    Neoplasms                                                                                                           \n",
       "656    Neoplasms                                                                                                           \n",
       "657    Neoplasms;    Stomatognathic Diseases                                                                               \n",
       "658    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                                               \n",
       "659    Neoplasms;    Skin and Connective Tissue Diseases                                                                   \n",
       "660    Neoplasms;    Skin and Connective Tissue Diseases;    Endocrine System Diseases                                     \n",
       "664    Neoplasms                                                                                                           \n",
       "665    Neoplasms                                                                                                           \n",
       "666    Digestive System Diseases;    Neoplasms                                                                             \n",
       "667    Neoplasms                                                                                                           \n",
       "669    Digestive System Diseases;    Neoplasms;    Endocrine System Diseases                                               \n",
       "670    Digestive System Diseases;    Neoplasms                                                                             \n",
       "673    Neoplasms;    Endocrine System Diseases                                                                             \n",
       "674    Pathological Conditions, Signs and Symptoms;    Neoplasms                                                           \n",
       "675    Digestive System Diseases;    Neoplasms                                                                             \n",
       "676    Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases                                                \n",
       "677    Neoplasms                                                                                                           \n",
       "679    Neoplasms;    Skin and Connective Tissue Diseases                                                                   \n",
       "681    Neoplasms                                                                                                           \n",
       "702    Neoplasms                                                                                                           \n",
       "707    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                                               \n",
       "708    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases                                               \n",
       "709    Neoplasms                                                                                                           \n",
       "    disease_type gene_dsi uniprotid disease_class protein_class_name\n",
       "8   disease      0.457    Q9ULZ3    C04;C08       Enzyme            \n",
       "9   disease      0.579    P13645    C04                             \n",
       "10  group        0.457    Q9ULZ3    C04           Enzyme            \n",
       "11  disease      0.457    Q9ULZ3    C06;C04       Enzyme            \n",
       "12  disease      0.457    Q9ULZ3    C06;C04       Enzyme            \n",
       "13  group        0.457    Q9ULZ3    C06;C04       Enzyme            \n",
       "14  disease      0.457    Q9ULZ3    C06;C04       Enzyme            \n",
       "16  disease      0.457    Q9ULZ3    C04           Enzyme            \n",
       "18  group        0.457    Q9ULZ3    C06;C04       Enzyme            \n",
       "19  disease      0.457    Q9ULZ3    C04           Enzyme            \n",
       "20  disease      0.457    Q9ULZ3    C04;C08       Enzyme            \n",
       "21  disease      0.457    Q9ULZ3    C04           Enzyme            \n",
       "24  disease      0.579    P13645    C04;C17                         \n",
       "26  group        0.579    P13645    C04;C17                         \n",
       "39  group        0.457    Q9ULZ3    C04;C08       Enzyme            \n",
       "41  disease      0.457    Q9ULZ3    C04           Enzyme            \n",
       "42  disease      0.457    Q9ULZ3    C04           Enzyme            \n",
       "43  disease      0.457    Q9ULZ3    C04           Enzyme            \n",
       "44  disease      0.457    Q9ULZ3    C04           Enzyme            \n",
       "45  disease      0.457    Q9ULZ3    C04           Enzyme            \n",
       "47  disease      0.457    Q9ULZ3    C04;C08       Enzyme            \n",
       "50  disease      0.457    Q9ULZ3    C06;C04       Enzyme            \n",
       "105 group        0.457    Q9ULZ3    C04           Enzyme            \n",
       "107 group        0.457    Q9ULZ3    C04           Enzyme            \n",
       "108 phenotype    0.457    Q9ULZ3    C23;C04;C13   Enzyme            \n",
       "109 disease      0.457    Q9ULZ3    C04;C12       Enzyme            \n",
       "110 disease      0.457    Q9ULZ3    C04;C12       Enzyme            \n",
       "111 disease      0.457    Q9ULZ3    C23;C04;C13   Enzyme            \n",
       "112 group        0.457    Q9ULZ3    C04           Enzyme            \n",
       "113 group        0.552    O75223    C04                             \n",
       "â‹®   â‹®            â‹®        â‹®         â‹®             â‹®                 \n",
       "639 disease      0.552    O75223    C04                             \n",
       "643 disease      0.552    O75223    C04;C13;C19                     \n",
       "646 disease      0.552    O75223    C04                             \n",
       "650 disease      0.552    O75223    C04;C19                         \n",
       "651 group        0.552    O75223    C04                             \n",
       "653 group        0.552    O75223    C04;C07                         \n",
       "654 disease      0.552    O75223    C04;C12;C19                     \n",
       "655 disease      0.552    O75223    C04                             \n",
       "656 disease      0.552    O75223    C04                             \n",
       "657 disease      0.552    O75223    C04;C07                         \n",
       "658 disease      0.552    O75223    C06;C04;C19                     \n",
       "659 disease      0.552    O75223    C04;C17                         \n",
       "660 disease      0.552    O75223    C04;C17;C19                     \n",
       "664 disease      0.552    O75223    C04                             \n",
       "665 disease      0.552    O75223    C04                             \n",
       "666 disease      0.552    O75223    C06;C04                         \n",
       "667 disease      0.552    O75223    C04                             \n",
       "669 disease      0.552    O75223    C06;C04;C19                     \n",
       "670 disease      0.552    O75223    C06;C04                         \n",
       "673 disease      0.552    O75223    C04;C19                         \n",
       "674 phenotype    0.552    O75223    C23;C04                         \n",
       "675 disease      0.552    O75223    C06;C04                         \n",
       "676 disease      0.552    O75223    C04;C12;C19                     \n",
       "677 disease      0.552    O75223    C04                             \n",
       "679 group        0.552    O75223    C04;C17                         \n",
       "681 disease      0.552    O75223    C04                             \n",
       "702 disease      0.751    Q96DU3    C04           Enzyme            \n",
       "707 disease      0.751    Q96DU3    C04;C20;C15   Enzyme            \n",
       "708 group        0.751    Q96DU3    C04;C20;C15   Enzyme            \n",
       "709 disease      0.751    Q96DU3    C04           Enzyme            \n",
       "    disease_name                                 gene_dpi diseaseid el ei   \n",
       "8   Non-Small Cell Lung Carcinoma                0.808    C0007131     1.000\n",
       "9   Squamous cell carcinoma                      0.692    C0007137     1.000\n",
       "10  Adenocarcinoma                               0.808    C0001418     1.000\n",
       "11  Colorectal Carcinoma                         0.808    C0009402     1.000\n",
       "12  Malignant neoplasm of stomach                0.808    C0024623     1.000\n",
       "13  Colorectal Neoplasms                         0.808    C0009404     1.000\n",
       "14  Liver carcinoma                              0.808    C2239176     1.000\n",
       "16  Squamous cell carcinoma                      0.808    C0007137     1.000\n",
       "18  Stomach Neoplasms                            0.808    C0038356     1.000\n",
       "19  Carcinoma, Large Cell                        0.808    C0206704     1.000\n",
       "20  Malignant neoplasm of lung                   0.808    C0242379     1.000\n",
       "21  Carcinoma, Small Cell                        0.808    C0262584     1.000\n",
       "24  Malignant neoplasm of skin                   0.692    C0007114     1.000\n",
       "26  Skin Neoplasms                               0.692    C0037286     1.000\n",
       "39  Lung Neoplasms                               0.808    C0024121     1.000\n",
       "41  Adenocarcinoma, Basal Cell                   0.808    C0205641     1.000\n",
       "42  Adenocarcinoma, Oxyphilic                    0.808    C0205642     1.000\n",
       "43  Carcinoma, Cribriform                        0.808    C0205643     1.000\n",
       "44  Carcinoma, Granular Cell                     0.808    C0205644     1.000\n",
       "45  Adenocarcinoma, Tubular                      0.808    C0205645     1.000\n",
       "47  Malignant mesothelioma                       0.808    C0345967     1.000\n",
       "50  Hereditary Diffuse Gastric Cancer            0.808    C1708349     1.000\n",
       "105 Malignant Neoplasms                          0.808    C0006826     1.000\n",
       "107 Neoplasms                                    0.808    C0027651     1.000\n",
       "108 High-Grade Squamous Intraepithelial Lesions  0.808    C0333875     0.920\n",
       "109 Malignant neoplasm of prostate               0.808    C0376358     0.917\n",
       "110 Prostate carcinoma                           0.808    C0600139     0.909\n",
       "111 Low Grade Squamous Intraepithelial Neoplasia 0.808    C1302773     0.963\n",
       "112 Primary malignant neoplasm                   0.808    C1306459     1.000\n",
       "113 Malignant Neoplasms                          0.808    C0006826     0.929\n",
       "â‹®   â‹®                                            â‹®        â‹®         â‹®  â‹®    \n",
       "639 melanoma                                     0.808    C0025202     1    \n",
       "643 Ovarian Carcinoma                            0.808    C0029925     1    \n",
       "646 Rhabdomyosarcoma                             0.808    C0035412     1    \n",
       "650 Thyroid Neoplasm                             0.808    C0040136     1    \n",
       "651 Uterine Fibroids                             0.808    C0042133     1    \n",
       "653 Malignant neoplasm of mouth                  0.808    C0153381     1    \n",
       "654 Malignant neoplasm of testis                 0.808    C0153594     1    \n",
       "655 Cholangiocarcinoma                           0.808    C0206698     1    \n",
       "656 Childhood Rhabdomyosarcoma                   0.808    C0220611     1    \n",
       "657 Lip and Oral Cavity Carcinoma                0.808    C0220641     1    \n",
       "658 Pancreatic carcinoma                         0.808    C0235974     1    \n",
       "659 Carcinoma of Male Breast                     0.808    C0238033     1    \n",
       "660 Malignant neoplasm of male breast            0.808    C0242787     1    \n",
       "664 Adult Glioblastoma                           0.808    C0278878     1    \n",
       "665 Adult Rhabdomyosarcoma                       0.808    C0279550     1    \n",
       "666 Squamous cell carcinoma of esophagus         0.808    C0279626     1    \n",
       "667 Childhood Glioblastoma                       0.808    C0280474     1    \n",
       "669 Malignant neoplasm of pancreas               0.808    C0346647     1    \n",
       "670 Early gastric cancer                         0.808    C0349530     1    \n",
       "673 Thyroid carcinoma                            0.808    C0549473     1    \n",
       "674 Carcinogenesis                               0.808    C0596263     1    \n",
       "675 Villous adenoma of rectum                    0.808    C0730199     1    \n",
       "676 Malignant Testicular Germ Cell Tumor         0.808    C0855197     1    \n",
       "677 Squamous cell carcinoma of the head and neck 0.808    C1168401     1    \n",
       "679 Mammary Neoplasms                            0.808    C1458155     1    \n",
       "681 Glioblastoma Multiforme                      0.808    C1621958     1    \n",
       "702 Melanoma, B16                                0.346    C0004565     1    \n",
       "707 Chronic Lymphocytic Leukemia                 0.346    C0023434     1    \n",
       "708 Lymphoma                                     0.346    C0024299     1    \n",
       "709 melanoma                                     0.346    C0025202     1    \n",
       "    score disease_semantic_type                             gene_symbol source\n",
       "8   0.35  Neoplastic Process                                PYCARD      ALL   \n",
       "9   0.34  Neoplastic Process                                KRT10       ALL   \n",
       "10  0.34  Neoplastic Process                                PYCARD      ALL   \n",
       "11  0.33  Neoplastic Process                                PYCARD      ALL   \n",
       "12  0.33  Neoplastic Process                                PYCARD      ALL   \n",
       "13  0.32  Neoplastic Process                                PYCARD      ALL   \n",
       "14  0.32  Neoplastic Process                                PYCARD      ALL   \n",
       "16  0.31  Neoplastic Process                                PYCARD      ALL   \n",
       "18  0.31  Neoplastic Process                                PYCARD      ALL   \n",
       "19  0.31  Neoplastic Process                                PYCARD      ALL   \n",
       "20  0.31  Neoplastic Process                                PYCARD      ALL   \n",
       "21  0.31  Neoplastic Process                                PYCARD      ALL   \n",
       "24  0.30  Neoplastic Process                                KRT10       ALL   \n",
       "26  0.30  Neoplastic Process                                KRT10       ALL   \n",
       "39  0.30  Neoplastic Process                                PYCARD      ALL   \n",
       "41  0.30  Neoplastic Process                                PYCARD      ALL   \n",
       "42  0.30  Neoplastic Process                                PYCARD      ALL   \n",
       "43  0.30  Neoplastic Process                                PYCARD      ALL   \n",
       "44  0.30  Neoplastic Process                                PYCARD      ALL   \n",
       "45  0.30  Neoplastic Process                                PYCARD      ALL   \n",
       "47  0.30  Neoplastic Process                                PYCARD      ALL   \n",
       "50  0.30  Neoplastic Process                                PYCARD      ALL   \n",
       "105 0.10  Neoplastic Process                                PYCARD      ALL   \n",
       "107 0.10  Neoplastic Process                                PYCARD      ALL   \n",
       "108 0.10  Neoplastic Process                                PYCARD      ALL   \n",
       "109 0.10  Neoplastic Process                                PYCARD      ALL   \n",
       "110 0.10  Neoplastic Process                                PYCARD      ALL   \n",
       "111 0.10  Neoplastic Process                                PYCARD      ALL   \n",
       "112 0.10  Neoplastic Process                                PYCARD      ALL   \n",
       "113 0.10  Neoplastic Process                                GGCT        ALL   \n",
       "â‹®   â‹®     â‹®                                                 â‹®           â‹®     \n",
       "639 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "643 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "646 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "650 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "651 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "653 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "654 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "655 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "656 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "657 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "658 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "659 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "660 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "664 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "665 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "666 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "667 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "669 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "670 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "673 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "674 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "675 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "676 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "677 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "679 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "681 0.01  Neoplastic Process                                GGCT        ALL   \n",
       "702 0.01  Neoplastic Process; Experimental Model of Disease SLAMF6      ALL   \n",
       "707 0.01  Neoplastic Process                                SLAMF6      ALL   \n",
       "708 0.01  Neoplastic Process                                SLAMF6      ALL   \n",
       "709 0.01  Neoplastic Process                                SLAMF6      ALL   \n",
       "    protein_class year_final\n",
       "8   DTO_05007624  2014      \n",
       "9                 2013      \n",
       "10  DTO_05007624  2014      \n",
       "11  DTO_05007624  2007      \n",
       "12  DTO_05007624  2016      \n",
       "13  DTO_05007624  2007      \n",
       "14  DTO_05007624  2017      \n",
       "16  DTO_05007624  2018      \n",
       "18  DTO_05007624  2006      \n",
       "19  DTO_05007624  2006      \n",
       "20  DTO_05007624  2006      \n",
       "21  DTO_05007624  2006      \n",
       "24                2008      \n",
       "26                2008      \n",
       "39  DTO_05007624  2006      \n",
       "41  DTO_05007624  2006      \n",
       "42  DTO_05007624  2006      \n",
       "43  DTO_05007624  2006      \n",
       "44  DTO_05007624  2006      \n",
       "45  DTO_05007624  2006      \n",
       "47  DTO_05007624  2016      \n",
       "50  DTO_05007624  2006      \n",
       "105 DTO_05007624  2019      \n",
       "107 DTO_05007624  2019      \n",
       "108 DTO_05007624  2019      \n",
       "109 DTO_05007624  2019      \n",
       "110 DTO_05007624  2019      \n",
       "111 DTO_05007624  2019      \n",
       "112 DTO_05007624  2019      \n",
       "113               2020      \n",
       "â‹®   â‹®             â‹®         \n",
       "639               2017      \n",
       "643               2007      \n",
       "646               1999      \n",
       "650               2019      \n",
       "651               2016      \n",
       "653               2015      \n",
       "654               2005      \n",
       "655               1996      \n",
       "656               1999      \n",
       "657               2015      \n",
       "658               2015      \n",
       "659               2003      \n",
       "660               2003      \n",
       "664               2019      \n",
       "665               1999      \n",
       "666               2017      \n",
       "667               2019      \n",
       "669               2015      \n",
       "670               2019      \n",
       "673               2019      \n",
       "674               2010      \n",
       "675               1993      \n",
       "676               2005      \n",
       "677               2007      \n",
       "679               2010      \n",
       "681               2019      \n",
       "702 DTO_05007624  2019      \n",
       "707 DTO_05007624  2019      \n",
       "708 DTO_05007624  2019      \n",
       "709 DTO_05007624  2018      "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "res3 = extract(gene2disease( gene = genesSG3, vocabulary = \"HGNC\",\n",
    "                     database = \"ALL\" , score =c(minScore, 1), warnings = F))\n",
    "nrow(res3)\n",
    "# filter disease_class_name on neoplasm (beign/malign), and optionally disease_name on melanoma, count\n",
    "wh =  grep(\"neoplasm\",res3$disease_class_name,ignore.case = T)\n",
    "res3 = res3[wh,]\n",
    "\n",
    "wh = grep(\"melanoma\",res3$disease_name, ignore.case = T)\n",
    "message(nrow(res3[wh,]), \" SG3 melanoma interaction:\") # 5 interactions, 3 genes: PYCARD GGCT SLAMF6\n",
    "cat(length(unique(res3$gene_symbol[wh])), \"genes:\", unique(res3$gene_symbol[wh]))\n",
    "res3[wh,]\n",
    "message(nrow(res3), \" SG3 neoplasm interaction:\")\n",
    "cat(length(unique(res3$gene_symbol)), \"genes:\", unique(res3$gene_symbol))\n",
    "res3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "7661ef05",
   "metadata": {},
   "outputs": [],
   "source": [
    "outfile = 'FiguresTables/Suppl-Table-S12-DisGeNET-analysis.xls'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "4be49cde",
   "metadata": {},
   "outputs": [],
   "source": [
    "write.xlsx(x = res1, file = outfile, sheetName = \"SG1 Higher\", row.names = F)\n",
    "write.xlsx(x = res3, file = outfile, sheetName = \"SG3 Slightly lower\", row.names = F, append=T)\n",
    "write.xlsx(x = res2, file = outfile, sheetName = \"SG2 Lower\", row.names = F, append=T)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "R",
   "language": "R",
   "name": "ir"
  },
  "language_info": {
   "codemirror_mode": "r",
   "file_extension": ".r",
   "mimetype": "text/x-r-source",
   "name": "R",
   "pygments_lexer": "r",
   "version": "4.2.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
